<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JSurg &#187; Surgery</title>
	<atom:link href="http://jsurg.com/blog/category/surgery/feed/" rel="self" type="application/rss+xml" />
	<link>http://jsurg.com</link>
	<description>{ JournAll of Surgery }</description>
	<lastBuildDate>Sat, 19 May 2012 18:31:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Evolution of general surgical problems in patients with left ventricular assist devices.</title>
		<link>http://jsurg.com/blog/evolution-of-general-surgical-problems-in-patients-with-left-ventricular-assist-devices/</link>
		<comments>http://jsurg.com/blog/evolution-of-general-surgical-problems-in-patients-with-left-ventricular-assist-devices/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:34 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Evolution of general surgical problems in patients with left ventricular assist devices.
        Surgery. 2012 May 8;
        Authors:  McKellar SH, Morris DS, Mauermann WJ, Park SJ, Zietlow SP
        Abstract
        BACKGROUND: Left ventr...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Evolution of general surgical problems in patients with left ventricular assist devices.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  McKellar SH, Morris DS, Mauermann WJ, Park SJ, Zietlow SP</p>
<p>Abstract<br/><br />
        BACKGROUND: Left ventricular assist devices (LVADs) are increasingly used to treat patients with end-stage heart failure. These patients may develop acute noncardiac surgical problems around the time of LVAD implantation or, as survival continues to improve, chronic surgical problems as ambulatory patients remote from the LVAD implant. Previous reports of noncardiac surgical problems in LVAD patients included patients with older, first-generation devices and do not address newer, second-generation devices. We describe the frequency and management of noncardiac surgical problems encountered during LVAD support with these newer-generation devices to assist noncardiac surgeons involved in the care of patients with LVADs. METHODS: We retrospectively reviewed the medical records of consecutive patients receiving LVADs at our institution. We collected data for any consultation by noncardiac surgeons within the scope of general surgery during LVAD support and subsequent treatment. RESULTS: Ninety-nine patients received implantable LVADs between 2003 and 2009 (first-generation, n = 19; second-generation, n = 80). Excluding intestinal hemorrhage, general surgical opinions were rendered for 34 patients with 49 problems, mostly in the acute recovery phase after LVAD implantation. Of those, 27 patients underwent 28 operations. Respiratory failure and intra-abdominal pathologies were the most common problems addressed, and LVAD rarely precluded operation. Patients with second-generation LVADs were more likely to survive hospitalization (P = .04) and develop chronic, rather than emergent, surgical problems. CONCLUSION: Patients with LVADs frequently require consultation from noncardiac surgeons within the scope of general surgeons and often require operation. Patients with second-generation LVADs are more likely to become outpatients and develop more elective surgical problems. Noncardiac surgeons will be increasingly involved in caring for patients with LVADs and should anticipate the problems unique to this patient population.<br/>
        </p>
<p>PMID: 22575878 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/evolution-of-general-surgical-problems-in-patients-with-left-ventricular-assist-devices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intraductal papillary mucinous neoplasm was associated with pancreatic carcinogenesis, but not with systemic carcinogenesis.</title>
		<link>http://jsurg.com/blog/intraductal-papillary-mucinous-neoplasm-was-associated-with-pancreatic-carcinogenesis-but-not-with-systemic-carcinogenesis/</link>
		<comments>http://jsurg.com/blog/intraductal-papillary-mucinous-neoplasm-was-associated-with-pancreatic-carcinogenesis-but-not-with-systemic-carcinogenesis/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:33 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Intraductal papillary mucinous neoplasm was associated with pancreatic carcinogenesis, but not with systemic carcinogenesis.
        Surgery. 2012 May 8;
        Authors:  Kawakubo K, Tada M, Koike K
        PMID: 22575879 [PubMed - as suppl...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Intraductal papillary mucinous neoplasm was associated with pancreatic carcinogenesis, but not with systemic carcinogenesis.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Kawakubo K, Tada M, Koike K</p>
<p>PMID: 22575879 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/intraductal-papillary-mucinous-neoplasm-was-associated-with-pancreatic-carcinogenesis-but-not-with-systemic-carcinogenesis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor.</title>
		<link>http://jsurg.com/blog/urokinase-requires-nadph-oxidase-to-transactivate-the-epidermal-growth-factor-receptor/</link>
		<comments>http://jsurg.com/blog/urokinase-requires-nadph-oxidase-to-transactivate-the-epidermal-growth-factor-receptor/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:32 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor.
        Surgery. 2012 May 8;
        Authors:  Duru EA, Fu Y, Davies MG
        Abstract
        BACKGROUND: Cell migration is an integral part of the ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Duru EA, Fu Y, Davies MG</p>
<p>Abstract<br/><br />
        BACKGROUND: Cell migration is an integral part of the development of intimal hyperplasia, and proteases are pivotal components in the process. Cell migration in response to urokinase is mediated through the aminoterminal fragment (ATF) of the protein. This study examines the role of NAD(P)H oxidase during epidermal growth factor receptor (EGFR) transactivation by ATF in human vascular smooth muscle cells (VSMC). METHODS: Human VSMCs were cultured in vitro. Linear wound and Boyden microchemotaxis assays of migration in response to ATF were performed in the presence and absence of NAD(P)H oxidase inhibitors (diphenyleneiodonium [DPI] and apocynin) and small interfering RNA (siRNA) to Nox1. Additional assays were performed to examine the upstream pathways that lead to NAD(P)H oxidase activity. Assays were also performed for EGFR activation. RESULTS: ATF produced concentration-dependent VSMC migration, which was inhibited by increasing concentrations of DPI and apocynin. ATF was shown to induce time-dependent EGFR phosphorylation, which peaked at 4-fold greater than control. This response was inhibited by DPI and apocynin in a concentration-dependent manner. ATF induced a concentration-dependent increase in intracellular oxygen free radical species, which was mitigated by the presence of DPI and apocynin. Inhibition of Gβγ by βARK(CT) reduced both NAD(P)H oxidase activity and EGFR activation. Inhibition of rac, which allows the NAD(P)H complex to assemble on the membrane, and inhibition of src, which induces assembly of the complex, both reduced ATF-dependent NAD(P)H oxidase activity and EGFR phosphorylation. siRNA to Nox1 prevented ATF-mediated EGFR activation and cell migration. CONCLUSION: ATF requires NAD(P)H oxidase activity through a Gβγ-, rac-, and src-mediated pathway to facilitate transactivation of EGFR and VSMC migration.<br/>
        </p>
<p>PMID: 22575880 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/urokinase-requires-nadph-oxidase-to-transactivate-the-epidermal-growth-factor-receptor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combination of total abdominal inferior vena cava resection with a novel technique of left renal outflow restoration.</title>
		<link>http://jsurg.com/blog/combination-of-total-abdominal-inferior-vena-cava-resection-with-a-novel-technique-of-left-renal-outflow-restoration/</link>
		<comments>http://jsurg.com/blog/combination-of-total-abdominal-inferior-vena-cava-resection-with-a-novel-technique-of-left-renal-outflow-restoration/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:31 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Combination of total abdominal inferior vena cava resection with a novel technique of left renal outflow restoration.
        Surgery. 2012 May 8;
        Authors:  Arkadopoulos N, Karmaniolou I, Ekonomopoulos N, Vassiliu P, Smyrniotis V
   ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Combination of total abdominal inferior vena cava resection with a novel technique of left renal outflow restoration.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Arkadopoulos N, Karmaniolou I, Ekonomopoulos N, Vassiliu P, Smyrniotis V</p>
<p>PMID: 22575881 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/combination-of-total-abdominal-inferior-vena-cava-resection-with-a-novel-technique-of-left-renal-outflow-restoration/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Traumatic fracture-dislocation of the lumbar spine.</title>
		<link>http://jsurg.com/blog/traumatic-fracture-dislocation-of-the-lumbar-spine/</link>
		<comments>http://jsurg.com/blog/traumatic-fracture-dislocation-of-the-lumbar-spine/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:30 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Traumatic fracture-dislocation of the lumbar spine.
        Surgery. 2012 May 8;
        Authors:  Tian NF, Mao FM, Xu HZ
        PMID: 22575882 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Traumatic fracture-dislocation of the lumbar spine.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Tian NF, Mao FM, Xu HZ</p>
<p>PMID: 22575882 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/traumatic-fracture-dislocation-of-the-lumbar-spine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The long-term behavior of lightweight and heavyweight meshes used to repair abdominal wall defects is determined by the host tissue repair process provoked by the mesh.</title>
		<link>http://jsurg.com/blog/the-long-term-behavior-of-lightweight-and-heavyweight-meshes-used-to-repair-abdominal-wall-defects-is-determined-by-the-host-tissue-repair-process-provoked-by-the-mesh/</link>
		<comments>http://jsurg.com/blog/the-long-term-behavior-of-lightweight-and-heavyweight-meshes-used-to-repair-abdominal-wall-defects-is-determined-by-the-host-tissue-repair-process-provoked-by-the-mesh/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:29 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The long-term behavior of lightweight and heavyweight meshes used to repair abdominal wall defects is determined by the host tissue repair process provoked by the mesh.
        Surgery. 2012 May 8;
        Authors:  Pascual G, Hernández-Gas...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The long-term behavior of lightweight and heavyweight meshes used to repair abdominal wall defects is determined by the host tissue repair process provoked by the mesh.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Pascual G, Hernández-Gascón B, Rodríguez M, Sotomayor S, Peña E, Calvo B, Bellón JM</p>
<p>Abstract<br/><br />
        BACKGROUND: Although heavyweight (HW) or lightweight (LW) polypropylene (PP) meshes are widely used for hernia repair, other alternatives have recently appeared. They have the same large-pore structure yet are composed of polytetrafluoroethylene (PTFE). This study compares the long-term (3 and 6 months) behavior of meshes of different pore size (HW compared with LW) and composition (PP compared with PTFE). METHODS: Partial defects were created in the lateral wall of the abdomen in New Zealand White rabbits and then repaired by the use of a HW or LW PP mesh or a new monofilament, large-pore PTFE mesh (Infinit). At 90 and 180 days after implantation, tissue incorporation, gene and protein expression of neocollagens (reverse transcription-polymerase chain reaction/immunofluorescence), macrophage response (immunohistochemistry), and biomechanical strength were determined. Shrinkage was measured at 90 days. RESULTS: All three meshes induced good host tissue ingrowth, yet the macrophage response was significantly greater in the PTFE implants (P &lt; .05). Collagen 1/3 mRNA levels failed to vary at 90 days yet in the longer term, the LW meshes showed the reduced genetic expression of both collagens (P &lt; .05) accompanied by increased neocollagen deposition, indicating more efficient mRNA translation. After 90-180 days of implant, tensile strengths and elastic modulus values were similar for all 3 implants (P &gt; .05). CONCLUSION: Host collagen deposition is mesh pore size dependent whereas the macrophage response induced is composition dependent with a greater response shown by PTFE. In the long term, macroporous meshes show comparable biomechanical behavior regardless of their pore size or composition.<br/>
        </p>
<p>PMID: 22575883 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-long-term-behavior-of-lightweight-and-heavyweight-meshes-used-to-repair-abdominal-wall-defects-is-determined-by-the-host-tissue-repair-process-provoked-by-the-mesh/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice.</title>
		<link>http://jsurg.com/blog/treatment-with-antithymocyte-globulin-ameliorates-intestinal-ischemia-and-reperfusion-injury-in-mice/</link>
		<comments>http://jsurg.com/blog/treatment-with-antithymocyte-globulin-ameliorates-intestinal-ischemia-and-reperfusion-injury-in-mice/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:27 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice.
        Surgery. 2012 May 8;
        Authors:  Watson MJ, Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW, Farmer DG
        Abstrac...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Watson MJ, Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW, Farmer DG</p>
<p>Abstract<br/><br />
        BACKGROUND: Antithymocyte therapy, specifically antithymocyte globulin (ATG; Thymoglobulin), is increasingly being used in organ transplantation to reduce allograft rejection. The T-lymphocyte has been purported to also play a role in ischemia and reperfusion injury (IRI); however, it has not been well studied. Our aim is to determine if ATG treatment impacts murine intestinal IRI. METHODS: Under anesthesia, male C57BL6 mice underwent 100 minutes of warm intestinal IRI by clamping the superior mesenteric artery. The treatment group received rabbit anti-murine ATG (10 mg/kg) intraperitoneally 6 hours before IRI. Separate survival and analysis groups were performed. Intestinal tissue was procured at 4 and 24 hours after IRI. Tissue analysis included hematoxylin-eosin staining, CD3, CD4, and CD8 immunostaining, myeloperoxidase assay (MPO), quantitative real-time polymerase chain reaction studies, and Western blot. RESULTS: ATG treatment led to marked improvement in 7-day survival and a reduction in tissue injury by histology. MPO was also reduced, and immunostaining confirmed a significant reduction in CD3(+), CD4(+), and CD8(+) infiltrating cells in the treatment group. Quantitative real-time polymerase chain reaction analysis revealed the decreased expression of tumor necrosis factor-α, interferon-inducible protein 10, monocyte chemotactic protein-1, interferon-γ, interleukin-2, and increased production of interleukins -13 and -10 in the treatment group. Western blot analysis revealed decreased caspase-3 and increased signal transducer and activator of transcription 6 levels in the ATG-treated group. CONCLUSION: This study is the first to show that ATG treatment ameliorates intestinal IRI. Treatment with ATG leads to reduced local infiltration by T-lymphocytes, with fewer inflammatory and chemotactic programs and less apoptosis. Treatment also is associated with a T(H)2-type cytokine switch. These novel findings suggest that T-lymphocytes represent important mediators of intestinal IRI and that ATG therapies may be beneficial in the prevention of IRI.<br/>
        </p>
<p>PMID: 22575884 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/treatment-with-antithymocyte-globulin-ameliorates-intestinal-ischemia-and-reperfusion-injury-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes.</title>
		<link>http://jsurg.com/blog/liver-epithelial-cells-proliferate-under-hypoxia-and-protect-the-liver-from-ischemic-injury-via-expression-of-hif-1-alpha-target-genes/</link>
		<comments>http://jsurg.com/blog/liver-epithelial-cells-proliferate-under-hypoxia-and-protect-the-liver-from-ischemic-injury-via-expression-of-hif-1-alpha-target-genes/#comments</comments>
		<pubDate>Sat, 19 May 2012 07:23:22 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes.
        Surgery. 2012 May 8;
        Authors:  Abe Y, Uchinami H, Kudoh K, Nakagawa Y, Ise N, Watanabe G,...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes.</b></p>
<p>Surgery. 2012 May 8;</p>
<p>Authors:  Abe Y, Uchinami H, Kudoh K, Nakagawa Y, Ise N, Watanabe G, Sato T, Seki E, Yamamoto Y</p>
<p>Abstract<br/><br />
        BACKGROUND: The remnant liver after extended liver resection is susceptible to ischemic injury, resulting in the failure of liver regeneration and liver dysfunction. The present study is aimed to investigate the protective role of the liver epithelial cells (LEC), a liver progenitor cell, on hepatocytes with ischemia in vitro and in vivo. METHODS: LECs were isolated from rats and cultured under hypoxic conditions (2% O(2)). The cell viability and intracellular ATP levels were measured. The activation of hypoxia-inducible factor-1α (HIF-1α) was assessed by immunofluorescence. The expression of pyruvate dehydrogenase kinase-1 (PDK-1), stromal cell-derived factor-1 (SDF-1), and chemokine receptor 4 (CXCR4) were measured. Hepatocytes were treated with SDF-1 or LEC-conditioned medium under hypoxia, and cell viability was assessed. Finally, hemorrhagic shock was induced in rats with in vivo induction of endogenous LECs, and liver damage was assessed. RESULTS: In LECs, but not in hepatocytes, cellular viability and intracellular ATP levels were maintained, and nuclear translocation of HIF-1α and expression of pyruvate dehydrogenase kinase-1 mRNA were increased under hypoxic culture conditions. LECs express SDF-1, and CXCR4 expression was increased in hepatocytes under hypoxia. The survival of hepatocytes under hypoxic condition was significantly increased after treatment with SDF-1 or LEC-conditioned medium. The protective effect of conditioned medium was impaired by CXCR4 antagonists. In vivo induction of endogenous LECs suppressed elevation of serum AST and ALT levels after hemorrhage shock and ischemia-reperfusion. CONCLUSION: LECs are resistant to hypoxia and have a protective role for hepatocytes against hypoxia. Our results suggest that induction of endogenous LECs protected the liver from lethal insults by paracrine signaling of SDF-1 and differentiation into parenchymal cells.<br/>
        </p>
<p>PMID: 22575885 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/liver-epithelial-cells-proliferate-under-hypoxia-and-protect-the-liver-from-ischemic-injury-via-expression-of-hif-1-alpha-target-genes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Critique of &quot;Evidence-Based Surgical Hypothesis: The case against BRCA1 and 2 testing&quot;.</title>
		<link>http://jsurg.com/blog/critique-of-evidence-based-surgical-hypothesis-the-case-against-brca1-and-2-testing/</link>
		<comments>http://jsurg.com/blog/critique-of-evidence-based-surgical-hypothesis-the-case-against-brca1-and-2-testing/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:47 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Critique of "Evidence-Based Surgical Hypothesis: The case against BRCA1 and 2 testing".
        Surgery. 2012 Apr;151(4):634-7
        Authors:  Nussbaum RL
        PMID: 22306835 [PubMed - indexed for MEDLINE]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Critique of &#8220;Evidence-Based Surgical Hypothesis: The case against BRCA1 and 2 testing&#8221;.</b></p>
<p>Surgery. 2012 Apr;151(4):634-7</p>
<p>Authors:  Nussbaum RL</p>
<p>PMID: 22306835 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/critique-of-evidence-based-surgical-hypothesis-the-case-against-brca1-and-2-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.</title>
		<link>http://jsurg.com/blog/a-critical-analysis-of-the-american-joint-committee-on-cancer-ajcc-staging-system-for-differentiated-thyroid-carcinoma-in-young-patients-on-the-basis-of-the-surveillance-epidemiology-and-end-resul/</link>
		<comments>http://jsurg.com/blog/a-critical-analysis-of-the-american-joint-committee-on-cancer-ajcc-staging-system-for-differentiated-thyroid-carcinoma-in-young-patients-on-the-basis-of-the-surveillance-epidemiology-and-end-resul/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:45 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.
        Surgery. 2012...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Tran Cao HS, Johnston LE, Chang DC, Bouvet M</p>
<p>Abstract<br/><br />
        BACKGROUND: Differentiated thyroid carcinomas (DTC) are the only tumors for which age is a determinant of stage in the American Joint Committee on Cancer&#8217;s (AJCC) staging protocol. In this study, we re-examined the relationship between age, extent of disease, and prognosis by using a large dataset with longer follow-up times. METHODS: We examined the Surveillance, Epidemiology, and End Results (SEER) registry data 1973 to 2005 for patients with DTC as their only known malignancy. We used Cox multivariate analyses to generate mortality hazard ratios, controlling for several variables, to evaluate the effects of age and disease extent. RESULTS: We identified 55,402 patients with DTC. Of these, 49,240 had sufficient data to generate a TNM stage on the basis of AJCC guidelines. Within stage II, younger patients (&lt;45 years) have worse outcomes than older patients (P &lt; .001). Younger patients had an 11-fold increase in mortality between stages I and II, whereas there was no difference for older patients. When we uniformly applied the 45-and-older staging protocol to all patients, we found that stages III-IVc had a significantly greater risk of mortality for all patients compared with stage I. CONCLUSION: The presence of regional and metastatic thyroid cancer bears prognostic significance for all ages. Under current AJCC guidelines, young patients with metastatic thyroid cancer may be understaged.<br/>
        </p>
<p>PMID: 22503316 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/a-critical-analysis-of-the-american-joint-committee-on-cancer-ajcc-staging-system-for-differentiated-thyroid-carcinoma-in-young-patients-on-the-basis-of-the-surveillance-epidemiology-and-end-resul/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.</title>
		<link>http://jsurg.com/blog/ki-67-predicts-disease-recurrence-and-poor-prognosis-in-pancreatic-neuroendocrine-neoplasms/</link>
		<comments>http://jsurg.com/blog/ki-67-predicts-disease-recurrence-and-poor-prognosis-in-pancreatic-neuroendocrine-neoplasms/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:44 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.
        Surgery. 2012 Apr 11;
        Authors:  Hamilton NA, Liu TC, Cavatiao A, Mawad K, Chen L, Strasberg SS, Linehan DC, Cao D, Hawkins WG
      ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Hamilton NA, Liu TC, Cavatiao A, Mawad K, Chen L, Strasberg SS, Linehan DC, Cao D, Hawkins WG</p>
<p>Abstract<br/><br />
        BACKGROUND: Pancreatic neuroendocrine neoplasms are rare malignancies for which the ideal staging method remains controversial. Ki-67 is a cell proliferation marker that has been shown to have some utility in predicting prognosis in neuroendocrine neoplasms. We sought to test the predictive ability of Ki-67 staining for disease recurrence and overall survival (OS) in pancreatic neuroendocrine neoplasms. METHODS: The medical records of patients who underwent pancreatic resection for pancreatic neuroendocrine neoplasms at a tertiary referral hospital from 1994 to 2009 were reviewed. The pathologic specimens of all were stained for Ki-67 and recorded as percentage of cells staining positive per high-powered field. The 10-year disease-free and OSs were analyzed. RESULTS: We identified 140 patients. Gender and age were not associated with increased risk of disease recurrence. Patients with tumors &gt;4 cm or with Ki-67 staining &gt;9% were more likely to have disease recurrence (P = .0454 and .047) and have decreased OS (P &lt; .0001 and .0007). CONCLUSION: Increasing tumor size and increasing Ki-67 staining both correlate with increased risk of disease recurrence and decreased OS. Designing a staging system that incorporates both of these clinical variables will enable better identification of patients at risk for recurrent pancreatic neuroendocrine neoplasms.<br/>
        </p>
<p>PMID: 22503317 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/ki-67-predicts-disease-recurrence-and-poor-prognosis-in-pancreatic-neuroendocrine-neoplasms/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.</title>
		<link>http://jsurg.com/blog/delivery-of-interferon-alpha-using-a-novel-cox2-controlled-adenovirus-for-pancreatic-cancer-therapy/</link>
		<comments>http://jsurg.com/blog/delivery-of-interferon-alpha-using-a-novel-cox2-controlled-adenovirus-for-pancreatic-cancer-therapy/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:43 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.
        Surgery. 2012 Apr 11;
        Authors:  Armstrong L, Davydova J, Brown E, Han J, Yamamoto M, Vickers SM
        Abstract
        BAC...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Armstrong L, Davydova J, Brown E, Han J, Yamamoto M, Vickers SM</p>
<p>Abstract<br/><br />
        BACKGROUND: Combination therapy with interferon alpha (IFN) is correlated with improved survival in patients with pancreatic ductal adenocarcinoma (PDAc) but frequently presents side effects. We designed a novel targeted adenovirus with replication restricted to cyclooxygenase 2 (Cox2)-overexpressing PDAcs and hypothesize that the locally delivered therapeutic gene IFN can augment oncolytic effects while minimizing systemic toxicity. METHODS: IFN-expressing vectors were tested in vitro with the use of 4 PDAc cell lines with cytocidal effect measured by crystal violet and colorimetrically and IFN production assayed by ELISA. Cox2 promoter activity was checked by a luciferase reporter assay. In vivo, subcutaneous tumor xenografts with 2 PDAc cell lines in nude mice were treated with a single intratumoral viral dose. RESULTS: All PDAc cell lines were Cox2-positive. Oncolysis from the novel Cox2-controlled virus was comparable or superior to Adwt, the wild-type virus without safety features. The absence of cytocidal effect in Cox2-negative cells with the novel virus indicated cancer specificity. In vivo, stronger tumor suppression from the novel virus was seen when compared with nonreplicating IFN-expressing vectors. CONCLUSION: We demonstrated the potent therapeutic effects of a novel tumor-specific conditionally replicative IFN-expressing adenovirus. With potential to locally deliver IFN and avoid systemic toxicity, this strategy may therefore expand the application of this robust and promising therapy.<br/>
        </p>
<p>PMID: 22503318 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/delivery-of-interferon-alpha-using-a-novel-cox2-controlled-adenovirus-for-pancreatic-cancer-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system.</title>
		<link>http://jsurg.com/blog/prevalence-of-alcohol-misuse-among-men-and-women-undergoing-major-noncardiac-surgery-in-the-veterans-affairs-health-care-system/</link>
		<comments>http://jsurg.com/blog/prevalence-of-alcohol-misuse-among-men-and-women-undergoing-major-noncardiac-surgery-in-the-veterans-affairs-health-care-system/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:42 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system.
        Surgery. 2012 Apr 11;
        Authors:  Bradley KA, Rubinsky AD, Sun H, Blough DK, Tønnesen H, Hughes G...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Bradley KA, Rubinsky AD, Sun H, Blough DK, Tønnesen H, Hughes G, Beste LA, Bishop MJ, Hawn MT, Maynard C, Harris AS, Hawkins EJ, Bryson CL, Houston TK, Henderson WG, Kivlahan DR</p>
<p>Abstract<br/><br />
        BACKGROUND: Patients who screen positive for alcohol misuse on the Alcohol Use Disorder Identification Test Consumption Questionnaire (AUDIT-C ≥5 points) have significantly increased postoperative complications. Severe alcohol misuse (AUDIT-C ≥9 points) is associated with increased postoperative health care use; however, little is known about the prevalence of alcohol misuse in demographic and clinical subgroups of surgical patients. METHODS: The prevalence of alcohol misuse was evaluated among 10,284 patients (9,771 men and 513 women) who underwent major noncardiac surgery in Veterans Affairs (VA) hospitals during the fiscal years 2004 to 2006 and completed the AUDIT-C. Sex-stratified analyses evaluated prevalence rates of alcohol misuse (AUDIT-C ≥5) and severe misuse (AUDIT-C ≥9) across demographic and clinical subgroups. RESULTS: Overall, 1,607 (16%) men and 24 (5%) women screened positive for alcohol misuse (AUDIT-C ≥5) in the year before operation, with 4% and 2% screening positive for severe misuse (AUDIT-C ≥9), respectively. Alcohol misuse was more common among men who were &lt;60 years of age, divorced or separated, current smokers, or American Stoke Association class 1 or 2, and those with cirrhosis/hepatitis or substance use disorders. Among patients with alcohol misuse, 36% of men and 58% of women were American Society of Anesthesiologists class 1 or 2, and most did not have diagnoses that were commonly associated with alcohol misuse. CONCLUSION: Alcohol misuse is relatively common in male surgical patients. Moreover, surgical patients undergoing operation who screen positive for alcohol misuse are often relatively healthy, without health problems that might alert providers to their alcohol misuse in the absence of screening.<br/>
        </p>
<p>PMID: 22503319 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/prevalence-of-alcohol-misuse-among-men-and-women-undergoing-major-noncardiac-surgery-in-the-veterans-affairs-health-care-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study.</title>
		<link>http://jsurg.com/blog/safety-and-feasibility-of-using-low-dose-perioperative-intravenous-steroids-in-inflammatory-bowel-disease-patients-undergoing-major-colorectal-surgery-a-pilot-study/</link>
		<comments>http://jsurg.com/blog/safety-and-feasibility-of-using-low-dose-perioperative-intravenous-steroids-in-inflammatory-bowel-disease-patients-undergoing-major-colorectal-surgery-a-pilot-study/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:41 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study.
        Surgery. 2012 Apr 11;
        Authors:  Zaghiyan K, Melmed G, Murr...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Zaghiyan K, Melmed G, Murrell Z, Fleshner P</p>
<p>Abstract<br/><br />
        BACKGROUND: High-dose perioperative corticosteroids are the standard of care for steroid-treated patients undergoing surgery. There is little evidence, however, to support this practice. We investigated the safety of perioperative low-dose steroids in patients with inflammatory bowel disease (IBD) undergoing major colorectal surgery. METHODS: Steroid-treated IBD patients undergoing major colorectal surgery were treated with the intravenous equivalent of their preoperative steroid dose in the perioperative period. Patients who were not taking steroids at the time of operation but who were treated with steroids within 1 year of surgery received no perioperative corticosteroids. Perioperative vital signs were analyzed. Hemodynamic instability was defined as heart rate &gt;120 beats per minute, heart rate &lt;60 beats per minute, or systolic blood pressure &lt;90 mm Hg. RESULTS: Thirty-two procedures were performed on 10 patients on steroids at the time of operation and 22 patients had who stopped steroids within 1 year of surgery. Five patients (16%) developed tachycardia and 8 patients (25%) had bradycardia. Hypotension occurred in 5 (16%) patients. All cases of hemodynamic instability resolved with no intervention, fluid boluses, or blood transfusion. No patients required vasopressors or high-dose corticosteroids for adrenal insufficiency. CONCLUSION: In steroid-treated IBD patients undergoing major colorectal surgery, the use of low-dose perioperative corticosteroids seems safe. A prospective study assessing perioperative corticosteroid dosing is in progress.<br/>
        </p>
<p>PMID: 22503320 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/safety-and-feasibility-of-using-low-dose-perioperative-intravenous-steroids-in-inflammatory-bowel-disease-patients-undergoing-major-colorectal-surgery-a-pilot-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Safety skills training for surgeons: A half-day intervention improves knowledge, attitudes and awareness of patient safety.</title>
		<link>http://jsurg.com/blog/safety-skills-training-for-surgeons-a%c2%a0half-day-intervention-improves-knowledge-attitudes-and-awareness-of-patient-safety/</link>
		<comments>http://jsurg.com/blog/safety-skills-training-for-surgeons-a%c2%a0half-day-intervention-improves-knowledge-attitudes-and-awareness-of-patient-safety/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:40 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Safety skills training for surgeons: A half-day intervention improves knowledge, attitudes and awareness of patient safety.
        Surgery. 2012 Apr 11;
        Authors:  Arora S, Sevdalis N, Ahmed M, Wong H, Moorthy K, Vincent C
        A...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Safety skills training for surgeons: A half-day intervention improves knowledge, attitudes and awareness of patient safety.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Arora S, Sevdalis N, Ahmed M, Wong H, Moorthy K, Vincent C</p>
<p>Abstract<br/><br />
        BACKGROUND: Education and training of health care professionals is necessary to achieve sustainable improvements in patient safety. Despite its inherently risky nature, little training specifically in safety has been conducted in the surgical disciplines. In this study we explored the effects of a safety skills training program on surgical residents&#8217; knowledge, attitudes, and awareness of patient safety. METHODS: A half-day training program incorporating safety awareness, analysis, and improvement skills was delivered to surgical residents from 19 hospitals in London, United Kingdom. Participants were assessed in terms of safety knowledge (MCQs) and attitudes to safety (validated questionnaire; scale 1 to 5) before and after training. To determine long-term effects, 6 months after training participants identified and reported on observed safety events in their own workplace by using an observational form for data collection. RESULTS: A total of 27 surgeons participated in the training program. Knowledge of safety significantly improved after the course (mean pre = 45.26% vs mean post = 70.59%, P &lt; .01) as did attitudes to error analysis and improving safety (mean pre 3.50 vs mean post 3.97, P &lt; .001) and ability to influence safety (mean pre 3.22 vs mean post 3.49, P &lt; .01). After the course, participants reported richer, detailed sets of observations demonstrating enhanced understanding, recognition, and analysis of patient safety issues in their workplace. CONCLUSION: Safety skills training with positive educational outcomes can be delivered in a half day. Such a course may allow patient safety to be integrated into any curriculum, thereby training the next generation of the healthcare workforce to maintain the safety momentum.<br/>
        </p>
<p>PMID: 22503321 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/safety-skills-training-for-surgeons-a%c2%a0half-day-intervention-improves-knowledge-attitudes-and-awareness-of-patient-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Surgical resident participation in laparoscopic Roux-en-Y bypass: Is it safe?</title>
		<link>http://jsurg.com/blog/surgical-resident-participation-in-laparoscopic-roux-en-y-bypass-is-it-safe/</link>
		<comments>http://jsurg.com/blog/surgical-resident-participation-in-laparoscopic-roux-en-y-bypass-is-it-safe/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:39 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Surgical resident participation in laparoscopic Roux-en-Y bypass: Is it safe?
        Surgery. 2012 Apr 11;
        Authors:  Fanous M, Carlin A
        Abstract
        BACKGROUND: The majority of bariatric surgeons use dedicated surgical a...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Surgical resident participation in laparoscopic Roux-en-Y bypass: Is it safe?</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Fanous M, Carlin A</p>
<p>Abstract<br/><br />
        BACKGROUND: The majority of bariatric surgeons use dedicated surgical assistants when performing laparoscopic Roux-en-Y gastric bypass (LGBP) because of the technical difficulty and steep learning curve involved in the operation. At our institution, either a senior surgical resident (SSR) or a physician assistant (PA) participates in LGBP cases. The PA&#8217;s role is confined to assisting, whereas the SSR progressively acts as the operating surgeon. We were interested in evaluating patient outcomes to determine whether any differences existed between the LGBP operations in which either the PA or the SSR participated. METHODS: All patients undergoing LGBP between January 2007 and December 2009 in our prospectively collected bariatric database were reviewed. Demographics, baseline measures, intraoperative parameters, and outcomes were compared. RESULTS: A total of 711 patients were identified. The group involving PAs included 343 patients, and the group involving SSRs included 368 patients. Preoperative comorbidities, including diabetes, hypertension, coronary artery disease, asthma, sleep apnea, hyperlipidemia, musculoskeletal disability, and depression, were similar in both groups. Personal histories of venous thromboembolism were higher in the PA group (5.1% vs 2.5%; P = .075). The mean body-mass indexes (BMI) (53 ± 9 vs 51 ± 8 kg/m(2); P = .006) and weights (323 ± 67 vs 306 ± 59 lbs; P &lt; .001) in the PA group were significantly higher than in the SSR group. The proportion of males was higher in the PA group (24% vs 16%; P = .008). The operative time was significantly shorter in the PA group (121 ± 36 vs 164 ± 30 minutes; P &lt; .001). There was no significant difference between the groups in intraoperative complications, length of hospital stay, 30-day complications, or reoperations within 1 year. There were no mortalities in either group. The 1-year percent excess weight loss (64% vs 66%) was similar in the PA and SSR groups, respectively. CONCLUSION: SSR participation in LGBP prolongs operative time but does not increase complications, mortality rates, or length of stay. Therefore, SSR participation in LGBP is safe and produces outcomes comparable to those performed with PAs.<br/>
        </p>
<p>PMID: 22503322 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/surgical-resident-participation-in-laparoscopic-roux-en-y-bypass-is-it-safe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting.</title>
		<link>http://jsurg.com/blog/previous-percutaneous-coronary-intervention-increases-morbidity-after-coronary-artery-bypass-grafting/</link>
		<comments>http://jsurg.com/blog/previous-percutaneous-coronary-intervention-increases-morbidity-after-coronary-artery-bypass-grafting/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:37 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting.
        Surgery. 2012 Apr 11;
        Authors:  Mehta GS, Lapar DJ, Bhamidipati CM, Kern JA, Kron IL, Upchurch GR, Ailawadi G
        Abst...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting.</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Mehta GS, Lapar DJ, Bhamidipati CM, Kern JA, Kron IL, Upchurch GR, Ailawadi G</p>
<p>Abstract<br/><br />
        BACKGROUND: We hypothesized that the incidence of previous percutaneous coronary intervention (PCI) is increasing and that prior PCI influences patient morbidity and mortality after coronary artery bypass grafting (CABG). METHODS: A total of 34,316 patients underwent isolated CABG operations at 16 different statewide, institutions from 2001 to 2008. Patients were stratified into prior PCI (n = 4346; 12.7%) and no prior PCI (n = 29,970). Patient risk factors, intraoperative variables, and outcomes were compared by univariate and multivariate analyses. RESULTS: The incidence of prior PCI in CABG has risen from &lt;1% to 22.0% from 2001 to 2008 (P &lt; .001). Prior PCI patients were younger (P &lt; .001) and more commonly had previous myocardial infarction (P &lt; .001), but less commonly had heart failure (P &lt; .001). The operative mortality was similar between groups (2.3% vs 1.9%; P = .13). Prior PCI patients had more major complications (15.0% vs 12.0%; P &lt; .001), longer hospitalization (P = .01), and higher readmission rates (P = .01). Importantly, by multivariate analyses, prior PCI was not associated with mortality, but was an independent predictor of major complications after CABG (odds ratio, 1.15; P = .01). CONCLUSION: The incidence of prior PCI in patients undergoing CABG is increasing. Previous PCI is associated with a higher risk of major complications, greater hospital length of stay, and higher readmission rates after CABG.<br/>
        </p>
<p>PMID: 22503323 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/previous-percutaneous-coronary-intervention-increases-morbidity-after-coronary-artery-bypass-grafting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laparoscopic cholecystectomy: What is the price of conversion?</title>
		<link>http://jsurg.com/blog/laparoscopic-cholecystectomy-what-is-the-price-of-conversion/</link>
		<comments>http://jsurg.com/blog/laparoscopic-cholecystectomy-what-is-the-price-of-conversion/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:36 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Laparoscopic cholecystectomy: What is the price of conversion?
        Surgery. 2012 Apr 11;
        Authors:  Lengyel BI, Panizales MT, Steinberg J, Ashley SW, Tavakkoli A
        Abstract
        BACKGROUND: Laparoscopic cholecystectomy (L...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Laparoscopic cholecystectomy: What is the price of conversion?</b></p>
<p>Surgery. 2012 Apr 11;</p>
<p>Authors:  Lengyel BI, Panizales MT, Steinberg J, Ashley SW, Tavakkoli A</p>
<p>Abstract<br/><br />
        BACKGROUND: Laparoscopic cholecystectomy (LC) is the gold standard procedure for gallbladder removal. Conversion to an open procedure is sometimes deemed necessary, especially in complex cases in which a prolonged laparoscopic operative time is anticipated. A prolonged LC case is thought to be associated with increased complications and cost and therefore generally discouraged. The purpose of this study was to test this assumption, and compare outcomes and cost of converted and prolonged LC cases. METHODS: By using institutional National Surgical Quality Improvement Program and financial databases, we retrospectively reviewed and compared prolonged laparoscopic cases (Long-LC) with converted (CONV) procedures. Surgical times, length of stay (LOS), 30-day complications, operative room, and total hospital charges were compared between the 2 groups. RESULTS: A total of 101 Long-LC and 66 CONV cases met our inclusion criteria. Long-LC cases were 19 minutes longer than CONV cases (123 vs 104 min; P &lt; .01). No differences in postoperative complications were found between the 2 groups (P &gt; .05). When Poisson regression was used, we found that LOS was significantly shorter in the Long-LC compared with CONV group (1 day vs 4 days; P &lt; .01). Long-LC cases had greater operative charges ($15,278 vs $13,128; P &lt; .01). However, hospital charges for Long-LC cases were 26% less than for CONV cases ($23,946 vs $32,446; P &lt; .01). CONCLUSION: Conversion is associated with a 3-day increase in LOS. Long-LC cases have greater operative room charges, but overall hospital charges were 26% less than CONV cases. Our data suggest that decision making regarding conversion should focus on safety and not time considerations.<br/>
        </p>
<p>PMID: 22503324 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/laparoscopic-cholecystectomy-what-is-the-price-of-conversion/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial.</title>
		<link>http://jsurg.com/blog/impact-of-perioperative-administration-of-synbiotics-in-patients-with-esophageal-cancer-undergoing-esophagectomy-a-prospective-randomized-controlled-trial/</link>
		<comments>http://jsurg.com/blog/impact-of-perioperative-administration-of-synbiotics-in-patients-with-esophageal-cancer-undergoing-esophagectomy-a-prospective-randomized-controlled-trial/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:34 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial.
        Surgery. 2012 Apr 12;
        Authors:  Tanaka K, Yano M, Motoori M, Kishi K...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial.</b></p>
<p>Surgery. 2012 Apr 12;</p>
<p>Authors:  Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Asahara T, Nomoto K, Ishikawa O</p>
<p>Abstract<br/><br />
        BACKGROUND: The clinical value of synbiotics in patients undergoing esophagectomy remains unclear. This study investigated the effects of synbiotics on intestinal microflora and surgical outcomes in a clinical setting. METHODS: We studied 70 patients with esophageal cancer who were scheduled to undergo esophagectomy. They were randomly allocated to 2 groups: 1 group received synbiotics before and after surgery, and the other did not. Fecal microflora and organic acid concentrations were determined. Postoperative infections, abdominal symptoms, and duration of systemic inflammatory response syndrome (SIRS) were recorded. RESULTS: Of the patients, 64 completed the trial (synbiotics, 30; control, 34). The counts of beneficial bacteria and harmful bacteria in the group given synbiotics were significantly larger and smaller, respectively, than those in the control group on postoperative day (POD) 7. The concentrations of total organic acid and acetic acid were higher in the synbiotics group than in the control group (P &lt; .01), and the intestinal pH in the synbiotics group was lower than that in the control (P &lt; .05) on POD 7. The rate of infections was 10% in the synbiotics group and 29.4% in the control group (P = .0676). The duration of SIRS in the synbiotics group was shorter than in the control group (P = .0057). The incidence of interruption or reduction of enteral nutrition by abdominal symptoms was 6.7% in the synbiotics group and 29.4% in the control group (P = .0259). CONCLUSION: Perioperative administration of synbiotics in patients with esophagectomy is useful because they suppress excessive inflammatory response and relieve uncomfortable abdominal symptoms through the adjustment of the intestinal microfloral environment.<br/>
        </p>
<p>PMID: 22503510 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/impact-of-perioperative-administration-of-synbiotics-in-patients-with-esophageal-cancer-undergoing-esophagectomy-a-prospective-randomized-controlled-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Development and evaluation of a decision-based simulation for assessment of team skills.</title>
		<link>http://jsurg.com/blog/development-and-evaluation-of-a-decision-based-simulation-for-assessment-of-team-skills/</link>
		<comments>http://jsurg.com/blog/development-and-evaluation-of-a-decision-based-simulation-for-assessment-of-team-skills/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:33 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Development and evaluation of a decision-based simulation for assessment of team skills.
        Surgery. 2012 Apr 12;
        Authors:  Andrew B, Plachta S, Salud L, Pugh CM
        Abstract
        BACKGROUND: There is a need to train and ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Development and evaluation of a decision-based simulation for assessment of team skills.</b></p>
<p>Surgery. 2012 Apr 12;</p>
<p>Authors:  Andrew B, Plachta S, Salud L, Pugh CM</p>
<p>Abstract<br/><br />
        BACKGROUND: There is a need to train and evaluate a wide variety of nontechnical surgical skills. The goal of this project was to develop and evaluate a decision-based simulation to assess team skills. METHODS: The decision-based exercise used our previously validated Laparoscopic Ventral Hernia simulator and a newly developed team evaluation survey. Five teams of 3 surgical residents (N = 15) were tasked with repairing a 10 × 10-cm right upper quadrant hernia. During the simulation, independent observers (N = 6) completed a 6-item survey assessing: (1) work quality; (2) communication; and (3) team effectiveness. After the simulation, team members self-rated their performance by using the same survey. RESULTS: Survey reliability revealed a Cronbach&#8217;s alpha of r = .811. Significant differences were found when we compared team members&#8217; (T) and observers&#8217; (O) ratings for communication (T = 4.33/5.00 vs O = 3.00/5.00, P &lt; .01) and work quality (T = 4.33/5.00 vs O = 3.33/5.00, P &lt; .05). The team with the greatest survey ratings was the only group to successfully complete the task. CONCLUSION: The team evaluation survey had good reliability and correlated with task performance on the simulator. Our current and previous work provides strong evidence that nontechnical and team related skills can be assessed without simulating a crisis situation.<br/>
        </p>
<p>PMID: 22503511 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/development-and-evaluation-of-a-decision-based-simulation-for-assessment-of-team-skills/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options.</title>
		<link>http://jsurg.com/blog/is-subtotal-thyroidectomy-a-cost-effective-treatment-for-graves-disease-a-cost-effectiveness-analysis-of-the-medical-and-surgical-treatment-options/</link>
		<comments>http://jsurg.com/blog/is-subtotal-thyroidectomy-a-cost-effective-treatment-for-graves-disease-a-cost-effectiveness-analysis-of-the-medical-and-surgical-treatment-options/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:31 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options.
        Surgery. 2012 Apr 12;
        Authors:  Zanocco K, Heller M, Elaraj D, Sturgeon C
 ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options.</b></p>
<p>Surgery. 2012 Apr 12;</p>
<p>Authors:  Zanocco K, Heller M, Elaraj D, Sturgeon C</p>
<p>Abstract<br/><br />
        BACKGROUND: The 3 treatment options for Graves disease (GD) are antithyroid drugs (ATDs), radioactive iodine (RAI), and thyroid surgery. We hypothesized that thyroid surgery is cost-effective for Graves disease when compared to RAI or ATD. METHODS: Cost-effectiveness analysis was performed to compare operative strategies to medical treatment strategies for GD. The decision model, based on a reference case, included treatment outcomes, probabilities, and costs derived from literature review. Outcomes were weighted using quality of life utility factors, yielding quality-adjusted life years (QALYs). The uncertainty of costs, probabilities, and utility estimates in the model were examined by univariate and multivariate sensitivity analysis and Monte Carlo simulation. RESULTS: The subtotal thyroidectomy strategy produced the greatest QALYs, 25.783, with an incremental cost-effectiveness ratio of $26,602 per QALY, reflecting a gain of 0.091 QALYs at an additional cost of $2416 compared to RAI. Surgery was cost-effective when the initial postoperative euthyroid rate was greater than 49.5% and the total cost was less than $7391. Monte Carlo simulation showed the subtotal thyroidectomy strategy to be optimal in 826 of 1000 cases. CONCLUSION: This study demonstrates that subtotal thyroidectomy can be a cost-effective treatment for GD. However, a 49.5% initial postoperative euthyroid rate was a necessary condition for cost-effective surgical management of GD.<br/>
        </p>
<p>PMID: 22503512 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/is-subtotal-thyroidectomy-a-cost-effective-treatment-for-graves-disease-a-cost-effectiveness-analysis-of-the-medical-and-surgical-treatment-options/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.</title>
		<link>http://jsurg.com/blog/peroxisome-proliferator-activated-receptor-%ce%b2%ce%b4-agonist-gw0742-ameliorates-cerulein-and-taurocholate-induced-acute-pancreatitis-in-mice/</link>
		<comments>http://jsurg.com/blog/peroxisome-proliferator-activated-receptor-%ce%b2%ce%b4-agonist-gw0742-ameliorates-cerulein-and-taurocholate-induced-acute-pancreatitis-in-mice/#comments</comments>
		<pubDate>Sat, 12 May 2012 06:42:24 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
        Surgery. 2012 Apr 20;
        Authors:  Paterniti I, Mazzon E, Riccardi L, Galuppo M, Impelliz...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.</b></p>
<p>Surgery. 2012 Apr 20;</p>
<p>Authors:  Paterniti I, Mazzon E, Riccardi L, Galuppo M, Impellizzeri D, Esposito E, Bramanti P, Cappellani A, Cuzzocrea S</p>
<p>Abstract<br/><br />
        BACKGROUND: Peroxisome proliferator-activated receptors (PPARs) are ligand activated transcription factors belonging to the nuclear receptor superfamily. PPARs activation has a profound impact on the local immune response with consequences affecting the progression of chronic inflammatory diseases. Relatively little is known on the role of PPAR-β/δ in the regulation of inflammatory responses. The aim of the present study was to evaluate the influence of PPAR-β/δ receptor in a model of edematous pancreatitis induced in mice by administration of cerulein at supramaximal doses, as well as in necrohemorrhagic model induced by intraductal administration of sodium taurocholate (STC). MEASUREMENTS: Mice were treated with cerulein (50 μg/kg) or STC (5%). GW0742 (0.3 mg/kg) was intraperitoneally administered 1 and 6 hours after cerulein injection or was injected 2 hours before STC infusion. The pancreas and exopancreatic organs were carefully removed for microscopic examination. Pancreatic weight, serum amylase, lipase, tumor necrosis factor-α and interleukin-1β levels, as well as cytokines, adhesion molecules, nitrotyrosine, poly (ADP-ribose), inducible nitric oxide, FAS ligand, Bax, Bcl-2 expression by immunohistochemistry, and myeloperoxidase activity of the pancreas were assayed. Moreover, the involvement of nuclear factor-κB pathway was investigated by Western blot analysis. RESULTS: Intraperitoneal injection of cerulein in mice resulted in severe, acute pancreatitis characterized by edema, neutrophil infiltration and apoptosis, and elevated serum levels of amylase and lipase. Taurocholate challenge caused a clear increase in serum amylase, neutrophil infiltration, and tissue damage in the pancreas. Tissue and inflammatory changes in the pancreata were significantly less in GW0742 group than in cerulein or STC groups. In addition, the pancreatic water content was reduced in mice treated with PPAR-β/δ agonist. In the mild pancreatitis, GW0742 was also able to decrease the expression of proinflammatory cytokines and enzymes, as well as of proteins involved in apoptosis and nuclear factor-Kappa B pathway. CONCLUSION: GW0742 attenuated pancreatic damage in 2 different experimental models of pancreatitis in mice.<br/>
        </p>
<p>PMID: 22521259 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/peroxisome-proliferator-activated-receptor-%ce%b2%ce%b4-agonist-gw0742-ameliorates-cerulein-and-taurocholate-induced-acute-pancreatitis-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The tragedy of the commons.</title>
		<link>http://jsurg.com/blog/the-tragedy-of-the-commons/</link>
		<comments>http://jsurg.com/blog/the-tragedy-of-the-commons/#comments</comments>
		<pubDate>Sun, 15 Apr 2012 05:49:15 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The tragedy of the commons.
        Surgery. 2012 Mar;151(3):490-1
        Authors:  Tsai MH, McFadden DW
        PMID: 22329963 [PubMed - indexed for MEDLINE]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The tragedy of the commons.</b></p>
<p>Surgery. 2012 Mar;151(3):490-1</p>
<p>Authors:  Tsai MH, McFadden DW</p>
<p>PMID: 22329963 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-tragedy-of-the-commons/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Feasibility of the practice guidelines for colonic diverticulitis.</title>
		<link>http://jsurg.com/blog/feasibility-of-the-practice-guidelines-for-colonic-diverticulitis/</link>
		<comments>http://jsurg.com/blog/feasibility-of-the-practice-guidelines-for-colonic-diverticulitis/#comments</comments>
		<pubDate>Sun, 15 Apr 2012 05:49:14 +0000</pubDate>
		<dc:creator>Fujita T</dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Feasibility of the practice guidelines for colonic diverticulitis.
        Surgery. 2012 Mar;151(3):491-2
        Authors:  Fujita T
        PMID: 22329964 [PubMed - indexed for MEDLINE]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Feasibility of the practice guidelines for colonic diverticulitis.</b></p>
<p>Surgery. 2012 Mar;151(3):491-2</p>
<p>Authors:  Fujita T</p>
<p>PMID: 22329964 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/feasibility-of-the-practice-guidelines-for-colonic-diverticulitis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endoscopic adrenalectomy in large adrenal tumors.</title>
		<link>http://jsurg.com/blog/endoscopic-adrenalectomy-in-large-adrenal-tumors/</link>
		<comments>http://jsurg.com/blog/endoscopic-adrenalectomy-in-large-adrenal-tumors/#comments</comments>
		<pubDate>Sun, 15 Apr 2012 05:49:11 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Endoscopic adrenalectomy in large adrenal tumors.
        Surgery. 2012 Apr 6;
        Authors:  Asari R, Koperek O, Niederle B
        Abstract
        BACKGROUND: The purpose of this study was to evaluate the frequency of malignancy, oncol...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Endoscopic adrenalectomy in large adrenal tumors.</b></p>
<p>Surgery. 2012 Apr 6;</p>
<p>Authors:  Asari R, Koperek O, Niederle B</p>
<p>Abstract<br/><br />
        BACKGROUND: The purpose of this study was to evaluate the frequency of malignancy, oncologic outcome and perioperative morbidity between small (≤60 mm) and large (&gt;60 mm) adrenal tumors treated by endoscopic adrenalectomy (EA). METHODS: EA was performed in 289 consecutive patients with a mean follow-up of 87.7 ± 45.1 months. Patients were divided in those with tumor size ≤60 mm (group 1; n = 252) and &gt;60 mm (group 2; n = 37). Data on patient&#8217;s age, gender, hormone function, tumor side, operation time, postoperative complications, conversion to open approach, and rate of malignancy were analyzed. Furthermore, disease-free survival in malignant tumors was estimated and compared between both groups. RESULTS: Patient age (P = .43), gender (P = .09), tumor side (P = .17), and operative time (P = .33) showed no difference in both groups. Functioning tumors were observed in 85% of patients in group 1 compared with 46% in group 2 (P = .0001). Seven (2.8%) patients in group 1 and 7 (18.9%) in group 2 had malignant tumors (P = .0001). Neither rate of conversion (P = .71) and postoperative complication (P = .27) nor recurrence of malignancy (P = .48) differed between both groups. Estimated disease-free survival after 5 years in malignant lesions was 87.5 ± 11.7% for group 1 and 62.5 ± 21.3% for group 2 (P = .49). CONCLUSION: EA is a safe and feasible procedure in the majority of large adrenal tumors. Tumor size does not affect the outcome of surgery. In case of malignancy, it does not increase the rate of local recurrence. In experienced hands, tumor size should not influence the decision of surgical access (endoscopic versus open).<br/>
        </p>
<p>PMID: 22483579 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/endoscopic-adrenalectomy-in-large-adrenal-tumors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Superior mesenteric artery syndrome.</title>
		<link>http://jsurg.com/blog/superior-mesenteric-artery-syndrome/</link>
		<comments>http://jsurg.com/blog/superior-mesenteric-artery-syndrome/#comments</comments>
		<pubDate>Sun, 15 Apr 2012 05:49:07 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Superior mesenteric artery syndrome.
        Surgery. 2012 Apr 6;
        Authors:  Agrawal S, Patel H
        PMID: 22483580 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Superior mesenteric artery syndrome.</b></p>
<p>Surgery. 2012 Apr 6;</p>
<p>Authors:  Agrawal S, Patel H</p>
<p>PMID: 22483580 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/superior-mesenteric-artery-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Image-enhanced laparoscopy: a promising technology for detection of peritoneal micrometastases.</title>
		<link>http://jsurg.com/blog/image-enhanced-laparoscopy-a-promising-technology-for-detection-of-peritoneal-micrometastases/</link>
		<comments>http://jsurg.com/blog/image-enhanced-laparoscopy-a-promising-technology-for-detection-of-peritoneal-micrometastases/#comments</comments>
		<pubDate>Tue, 10 Apr 2012 19:45:25 +0000</pubDate>
		<dc:creator>Schnelldorfer T</dc:creator>
				<category><![CDATA[Review Articles]]></category>
		<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Image-enhanced laparoscopy: a promising technology for detection of peritoneal micrometastases.
        Surgery. 2012 Mar;151(3):345-50
        Authors:  Schnelldorfer T
        PMID: 22329962 [PubMed - indexed for MEDLINE]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Image-enhanced laparoscopy: a promising technology for detection of peritoneal micrometastases.</b></p>
<p>Surgery. 2012 Mar;151(3):345-50</p>
<p>Authors:  Schnelldorfer T</p>
<p>PMID: 22329962 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/image-enhanced-laparoscopy-a-promising-technology-for-detection-of-peritoneal-micrometastases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cheating experience: Guiding novices to adopt the gaze strategies of experts expedites the learning of technical laparoscopic skills.</title>
		<link>http://jsurg.com/blog/cheating-experience-guiding-novices-to-adopt-the-gaze-strategies-of-experts-expedites-the-learning-of-technical-laparoscopic-skills/</link>
		<comments>http://jsurg.com/blog/cheating-experience-guiding-novices-to-adopt-the-gaze-strategies-of-experts-expedites-the-learning-of-technical-laparoscopic-skills/#comments</comments>
		<pubDate>Wed, 04 Apr 2012 04:45:36 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Cheating experience: Guiding novices to adopt the gaze strategies of experts expedites the learning of technical laparoscopic skills.
        Surgery. 2012 Mar 30;
        Authors:  Vine SJ, Masters RS, McGrath JS, Bright E, Wilson MR
      ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Cheating experience: Guiding novices to adopt the gaze strategies of experts expedites the learning of technical laparoscopic skills.</b></p>
<p>Surgery. 2012 Mar 30;</p>
<p>Authors:  Vine SJ, Masters RS, McGrath JS, Bright E, Wilson MR</p>
<p>Abstract<br/><br />
        BACKGROUND: Previous research has demonstrated that trainees can be taught (via explicit verbal instruction) to adopt the gaze strategies of expert laparoscopic surgeons. The current study examined a software template designed to guide trainees to adopt expert gaze control strategies passively, without being provided with explicit instructions. METHODS: We examined 27 novices (who had no laparoscopic training) performing 50 learning trials of a laparoscopic training task in either a discovery-learning (DL) group or a gaze-training (GT) group while wearing an eye tracker to assess gaze control. The GT group performed trials using a surgery-training template (STT); software that is designed to guide expert-like gaze strategies by highlighting the key locations on the monitor screen. The DL group had a normal, unrestricted view of the scene on the monitor screen. Both groups then took part in a nondelayed retention test (to assess learning) and a stress test (under social evaluative threat) with a normal view of the scene. RESULTS: The STT was successful in guiding the GT group to adopt an expert-like gaze strategy (displaying more target-locking fixations). Adopting expert gaze strategies led to an improvement in performance for the GT group, which outperformed the DL group in both retention and stress tests (faster completion time and fewer errors). CONCLUSION: The STT is a practical and cost-effective training interface that automatically promotes an optimal gaze strategy. Trainees who are trained to adopt the efficient target-locking gaze strategy of experts gain a performance advantage over trainees left to discover their own strategies for task completion.<br/>
        </p>
<p>PMID: 22464048 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/cheating-experience-guiding-novices-to-adopt-the-gaze-strategies-of-experts-expedites-the-learning-of-technical-laparoscopic-skills/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multiple duodenal stromal tumors revealing type 1 neurofibromatosis: An indication for pancreas-preserving duodenectomy.</title>
		<link>http://jsurg.com/blog/multiple-duodenal-stromal-tumors-revealing-type-1-neurofibromatosis-an%c2%a0indication-for-pancreas-preserving-duodenectomy/</link>
		<comments>http://jsurg.com/blog/multiple-duodenal-stromal-tumors-revealing-type-1-neurofibromatosis-an%c2%a0indication-for-pancreas-preserving-duodenectomy/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 04:30:43 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Multiple duodenal stromal tumors revealing type 1 neurofibromatosis: An indication for pancreas-preserving duodenectomy.
        Surgery. 2012 Mar 27;
        Authors:  Ravoire A, Poussier M, Facy O, Jouve JL, Funes de la Vega M, Rat P
    ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Multiple duodenal stromal tumors revealing type 1 neurofibromatosis: An indication for pancreas-preserving duodenectomy.</b></p>
<p>Surgery. 2012 Mar 27;</p>
<p>Authors:  Ravoire A, Poussier M, Facy O, Jouve JL, Funes de la Vega M, Rat P</p>
<p>PMID: 22459283 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/multiple-duodenal-stromal-tumors-revealing-type-1-neurofibromatosis-an%c2%a0indication-for-pancreas-preserving-duodenectomy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lack of significant liver enzyme elevation and gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectomy: a population-based study.</title>
		<link>http://jsurg.com/blog/lack-of-significant-liver-enzyme-elevation-and-gallstones-andor-sludge-on-ultrasound-on-day-1-of-acute-pancreatitis-is-associated-with-recurrence-after-cholecystectomy-a-population-based-study/</link>
		<comments>http://jsurg.com/blog/lack-of-significant-liver-enzyme-elevation-and-gallstones-andor-sludge-on-ultrasound-on-day-1-of-acute-pancreatitis-is-associated-with-recurrence-after-cholecystectomy-a-population-based-study/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:19 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Lack of significant liver enzyme elevation and gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectomy: a population-based study.
        Surgery. 2012 Feb;151(2):199-205
    ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Lack of significant liver enzyme elevation and gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectomy: a population-based study.</b></p>
<p>Surgery. 2012 Feb;151(2):199-205</p>
<p>Authors:  Trna J, Vege SS, Pribramska V, Chari ST, Kamath PS, Kendrick ML, Farnell MB</p>
<p>Abstract<br/><br />
        BACKGROUND: In a population-based study, we examined recurrence rates of acute pancreatitis (AP) after cholecystectomy performed to prevent recurrences of AP.<br/><br />
        METHODS: We abstracted data from medical records of all Olmsted county residents who underwent cholecystectomy at Mayo Clinic for the management of presumed gallstone or idiopathic AP between 1990 and 2005 (n = 239). Based on (i) significantly elevated liver enzymes (≥threefold increase of alanine aminotransferase or aspartate aminotransferase) on day 1 and (ii) the presence of gallstones/sludge in the gall bladder, we categorized patients into 4 groups: A (i + ii), B (i but not ii), C (ii but not i), and D (neither i nor ii). Recurrence rates of AP after cholecystectomy were determined in all groups.<br/><br />
        RESULTS: The median follow-up after cholecystectomy was 99 months (range, 8-220). AP recurred in 13 of 142 patients (9%) in group A, 1 of 17 patients (6%) in group B, 13 of 57 patients (23%) in group C, and 14 of 23 patients (61%) in group D (P &lt; .0001 D vs. all other groups and P = .001 C vs. groups A and B). No difference was seen in recurrence rates in groups A vs. B (P = 1.0). Recurrences were more frequent in patients with normal liver enzymes (A + B vs. C + D; P = .000003) and in patients without sonographic evidence of gallstones/sludge (A + C vs. B + D; P = .0008).<br/><br />
        CONCLUSION: When AP is associated with significantly elevated liver enzymes on day 1, recurrence rates after cholecystectomy are low (9%). However, postcholecystectomy recurrence rates of AP are high in those without such laboratory abnormalities (34%), especially in those without gall bladder stones/sludge (61%) on abdominal ultrasonography. Our results raise doubts about the efficacy of cholecystectomy to prevent recurrent AP in patients with the absence of either a significant elevation of liver tests on day 1 of AP or gallstones and/or sludge in the gall bladder on initial ultrasound examination.<br/>
        </p>
<p>PMID: 21975288 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/lack-of-significant-liver-enzyme-elevation-and-gallstones-andor-sludge-on-ultrasound-on-day-1-of-acute-pancreatitis-is-associated-with-recurrence-after-cholecystectomy-a-population-based-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.</title>
		<link>http://jsurg.com/blog/the-impact-of-cd4-cd25-t-cells-in-the-tumor-microenvironment-of-hepatocellular-carcinoma/</link>
		<comments>http://jsurg.com/blog/the-impact-of-cd4-cd25-t-cells-in-the-tumor-microenvironment-of-hepatocellular-carcinoma/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:18 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
        Surgery. 2012 Feb;151(2):213-22
        Authors:  Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC
        Abstract
        BACKGROUND:...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.</b></p>
<p>Surgery. 2012 Feb;151(2):213-22</p>
<p>Authors:  Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC</p>
<p>Abstract<br/><br />
        BACKGROUND: Hepatocellular carcinoma (HCC) is the most common liver cancer. Therapeutic results are usually unsatisfactory because liver tumors recur often. Immunologic factors may be related to the recurrence of HCC; however, this possibility is mentioned only rarely.<br/><br />
        METHODS: Thirty HCC patients undergoing hepatectomies were divided into 3 groups according to the diameters of their HCCs: group A (n = 8), diameter ≤3 cm; group B (n = 8), diameter &gt;3 cm and ≤5 cm; and group C (n = 14), diameter &gt;5 cm. T-lymphocytes from peripheral blood, nontumor liver tissue, and the HCC were analyzed.<br/><br />
        RESULTS: The percentage of CD25+ in the CD4+ T cells did not differ between the peripheral blood and the nontumor liver tissue among the 3 groups. CD25+ cells were increased in the tumor tissue in group C patients (range, 6-41%; median, 22.9%; P = .003), compared to group A patients. The percentage of CD25+ in the CD4+ T cells in tumor tissue was positively correlated with tumor sizes (r = 0.556). These CD4+ CD25+ lymphocytes produced transforming growth factor-β and interferon-γ but not interleukin-10, and were anergic to plate-coated monoclonal antibodies (anti-CD3/anti-CD28). The characteristics of these antibodies were comparable to those of regulatory T cells. When the infiltration lymphocytes including CD4+ CD25+ T cells were added to the mixed lymphocyte reaction activated by autologous tumor lysate-pulsed dendritic cells, the proliferation of lymphocytes was inhibited.<br/><br />
        CONCLUSION: The increase of CD4+ CD25+ T cells in the tumor microenvironment correlates with tumor sizes. These CD4+ CD25+ regulatory T cells appeared to suppress the immune response activated by dendritic cells.<br/>
        </p>
<p>PMID: 21975289 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-impact-of-cd4-cd25-t-cells-in-the-tumor-microenvironment-of-hepatocellular-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.</title>
		<link>http://jsurg.com/blog/neutralization-of-interleukin-10-or-transforming-growth-factor-%ce%b2-decreases-the-percentages-of-cd4-cd25-foxp3-regulatory-t-cells-in-septic-mice-thereby-leading-to-an-improved-survival/</link>
		<comments>http://jsurg.com/blog/neutralization-of-interleukin-10-or-transforming-growth-factor-%ce%b2-decreases-the-percentages-of-cd4-cd25-foxp3-regulatory-t-cells-in-septic-mice-thereby-leading-to-an-improved-survival/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:16 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
        Surgery. 2012 Feb;151(2):313-22
        Auth...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.</b></p>
<p>Surgery. 2012 Feb;151(2):313-22</p>
<p>Authors:  Hiraki S, Ono S, Tsujimoto H, Kinoshita M, Takahata R, Miyazaki H, Saitoh D, Hase K</p>
<p>Abstract<br/><br />
        OBJECTIVES: To investigate the role of CD4+ CD25+ Foxp3+ regulatory T cells (Tregs) in septic conditions, and to examine the potential of targeting them for the treatment of sepsis.<br/><br />
        BACKGROUND: Sepsis-induced immunosuppression has long been considered a factor in late mortality of patients with sepsis. Although Tregs are central to the maintenance of immunologic homeostasis and tolerance, little is known about Treg-mediated immunosuppression in the late stages of sepsis.<br/><br />
        METHODS: Peripheral blood mononuclear cells (MNCs) in septic patients and liver or spleen MNCs collected after a cecal ligation and puncture (CLP) model in C57BL/6 mice were examined to evaluate the roles of Tregs and the correlation of transforming growth factor (TGF)-β or interleukin (IL)-10 with their activity. We next examined the effects of neutralization of TGF-β or IL-10 on the percentages of Tregs in CD4+ T cells and the survival rates of septic mice.<br/><br />
        RESULTS: The percentages of Tregs in peripheral blood lymphocytes were significantly increased in patients with sepsis, and there was a significantly positive correlation between serum IL-10 levels and the percentage of Tregs. CLP injury increases the percentages of Tregs in the CD4+ T cells in the spleen, and there was a significantly positive correlation between the percentages of Tregs and the serum IL-10 or TGF-β levels. The neutralization of TGF-β or IL-10 decreased the percentages of Tregs in CD4+ T cells, restored the percentages of CD4+ T cells in spleen MNCs, and improved survival rates in septic mice.<br/><br />
        CONCLUSION: We found an increase in the percentages of Tregs in peripheral blood circulating CD4+ T cells from patients with sepsis, and in splenic MNCs from septic mice, and observed that regulation of Tregs by neutralizing IL-10 or TGF-β might represent a novel strategy for treating the immunosuppressive conditions in sepsis.<br/>
        </p>
<p>PMID: 21982068 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/neutralization-of-interleukin-10-or-transforming-growth-factor-%ce%b2-decreases-the-percentages-of-cd4-cd25-foxp3-regulatory-t-cells-in-septic-mice-thereby-leading-to-an-improved-survival/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hereditary diffuse gastric cancer: the always-forgotten Meckel&#8217;s diverticulum.</title>
		<link>http://jsurg.com/blog/hereditary-diffuse-gastric-cancer-the-always-forgotten-meckels-diverticulum/</link>
		<comments>http://jsurg.com/blog/hereditary-diffuse-gastric-cancer-the-always-forgotten-meckels-diverticulum/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:14 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Hereditary diffuse gastric cancer: the always-forgotten Meckel's diverticulum.
        Surgery. 2012 Feb;151(2):342
        Authors:  Bridoux V, Kianifard B, Schwarz L, Michot F, Tuech JJ
        PMID: 22240148 [PubMed - indexed for MEDLINE]...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Hereditary diffuse gastric cancer: the always-forgotten Meckel&#8217;s diverticulum.</b></p>
<p>Surgery. 2012 Feb;151(2):342</p>
<p>Authors:  Bridoux V, Kianifard B, Schwarz L, Michot F, Tuech JJ</p>
<p>PMID: 22240148 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/hereditary-diffuse-gastric-cancer-the-always-forgotten-meckels-diverticulum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.</title>
		<link>http://jsurg.com/blog/acoustic-radiation-force-impulse-imaging-predicts-postoperative-ascites-resulting-from-curative-hepatic-resection-for-hepatocellular-carcinoma/</link>
		<comments>http://jsurg.com/blog/acoustic-radiation-force-impulse-imaging-predicts-postoperative-ascites-resulting-from-curative-hepatic-resection-for-hepatocellular-carcinoma/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:12 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.
        Surgery. 2012 Mar 2;
        Authors:  Harada N, Shirabe K, Ijichi H, Matono R, Uchiyama ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.</b></p>
<p>Surgery. 2012 Mar 2;</p>
<p>Authors:  Harada N, Shirabe K, Ijichi H, Matono R, Uchiyama H, Yoshizumi T, Taketomi A, Soejima Y, Maehara Y</p>
<p>Abstract<br/><br />
        BACKGROUND: Measurement of liver stiffness using Virtual Touch Tissue Quantification (VTTQ) based on acoustic radiation force impulse imaging reflects the degree of hepatic fibrosis and reserve. This prospective study investigated how well the VTTQ value predicts the development of postoperative complications before curative hepatic resection for hepatocellular carcinoma (HCC). METHODS: The study enrolled 50 consecutive patients between February 2009 and October 2010 whose preoperative VTTQ values were determined before they underwent curative hepatic resection for HCC. We assessed the relationship between postoperative complications and VTTQ values. RESULTS: The study included 41 (82%) patients with chronic hepatitis and 9 (18%) with nonviral cirrhosis. The mean VTTQ value was 1.60 (m/sec), which correlated with the fibrosis stage (P = .0058). The VTTQ value was the only variable correlated with postoperative ascites that did not respond to pharmacologic treatment and required invasive management. Univariate and subsequent multivariate analyses revealed that the preoperative VTTQ value was the only independent risk factor for predicting the development of postoperative ascites (cutoff, 1.68 cm/sec; P = .007; odds ratio, 76.481). The area under the receiver operating characteristic curve for the diagnosis of postoperative ascites using VTTQ values was 0.90, whereas those using the aspartate transaminase-to-platelet ratio index and indocyanine green retention rate at 15 minutes values were 0.68 and 0.55, respectively. CONCLUSION: These data suggest that the VTTQ value is a reliable surrogate marker for predicting postoperative ascites before curative hepatic resection for HCC.<br/>
        </p>
<p>PMID: 22386275 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/acoustic-radiation-force-impulse-imaging-predicts-postoperative-ascites-resulting-from-curative-hepatic-resection-for-hepatocellular-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.</title>
		<link>http://jsurg.com/blog/prognostic-significance-of-tumor-deposits-in-gastric-cancer-patients-who-underwent-radical-surgery/</link>
		<comments>http://jsurg.com/blog/prognostic-significance-of-tumor-deposits-in-gastric-cancer-patients-who-underwent-radical-surgery/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:10 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.
        Surgery. 2012 Mar 2;
        Authors:  Sun Z, Wang ZN, Xu YY, Zhu GL, Huang BJ, Xu Y, Liu FN, Zhu Z, Xu HM
        Abstract
        B...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.</b></p>
<p>Surgery. 2012 Mar 2;</p>
<p>Authors:  Sun Z, Wang ZN, Xu YY, Zhu GL, Huang BJ, Xu Y, Liu FN, Zhu Z, Xu HM</p>
<p>Abstract<br/><br />
        BACKGROUND: To investigate the prognostic significance of tumor deposits (TDs) in gastric cancers patients who underwent radical surgery. METHODS: Clinicopathologic and prognostic data from 2998 gastric cancer patients who underwent R0 surgery with D2/D3 lymphadenectomy were retrospectively reviewed. A TD was defined as discrete foci of tumor found in the perigastric fat or in adjacent ligament away from the leading edge of the tumor and showing no evidence of residual lymph node tissue, but within the lymph drainage area of the primary carcinoma. RESULTS: TDs were detected in 17.8% of patients. TDs were more frequently observed in cancers of larger size, of Borrmann type 4, with lymphovascular invasion, deeper in depth of invasion, and with extended lymph node metastasis. Multivariate analysis confirmed the presence of TDs as 1 of independent factors predicting a poorer outcome. When stratified by pN category, significant differences in survival were observed between patients with and without TDs for those in pN0/pT1-3, pN1/pT3, pN2/pT1-3 and pN3/pT2-3 category, but not for those in pT4a and pT4b category. Moreover, for cancers in each pN category, the prognosis for patients with TDs in pT1-4a category was similar with that of those without TDs in pT4a category, but significantly better than that of those with or without TDs in pT4b category. A revised pT category and a revised pTNM system were proposed, in which all the cancers with TDs in pT1-4a category were incorporated into those without TDs in pT4a category according to the pN category. Further analysis revealed the revised pT category and the revised pTNM system had better homogeneity, discriminatory ability, and monotonicity of gradients than the American Joint Committee on Cancer (AJCC) pT category and the AJCC pTNM system, respectively, representing optimum prognostic stratification. CONCLUSION: TDs significantly correlated with gastric cancer patients&#8217; survival. It might be more suitable for TDs to be treated as a form of serosal invasion. Consequently, en bloc resection of the primary carcinoma is crucially important, and adjuvant chemotherapy should always be considered if TDs have been detected.<br/>
        </p>
<p>PMID: 22386276 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/prognostic-significance-of-tumor-deposits-in-gastric-cancer-patients-who-underwent-radical-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?</title>
		<link>http://jsurg.com/blog/sentinel-lymph-node-biopsy-in-management-of-early-breast-cancer-is-it-rational-to-omit-blue-dye-injection/</link>
		<comments>http://jsurg.com/blog/sentinel-lymph-node-biopsy-in-management-of-early-breast-cancer-is-it-rational-to-omit-blue-dye-injection/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:09 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?
        Surgery. 2012 Mar 2;
        Authors:  Kaviani A, Noveiry BB, Noaparast M
        PMID: 22386708 [PubMed - as supplied by pub...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?</b></p>
<p>Surgery. 2012 Mar 2;</p>
<p>Authors:  Kaviani A, Noveiry BB, Noaparast M</p>
<p>PMID: 22386708 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/sentinel-lymph-node-biopsy-in-management-of-early-breast-cancer-is-it-rational-to-omit-blue-dye-injection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: Long-term follow-up.</title>
		<link>http://jsurg.com/blog/intestinal-and-multivisceral-autotransplantation-for-tumors-of-the-root-of-the-mesentery-long-term-follow-up/</link>
		<comments>http://jsurg.com/blog/intestinal-and-multivisceral-autotransplantation-for-tumors-of-the-root-of-the-mesentery-long-term-follow-up/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:05 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: Long-term follow-up.
        Surgery. 2012 Mar 2;
        Authors:  Tzakis AG, Pararas NB, Tekin A, Gonzalez-Pinto I, Levi D, Nishida S, Selvaggi G, Ga...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: Long-term follow-up.</b></p>
<p>Surgery. 2012 Mar 2;</p>
<p>Authors:  Tzakis AG, Pararas NB, Tekin A, Gonzalez-Pinto I, Levi D, Nishida S, Selvaggi G, Garcia J, Kato T, Ruiz P</p>
<p>Abstract<br/><br />
        OBJECTIVE: To present the indications, techniques, short- and long-term outcomes after visceral exenteration, ex vivo resection, and intestinal/multivisceral autotransplantation. PATIENTS AND METHODS: All patients who have undergone this procedure at our center were studied. Technique, postoperative complications, survival, tumor recurrence, and functional status were recorded. RESULTS: Ten patients, 4 children and 6 adults, have undergone these procedures since January 1999. Seven patients are alive at 13-138 months later, 6 with functioning autografts and one after rescue with an allotransplantation. CONCLUSION: Intestinal/multivisceral autotransplantation is a potentially valuable option for some otherwise unresectable neoplasms of the root of the mesentery.<br/>
        </p>
<p>PMID: 22386709 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/intestinal-and-multivisceral-autotransplantation-for-tumors-of-the-root-of-the-mesentery-long-term-follow-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unique moments in time: What patients teach us.</title>
		<link>http://jsurg.com/blog/unique-moments-in-time-what-patients-teach-us/</link>
		<comments>http://jsurg.com/blog/unique-moments-in-time-what-patients-teach-us/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:03 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Unique moments in time: What patients teach us.
        Surgery. 2012 Mar 1;
        Authors:  van Heerden JA
        PMID: 22386710 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Unique moments in time: What patients teach us.</b></p>
<p>Surgery. 2012 Mar 1;</p>
<p>Authors:  van Heerden JA</p>
<p>PMID: 22386710 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/unique-moments-in-time-what-patients-teach-us/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spleen-preserving distal pancreatectomy with splenic vessels excision.</title>
		<link>http://jsurg.com/blog/spleen-preserving-distal-pancreatectomy-with-splenic-vessels-excision/</link>
		<comments>http://jsurg.com/blog/spleen-preserving-distal-pancreatectomy-with-splenic-vessels-excision/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:29:01 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Spleen-preserving distal pancreatectomy with splenic vessels excision.
        Surgery. 2012 Mar 1;
        Authors:  Sperti C, Beltrame V, Bellamio B, Pasquali C
        PMID: 22386711 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Spleen-preserving distal pancreatectomy with splenic vessels excision.</b></p>
<p>Surgery. 2012 Mar 1;</p>
<p>Authors:  Sperti C, Beltrame V, Bellamio B, Pasquali C</p>
<p>PMID: 22386711 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/spleen-preserving-distal-pancreatectomy-with-splenic-vessels-excision/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laryngeal approach to the recurrent laryngeal nerve involved by thyroid cancer at the ligament of Berry.</title>
		<link>http://jsurg.com/blog/laryngeal-approach-to-the-recurrent-laryngeal-nerve-involved-by-thyroid-cancer-at-the-ligament-of-berry/</link>
		<comments>http://jsurg.com/blog/laryngeal-approach-to-the-recurrent-laryngeal-nerve-involved-by-thyroid-cancer-at-the-ligament-of-berry/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:28:59 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Laryngeal approach to the recurrent laryngeal nerve involved by thyroid cancer at the ligament of Berry.
        Surgery. 2012 Mar 1;
        Authors:  Miyauchi A, Masuoka H, Tomoda C, Takamura Y, Ito Y, Kobayashi K, Miya A
        Abstract
...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Laryngeal approach to the recurrent laryngeal nerve involved by thyroid cancer at the ligament of Berry.</b></p>
<p>Surgery. 2012 Mar 1;</p>
<p>Authors:  Miyauchi A, Masuoka H, Tomoda C, Takamura Y, Ito Y, Kobayashi K, Miya A</p>
<p>Abstract<br/><br />
        BACKGROUND: Thyroid cancer often involves the RLN at the ligament of Berry, which makes preservation of the nerve difficult. If the portion of RLN is resected, finding the peripheral RLN for reconstruction is difficult. Here we describe a laryngeal approach performed before dissecting the RLN to overcome these problems. METHODS: Between January 2007 and April 2011, 13 patients with papillary thyroid carcinoma had unilateral RLN involvement by the cancer at the ligament of Berry. Preoperatively, 8 had functioning vocal cords and 5 had unilateral paralysis. The laryngeal approach involves dividing the inferior pharyngeal constrictor muscle along the lateral edge of the thyroid cartilage and identifying the nerve under the muscle or behind the thyroid cartilage. This procedure was performed before resecting the tumor in 10 patients (Group 1) and after resection in the remaining 3 (Group 2). RESULTS: In Group 1, the RLN could be preserved with sharp dissection in 3 with functioning vocal cords preoperatively. Postoperatively they restored vocal cord function. The remaining 7 needed resection of the portion of RLN. RLN reconstruction was easily, since the peripheral RLN had already been identified. All patients in Group 2 needed resection of the portion of RLN. The peripheral RLN was identified in 2, and ansa-RLN anastomosis was performed. However, this was not possible in 1 patient. CONCLUSION: In patients with thyroid cancer involving the RLN at the ligament of Berry, performing the laryngeal approach before dissecting the nerve facilitates preservation or reconstruction of the nerve.<br/>
        </p>
<p>PMID: 22386712 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/laryngeal-approach-to-the-recurrent-laryngeal-nerve-involved-by-thyroid-cancer-at-the-ligament-of-berry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A 5-year review of a trauma-trained hospitalist program for trauma patients: A matched cohort study.</title>
		<link>http://jsurg.com/blog/a-5-year-review-of-a-trauma-trained-hospitalist-program-for-trauma-patients-a-matched-cohort-study/</link>
		<comments>http://jsurg.com/blog/a-5-year-review-of-a-trauma-trained-hospitalist-program-for-trauma-patients-a-matched-cohort-study/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:28:54 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        A 5-year review of a trauma-trained hospitalist program for trauma patients: A matched cohort study.
        Surgery. 2012 Mar 1;
        Authors:  Orlando A, Salottolo K, Uribe P, Howell PA, Slone DS, Bar-Or D
        Abstract
        BACKG...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>A 5-year review of a trauma-trained hospitalist program for trauma patients: A matched cohort study.</b></p>
<p>Surgery. 2012 Mar 1;</p>
<p>Authors:  Orlando A, Salottolo K, Uribe P, Howell PA, Slone DS, Bar-Or D</p>
<p>Abstract<br/><br />
        BACKGROUND: Level I trauma centers have requirements on the percentage of trauma patients admitted to either a trauma surgeon or surgical subspecialist; however, surgical resources are in steady decline. Therefore, a trauma system might better utilize its surgical resources if trained hospitalists admitted a larger percentage of mild to moderately injured trauma patients. The objective of this report is to provide a 5-year evaluation of a trauma medical service (TMED) at treating mild to moderately injured trauma patients. METHODS: Adult trauma patients consecutively admitted to a Level I trauma center between January 2006 and December 2010 were analyzed. Patients admitted to trauma surgical services were matched 1:1 to those admitted to TMED, via propensity scores. Paired t tests examined differences in hospital duration of stay (DOS), and exact conditional logistic regression examined differences in the odds of having a delayed diagnosis, developing a complication, and dying. RESULTS: Of 1,202 TMED patients, 494 were matched; matched TMED patients had similar patient outcomes to nonmatched TMED patients. There were no differences between study groups in the mean hospital DOS, the proportion having a delayed diagnosis, or in the odds of dying in the hospital (P &gt; .05 for all). The TMED group had a nominally higher complication rate (P = .12) owing to a higher rate of urinary tract infections. CONCLUSION: Since its inception, the TMED service has successfully and safely treated mild to moderately injured trauma patients, and decreased the dependency on trauma surgical services. Trauma centers might utilize declining surgical services more efficiently with the addition of trauma medical hospitalists.<br/>
        </p>
<p>PMID: 22386713 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/a-5-year-review-of-a-trauma-trained-hospitalist-program-for-trauma-patients-a-matched-cohort-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Professor Carl Alfred Moyer (1908-1970).</title>
		<link>http://jsurg.com/blog/professor-carl-alfred-moyer-1908-1970/</link>
		<comments>http://jsurg.com/blog/professor-carl-alfred-moyer-1908-1970/#comments</comments>
		<pubDate>Sun, 11 Mar 2012 02:28:44 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Professor Carl Alfred Moyer (1908-1970).
        Surgery. 2012 Mar 1;
        Authors:  Grossman JB
        PMID: 22386714 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Professor Carl Alfred Moyer (1908-1970).</b></p>
<p>Surgery. 2012 Mar 1;</p>
<p>Authors:  Grossman JB</p>
<p>PMID: 22386714 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/professor-carl-alfred-moyer-1908-1970/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Midline abdominal wall incisional hernia after aortic reconstructive surgery: A prospective study.</title>
		<link>http://jsurg.com/blog/midline-abdominal-wall-incisional-hernia-after-aortic-reconstructive-surgery-a-prospective-study/</link>
		<comments>http://jsurg.com/blog/midline-abdominal-wall-incisional-hernia-after-aortic-reconstructive-surgery-a-prospective-study/#comments</comments>
		<pubDate>Sun, 04 Mar 2012 01:42:16 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Midline abdominal wall incisional hernia after aortic reconstructive surgery: A prospective study.
        Surgery. 2012 Feb 28;
        Authors:  Gruppo M, Mazzalai F, Lorenzetti R, Piatto G, Toniato A, Ballotta E
        Abstract
        B...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Midline abdominal wall incisional hernia after aortic reconstructive surgery: A prospective study.</b></p>
<p>Surgery. 2012 Feb 28;</p>
<p>Authors:  Gruppo M, Mazzalai F, Lorenzetti R, Piatto G, Toniato A, Ballotta E</p>
<p>Abstract<br/><br />
        BACKGROUND AND PURPOSE: To evaluate rate of formation of midline abdominal wall incisional hernia (MAIH) after elective open repair of abdominal aortic aneurysm (AAA) and revascularization for aortoiliac occlusive disease (AOD). METHODS: AAA and AOD patients operated electively via a primary midline abdominal incision at our institution over a decade were entered in this prospective study. Patients who had already undergone midline laparotomy or had an MAIH after previous celiotomy were excluded. Patients were examined for MAIH 6-monthly for 2 years, then yearly. RESULTS: We included 1,065 patients who underwent aortic reconstructive surgery (412 with AAA and 653 with AOD). The follow-up (mean ± standard deviation) was 6.4 ± 3.8 years (range, 0.5-12.7). Wounds were closed with a suture length-to-wound length (SL:WL) ratio of at least 4:1 in 58% (239 of 653) of AAA patients and 66% (431 of 653) of AOD patients (P = .01). There were 124 (11.6%) MAIHs, with an incidence of 12.4% (51 of 412) in the AAA group and 11.2% (73 of 653) in the AOD group (P = .62), and 3 (0.4%) wound infections (all among the AOD patients), none of which resulted in MAIH. At multivariate analysis, a SL:WL ratio of &lt;4:1 was the only independent predictor of MAIH in AAA (P = .004) and AOD patients (P &lt; .001). CONCLUSION: AAA and AOD patients had a similar incidence of MAIH, which seems related to the wound closure technique. A SL:WL ratio of at least 4:1 is recommended. Further clinical studies are required to determine possible technical and perioperative variables that may be modified to decrease the incidence of MAIH development after aortic reconstructive surgery.<br/>
        </p>
<p>PMID: 22381694 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/midline-abdominal-wall-incisional-hernia-after-aortic-reconstructive-surgery-a-prospective-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.</title>
		<link>http://jsurg.com/blog/risk-of-second-primary-malignancy-in-differentiated-thyroid-carcinoma-treated-with-radioactive-iodine-therapy/</link>
		<comments>http://jsurg.com/blog/risk-of-second-primary-malignancy-in-differentiated-thyroid-carcinoma-treated-with-radioactive-iodine-therapy/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 00:52:27 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
        Surgery. 2012 Feb 14;
        Authors:  Lang BH, Wong IO, Wong KP, Cowling BJ, Wan KY
        Abstract
        BACKGROUND:...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.</b></p>
<p>Surgery. 2012 Feb 14;</p>
<p>Authors:  Lang BH, Wong IO, Wong KP, Cowling BJ, Wan KY</p>
<p>Abstract<br/><br />
        BACKGROUND: Differentiated thyroid cancer survivors are at increased risk of nonsynchronous second primary malignancy, but the cause remains unclear. This study aimed to evaluate the association between radioiodine therapy and risk of nonsynchronous second primary malignancy and to examine whether the risk of nonsynchronous second primary malignancy in differentiated thyroid cancer survivors treated with radioiodine therapy is increased relative to the general population. METHODS: Among 895 radiation-naïve patients with differentiated thyroid cancer, 643 (71.8%) received ≥1 course of radioiodine therapy (radioiodine therapy-positive group) and 252 (28.2%) received no radioiodine therapy (radioiodine therapy-negative group). After a median follow-up of 93.5 months (range, 23.4-570.8), 64 (7.2%) patients developed ≥1 nonsynchronous second primary malignancy. Potential risk factors for nonsynchronous second primary malignancy were entered into a multivariable regression model and cancer incidence in the radioiodine therapy-positive and -negative groups were compared to that of the general population by estimating the standardized incidence ratios. RESULTS: The 20-year cumulative nonsynchronous second primary malignancy risk in radioiodine therapy-positive group was significantly higher than radioiodine therapy-negative group (13.5% vs 3.1%; P = .015). Cumulative radioiodine therapy activity of 3.0 to 8.9 GBq (relative risk, 2.77; 95% CI, 1.079-7.154; P = .034) was the only independent risk factor for nonsynchronous second primary malignancy after adjusting for age, sex, period of differentiated thyroid cancer diagnosis, and stage of differentiated thyroid cancer. For females, the standardized incidence ratio in the radioiodine therapy-positive group was 1.54 (95% CI, 1.11-2.08) and in the radioiodine therapy-negative group it was 0.92 (95% CI, 0.37-1.90). CONCLUSION: Differentiated thyroid cancer female survivors treated by radioiodine therapy appeared to be at elevated risk of nonsynchronous second primary malignancy when compared to the general population and this risk was not apparent in those not previously treated by radioiodine therapy.<br/>
        </p>
<p>PMID: 22341041 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/risk-of-second-primary-malignancy-in-differentiated-thyroid-carcinoma-treated-with-radioactive-iodine-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Response to &quot;Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: Disease modification or linkage disequilibrium?&quot;</title>
		<link>http://jsurg.com/blog/response-to-single-nucleotide-polymorphisms-and-development-of-hereditary-medullary-thyroid-cancer-in-v804m-ret-families-disease-modification-or-linkage-disequilibrium/</link>
		<comments>http://jsurg.com/blog/response-to-single-nucleotide-polymorphisms-and-development-of-hereditary-medullary-thyroid-cancer-in-v804m-ret-families-disease-modification-or-linkage-disequilibrium/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 00:52:26 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Response to "Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: Disease modification or linkage disequilibrium?"
        Surgery. 2012 Feb 14;
        Authors:  Shifrin AL, Kuo YH, O...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Response to &#8220;Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: Disease modification or linkage disequilibrium?&#8221;</b></p>
<p>Surgery. 2012 Feb 14;</p>
<p>Authors:  Shifrin AL, Kuo YH, Ogilvie J</p>
<p>PMID: 22341042 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/response-to-single-nucleotide-polymorphisms-and-development-of-hereditary-medullary-thyroid-cancer-in-v804m-ret-families-disease-modification-or-linkage-disequilibrium/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mortality risk after liver transplantation in hepatocellular carcinoma recipients: A nonlinear predictive model.</title>
		<link>http://jsurg.com/blog/mortality-risk-after-liver-transplantation-in-hepatocellular-carcinoma-recipients-a-nonlinear-predictive-model/</link>
		<comments>http://jsurg.com/blog/mortality-risk-after-liver-transplantation-in-hepatocellular-carcinoma-recipients-a-nonlinear-predictive-model/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 00:52:24 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Mortality risk after liver transplantation in hepatocellular carcinoma recipients: A nonlinear predictive model.
        Surgery. 2012 Feb 14;
        Authors:  Zhang M, Yin F, Chen B, Li B, Li YP, Yan LN, Wen TF
        Abstract
        BAC...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Mortality risk after liver transplantation in hepatocellular carcinoma recipients: A nonlinear predictive model.</b></p>
<p>Surgery. 2012 Feb 14;</p>
<p>Authors:  Zhang M, Yin F, Chen B, Li B, Li YP, Yan LN, Wen TF</p>
<p>Abstract<br/><br />
        BACKGROUND: The balanced application of a model for the estimate of outcomes of liver transplantation, in concert with assessment of disease severity, would not only improve transplant outcomes and maximize patient benefit from transplantation, but also facilitate informed decision making by patients and their relatives when considering transplantation. So far, however, linear discriminating methods have failed to attain sufficient power to predict post-transplant prognosis. Therefore, our aim was to develop a cancer-specific prognostic model by a nonlinear methodology based on pretransplant characteristics. METHODS: With data collected retrospectively from 290 liver transplant recipients with HCC from February 1999 to August 2009, a multilayer perceptron (MLP) neural network was constructed to predict mortality risk after transplantation. Its predictive performances at posttransplant 1-, 2-, and 5-year intervals were evaluated using a receiver operating characteristic curve. RESULTS: By the forward stepwise selection in MLP network, donor age, donor body mass index, recipient hemoglobin, serum concentrations of total bilirubin, alkaline phosphatase, creatinine, aspartate aminotransferase, international normalized ratio of prothrombin time, and Na(+); alpha fetoprotein categorization, total diameter, number of tumor lesions, presence of imaging macrovascular invasion, and lobe distribution of the tumor were identified to be the optimal input features. The MLP, employing 24 inputs and 7 hidden neurons, yielded c-statistics of 0.909 (P &lt; .001) in the 1-year, 0.888 (P &lt; .001), in the 2-year, and 0.845 (P &lt; .001) in the 5-year prediction. CONCLUSION: Post-transplant prognosis is a multidimensional, nonlinear problem, and the specific MLP can achieve high accuracy in the prediction of posttransplant mortality risk for HCC recipients. The pattern recognition methodologies like MLP hold promise for solving outcome prediction after liver transplantation.<br/>
        </p>
<p>PMID: 22341043 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/mortality-risk-after-liver-transplantation-in-hepatocellular-carcinoma-recipients-a-nonlinear-predictive-model/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laparoscopic simulation training: Testing for skill acquisition and retention.</title>
		<link>http://jsurg.com/blog/laparoscopic-simulation-training-testing-for-skill-acquisition-and-retention/</link>
		<comments>http://jsurg.com/blog/laparoscopic-simulation-training-testing-for-skill-acquisition-and-retention/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 00:52:20 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Laparoscopic simulation training: Testing for skill acquisition and retention.
        Surgery. 2012 Feb 16;
        Authors:  Bonrath EM, Weber BK, Fritz M, Mees ST, Wolters HH, Senninger N, Rijcken E
        Abstract
        BACKGROUND: Si...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Laparoscopic simulation training: Testing for skill acquisition and retention.</b></p>
<p>Surgery. 2012 Feb 16;</p>
<p>Authors:  Bonrath EM, Weber BK, Fritz M, Mees ST, Wolters HH, Senninger N, Rijcken E</p>
<p>Abstract<br/><br />
        BACKGROUND: Simulation in laparoscopy leads to skill acquisition. Although many curricula for simulation training have been described, the nature of skill deterioration remains unclear. We evaluated skill acquisition and retention after laparoscopic simulation training. METHODS: Thirty-six novices in surgery (medical students) underwent a 5-day curriculum consisting of 9 skills of increasing complexity. Each subject underwent baseline and post-training evaluation after completion of the course. Skill retention testing was measured after 6 weeks (group 1; n = 18) and after 11 weeks (group 2; n = 18). Neither group had access to a training facility during this interval. Task completion was measured in time (s) with penalties for inaccurate performance. RESULTS: Comparison of the baseline and post-training values revealed a significant learning outcome for all exercises in both groups (P &lt; .001). In group 1, skill retention testing found no significant decrease in skill level when compared to post-training values in all but 1 task (extracorporeal knot tying; P = .007). In group 2, differences between skill retention and post-training evaluation were observed for 5 of the 9 tasks (transfer task, positioning, loop tie, extracorporeal knot, and intracorporeal knot; P ≤ .05 for each). CONCLUSION: Basic laparoscopic skills can be learned successfully by novices in surgery using a compact curriculum. These skills are retained for at least 6 weeks. Eleven weeks after initial training, skill deterioration is likely, and therefore an opportunity for practice and repetition is desirable.<br/>
        </p>
<p>PMID: 22341719 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/laparoscopic-simulation-training-testing-for-skill-acquisition-and-retention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.</title>
		<link>http://jsurg.com/blog/immunosuppressants-accelerate-microvascular-thrombus-formation-in-vivo-role-of-endothelial-cell-activation/</link>
		<comments>http://jsurg.com/blog/immunosuppressants-accelerate-microvascular-thrombus-formation-in-vivo-role-of-endothelial-cell-activation/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:20:03 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.
        Surgery. 2012 Jan;151(1):26-36
        Authors:  Püschel A, Lindenblatt N, Katzfuss J, Vollmar B, Klar E
        Abstract
 ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.</b></p>
<p>Surgery. 2012 Jan;151(1):26-36</p>
<p>Authors:  Püschel A, Lindenblatt N, Katzfuss J, Vollmar B, Klar E</p>
<p>Abstract<br/><br />
        BACKGROUND: In the early postoperative period after pancreas-kidney transplantation, pancreatic venous thrombosis is a major complication that leads to allograft dysfunction and graft loss. Beside ischemia and reperfusion injury, immunosuppressive drugs have been accused of supporting thrombogenicity. The aim of this study was to evaluate the effect of commonly applied immunosuppressants on microvascular thrombus formation in normal and postischemic tissue in vivo.<br/><br />
        METHODS: In the skin fold chambers of tacrolimus-, cyclosporine A-, antithymocyte globulin-, rapamycine-, or saline-treated mice, light/dye-induced microvascular thrombus formation was studied. Additional mice underwent ischemia and reperfusion of the skin fold chamber tissue and received tacrolimus, antithymocyte globulin, or saline before reperfusion. Additionally, the effect of prednisolone was tested in animals with ischemia and reperfusion. Concentrations of sP-selectin, soluble vascular cell adhesion molecule-1, and asymmetric dimethylarginine were assessed by enzyme-linked immunosorbent assay. Immunohistochemistry of the skin fold chamber tissue served for analysis of vascular endothelial nitric oxide synthase and inducible nitric oxide synthase expression.<br/><br />
        RESULTS: In normal tissue, tacrolimus, cyclosporine A, antithymocyte globulin, and rapamycine accelerated microvascular thrombus formation significantly when compared with saline. Whereas ischemia and reperfusion in saline-treated mice enhanced thrombus formation, thrombogenicity was not further increased by ischemia and reperfusion in tacrolimus- or antithymocyte globulin-treated animals. Application of prednisolone reversed the tacrolimus- and antithymocyte globulin-induced prothrombotic effect. Antithymocyte globulin increased sP-selectin and soluble vascular cell adhesion molecule-1, whereas tacrolimus induced asymmetric dimethylarginine production significantly. While tacrolimus and antithymocyte globulin additionally induced endothelial nitric oxide synthase and inducible nitric oxide synthase expression, cyclosporine A influenced only endothelial inducible nitric oxide synthase expression.<br/><br />
        CONCLUSION: Immunosuppressants enhance thrombus formation in vivo. Although antithymocyte globulin activates the microvascular endothelium, we show for the first time that tacrolimus increases asymmetric dimethylarginine plasma levels. Thus, impaired nitric oxide availability might be the underlying mechanism for the tacrolimus-associated increased thrombogenicity. The efficacy of prednisolone to reverse the tacrolimus-associated and antithymocyte globulin-associated acceleration of thrombus formation underlines the application of this anti-inflammatory drug prior to reperfusion in immunosuppressive regimens.<br/>
        </p>
<p>PMID: 22019501 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/immunosuppressants-accelerate-microvascular-thrombus-formation-in-vivo-role-of-endothelial-cell-activation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>General surgery residency and international medical graduates: A perspective from Greece.</title>
		<link>http://jsurg.com/blog/general-surgery-residency-and-international-medical-graduates-a-perspective-from-greece/</link>
		<comments>http://jsurg.com/blog/general-surgery-residency-and-international-medical-graduates-a-perspective-from-greece/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:20:02 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        General surgery residency and international medical graduates: A perspective from Greece.
        Surgery. 2012 Jan 31;
        Authors:  Economopoulos KP, Linos D
        PMID: 22296987 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>General surgery residency and international medical graduates: A perspective from Greece.</b></p>
<p>Surgery. 2012 Jan 31;</p>
<p>Authors:  Economopoulos KP, Linos D</p>
<p>PMID: 22296987 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/general-surgery-residency-and-international-medical-graduates-a-perspective-from-greece/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BRCA testing is important for our patients.</title>
		<link>http://jsurg.com/blog/brca-testing-is-important-for-our-patients/</link>
		<comments>http://jsurg.com/blog/brca-testing-is-important-for-our-patients/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:20:01 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        BRCA testing is important for our patients.
        Surgery. 2012 Feb 3;
        Authors:  Anderson BO, Javid SH, Calhoun KE, Byrd DR
        PMID: 22306834 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>BRCA testing is important for our patients.</b></p>
<p>Surgery. 2012 Feb 3;</p>
<p>Authors:  Anderson BO, Javid SH, Calhoun KE, Byrd DR</p>
<p>PMID: 22306834 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/brca-testing-is-important-for-our-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Social media in low-resource settings: A role for Twitter and Facebook in global surgery?</title>
		<link>http://jsurg.com/blog/social-media-in-low-resource-settings-a-role-for-twitter-and-facebook-in-global-surgery/</link>
		<comments>http://jsurg.com/blog/social-media-in-low-resource-settings-a-role-for-twitter-and-facebook-in-global-surgery/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:58 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Social media in low-resource settings: A role for Twitter and Facebook in global surgery?
        Surgery. 2012 Feb 3;
        Authors:  Leow JJ, Pozo ME, Groen RS, Kushner AL
        PMID: 22306836 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Social media in low-resource settings: A role for Twitter and Facebook in global surgery?</b></p>
<p>Surgery. 2012 Feb 3;</p>
<p>Authors:  Leow JJ, Pozo ME, Groen RS, Kushner AL</p>
<p>PMID: 22306836 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/social-media-in-low-resource-settings-a-role-for-twitter-and-facebook-in-global-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Recommendation for standardized surgical management of primary adrenocortical carcinoma.</title>
		<link>http://jsurg.com/blog/recommendation-for-standardized-surgical-management-of-primary-adrenocortical-carcinoma/</link>
		<comments>http://jsurg.com/blog/recommendation-for-standardized-surgical-management-of-primary-adrenocortical-carcinoma/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:57 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Recommendation for standardized surgical management of primary adrenocortical carcinoma.
        Surgery. 2012 Feb 3;
        Authors:  Gaujoux S, Brennan MF
        Abstract
        BACKGROUND: Operative resection is the only potentially cu...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Recommendation for standardized surgical management of primary adrenocortical carcinoma.</b></p>
<p>Surgery. 2012 Feb 3;</p>
<p>Authors:  Gaujoux S, Brennan MF</p>
<p>Abstract<br/><br />
        BACKGROUND: Operative resection is the only potentially curative treatment for primary adrenocortical carcinoma (ACC), but standards of operative care are not defined with regards to the extent of local resection. We propose recommendations for operative management. METHODS: Anatomic and clinical literature review focusing on local management of ACC, including lymphadenectomy and resection of adjacent organs or large vessels. RESULTS: First-order drainage nodes of the adrenal gland include the renal hilum lymph nodes, the celiac lymph nodes, and the para-aortic and paracaval lymph nodes, mainly above the renal pedicle and ipsilateral to the adrenal glands. Lymph node involvement occurs in about 20% of patients with ACC, and is an important prognostic factor, but lymphadenectomy is performed infrequently. The adrenal glands and kidneys are contained in the same anatomic space, but systematic en bloc nephrectomy has no proven benefits for survival. Direct invasion of the kidney or adjacent organs is rare, but major venous invasion with tumor thrombus is relatively common. Both are associated with decreased survival, but complete resection can lead to long-term survival. CONCLUSION: Standardization of regional lymphadenectomy including first-order drainage nodes is proposed. Systematic nephrectomy is not necessary in the absence of gross local invasion, but locally involved organs or large veins should be resected en bloc, with tumor thrombus embolectomy, if R0 resection is possible. Operative standardization improves tumor staging, potentially decreases local recurrence, and may be associated with better survival. Evidence-based standards of operative care and prospective investigations within international collaborating groups are necessary.<br/>
        </p>
<p>PMID: 22306837 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/recommendation-for-standardized-surgical-management-of-primary-adrenocortical-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Liver resection for liver metastases from nondigestive endocrine cancer: Extrahepatic disease burden defines outcome.</title>
		<link>http://jsurg.com/blog/liver-resection-for-liver-metastases-from-nondigestive-endocrine-cancer-extrahepatic-disease-burden-defines-outcome/</link>
		<comments>http://jsurg.com/blog/liver-resection-for-liver-metastases-from-nondigestive-endocrine-cancer-extrahepatic-disease-burden-defines-outcome/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:56 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Liver resection for liver metastases from nondigestive endocrine cancer: Extrahepatic disease burden defines outcome.
        Surgery. 2012 Feb 3;
        Authors:  Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glane...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Liver resection for liver metastases from nondigestive endocrine cancer: Extrahepatic disease burden defines outcome.</b></p>
<p>Surgery. 2012 Feb 3;</p>
<p>Authors:  Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA</p>
<p>Abstract<br/><br />
        BACKGROUND: For patients with hepatic nondigestive endocrine metastases (HNEM), the role of liver resection is not well-defined. METHODS: We reviewed outcomes for patients who underwent liver resection for HNEM at 2 centers to identify predictors of survival. RESULTS: From 1991 to 2010, 51 patients underwent liver resection for HNEM. Primary tumor types were adrenal gland (n = 26), thyroid (n = 11), testicular germ cell (n = 9), and ovarian granulosa cell (n = 5). 28 patients (55%) had synchronous or early (diagnosed within 12 months after primary tumor resection) liver metastases. At liver resection, 26 patients (51%) had extrahepatic metastases, and 7 (14%) had ≥2 sites of extrahepatic metastases. 32 patients (63%) had major liver resection and 19 (37%) had a simultaneous extrahepatic procedure. 90-day postoperative morbidity and mortality rates were 27% and 2%, respectively. After median follow-up of 20 months (range, 1-144), the 5-year overall and recurrence-free survival rates were 58% and 37%, respectively. Survival was not affected by primary tumor type. In multivariate analysis, ≥2 sites of extrahepatic metastases (hazard ratio [HR] = 4.80; 95% confidence interval [CI] = 1.18-19.50; P = .028) and interval of ≤12 months between primary tumor resection and diagnosis of liver metastases (HR = 5.33; 95% CI = 1.11-25.71; P = .037) were associated with worse overall survival after liver resection. CONCLUSION: For selected patients, liver resection for HNEM is associated with long-term survival. The number of extrahepatic sites of metastasis and the timing of appearance of liver metastases should be considered in patient selection.<br/>
        </p>
<p>PMID: 22306838 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/liver-resection-for-liver-metastases-from-nondigestive-endocrine-cancer-extrahepatic-disease-burden-defines-outcome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.</title>
		<link>http://jsurg.com/blog/quantification-of-hypercoagulable-state-after-blunt-trauma-microparticle-and-thrombin-generation-are-increased-relative-to-injury-severity-while-standard-markers-are-not/</link>
		<comments>http://jsurg.com/blog/quantification-of-hypercoagulable-state-after-blunt-trauma-microparticle-and-thrombin-generation-are-increased-relative-to-injury-severity-while-standard-markers-are-not/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:52 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.
        Surgery. 2012 Feb 6;
        Authors:  Park MS, Owen BA, Bal...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.</b></p>
<p>Surgery. 2012 Feb 6;</p>
<p>Authors:  Park MS, Owen BA, Ballinger BA, Sarr MG, Schiller HJ, Zietlow SP, Jenkins DH, Ereth MH, Owen WG, Heit JA</p>
<p>Abstract<br/><br />
        BACKGROUND: Major trauma is an independent risk factor for developing venous thromboembolism. While increases in thrombin generation and/or procoagulant microparticles have been detected in other patient groups at greater risk for venous thromboembolism, such as cancer or coronary artery disease, this association has yet to be documented in trauma patients. This pilot study was designed to characterize and quantify thrombin generation and plasma microparticles in individuals early after traumatic injury. METHODS: Blood was collected in the trauma bay from 52 blunt injured patients (cases) and 19 uninjured outpatients (controls) and processed to platelet poor plasma to allow for (1) isolation of microparticles for identification and quantification by flow cytometry, and (2) in vitro thrombin generation as measured by calibrated automatic thrombography. Data collected are expressed as either mean ± standard deviation or median with interquartile range. RESULTS: Among the cases, which included 39 men and 13 women (age, 40 ± 17 years), the injury severity score was 13 ± 11, the international normalized ratio was 1.0 ± 0.1, the thromboplastin time was 25 ± 3 seconds, and platelet count was 238 ± 62 (thousands). The numbers of total (cell type not specified) procoagulant microparticles, as measured by Annexin V staining, were increased compared to nontrauma controls (541 ± 139/μL and 155 ± 148/μL, respectively; P &lt; .001). There was no significant difference in the amount of thrombin generated in trauma patients compared to controls; however, peak thrombin was correlated to injury severity (Spearman correlation coefficient R, 0.35; P = .02). CONCLUSION: Patients with blunt trauma have greater numbers of circulating procoagulant microparticles and increased in vitro thrombin generation. Future studies to characterize the cell-specific profiles of microparticles and changes in thrombin generation kinetics after traumatic injury will determine whether microparticles contribute to the hypercoagulable state observed after injury.<br/>
        </p>
<p>PMID: 22316436 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/quantification-of-hypercoagulable-state-after-blunt-trauma-microparticle-and-thrombin-generation-are-increased-relative-to-injury-severity-while-standard-markers-are-not/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gastric volvulus after sleeve gastrectomy for morbid obesity.</title>
		<link>http://jsurg.com/blog/gastric-volvulus-after-sleeve-gastrectomy-for-morbid-obesity/</link>
		<comments>http://jsurg.com/blog/gastric-volvulus-after-sleeve-gastrectomy-for-morbid-obesity/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:51 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Gastric volvulus after sleeve gastrectomy for morbid obesity.
        Surgery. 2012 Feb 6;
        Authors:  Del Castillo Déjardin D, Sabench Pereferrer F, Hernàndez Gonzàlez M, Blanco Blasco S, Cabrera Vilanova A
        Abstract
       ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Gastric volvulus after sleeve gastrectomy for morbid obesity.</b></p>
<p>Surgery. 2012 Feb 6;</p>
<p>Authors:  Del Castillo Déjardin D, Sabench Pereferrer F, Hernàndez Gonzàlez M, Blanco Blasco S, Cabrera Vilanova A</p>
<p>Abstract<br/><br />
        BACKGROUND: Laparoscopic sleeve gastrectomy in morbid obesity has proved to be a safe and reproducible technique. Sleeve gastrectomy, however, is not free of complications. On the other hand, gastric volvulus is reported in those subjects where, either because of laxity of the gastric anatomical fixations or incorrect position of the stomach, rotation or turning is facilitated. CASE: We report the case of a patient with morbid obesity (Bone mass index / BMI 63 Kg/m(2)), who in the post-operative period immediately following a sleeve gastrectomy, presented early symptoms of upper gastrointestinal occlusion indicative of gastric volvulus of the gastric sleeve. RESULTS: The patient developed a partial obstruction secondary to a mixed volvulus mechanism (organo-axial and partially mesenteric-axial) after sleeve gastrectomy. We performed a laparoscopic antrectomy of the gastric sleeve and then a gastroileal anastomosis, a form of biliopancreatic diversion, with a common channel of 80 cm and alimentary limb of 160 cm). 18 months after, the patient has a BMI of 28 kg/m(2) and enjoys a good quality of life. CONCLUSION: Sleeve gastrectomy leaves the stomach with no fixations along the entire greater curvature, which may predispose to volvulus. This complication is a rare finding and not reported to date following this intervention, but still needs to be considered in this type of patient.<br/>
        </p>
<p>PMID: 22316437 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/gastric-volvulus-after-sleeve-gastrectomy-for-morbid-obesity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effects of ileal interposition on glucose metabolism in obese rats with diabetes.</title>
		<link>http://jsurg.com/blog/effects-of-ileal-interposition-on-glucose-metabolism-in-obese-rats-with-diabetes/</link>
		<comments>http://jsurg.com/blog/effects-of-ileal-interposition-on-glucose-metabolism-in-obese-rats-with-diabetes/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:48 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Effects of ileal interposition on glucose metabolism in obese rats with diabetes.
        Surgery. 2012 Feb 6;
        Authors:  Ikezawa F, Shibata C, Kikuchi D, Imoto H, Miura K, Naitoh T, Ogawa H, Sasaki I, Tsuchiya T
        Abstract
    ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Effects of ileal interposition on glucose metabolism in obese rats with diabetes.</b></p>
<p>Surgery. 2012 Feb 6;</p>
<p>Authors:  Ikezawa F, Shibata C, Kikuchi D, Imoto H, Miura K, Naitoh T, Ogawa H, Sasaki I, Tsuchiya T</p>
<p>Abstract<br/><br />
        BACKGROUND: Ileal interposition (IT), in which the distal ileum is transposed isoperistaltically into the proximal jejunum, is considered as a procedure for metabolic or antidiabetes surgery. Our aim was to study the effects of IT on glycemic control, fat metabolism, and hormonal changes in obese rats with spontaneous diabetes. METHODS: Animals were divided into either an IT or a sham (SH) group. They underwent an oral glucose tolerance test (OGTT) before and 4 and 8 weeks after the operation. All animals were killed 10 weeks after operation for analyses of tissue weight (liver, pancreas, epididymal fat, brown fat), immunoblotting of uncoupling protein-1 (UCP1) protein in brown adipose tissue (BAT), and fasting plasma levels of glucose, insulin, glucagon-like peptide (GLP)-1, peptide YY (PYY), glucose-dependent insulinotropic polypeptide (GIP), and leptin. RESULTS: Body weight increased postoperatively in both groups compared with preoperative weight, but it did not differ between the 2 groups. Eight weeks postoperatively, integrated blood glucose levels during the OGTT were decreased in IT compared with SH (P &lt; .05). Fasting plasma levels of insulin, GLP-1, and GIP did not differ between the 2 groups, but PYY levels were higher in the IT animals (P &lt; .01). The weight of epididymal and BATs, homeostasis model assessment insulin resistance, and fasting plasma leptin levels were decreased in the IT group (P &lt; .05). Expression of UCP1 was higher in IT than SH animals (P &lt; .05). CONCLUSION: These results suggest that IT improves glucose and lipid metabolism by decreasing insulin resistance and epididymal fat, and increased expression of UCP1 in BAT might be among the mechanisms responsible.<br/>
        </p>
<p>PMID: 22316438 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/effects-of-ileal-interposition-on-glucose-metabolism-in-obese-rats-with-diabetes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review.</title>
		<link>http://jsurg.com/blog/the-role-of-liver-resection-for-colorectal-cancer-metastases-in-an-era-of-multimodality-treatment-a-systematic-review/</link>
		<comments>http://jsurg.com/blog/the-role-of-liver-resection-for-colorectal-cancer-metastases-in-an-era-of-multimodality-treatment-a-systematic-review/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:45 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review.
        Surgery. 2012 Feb 6;
        Authors:  Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moult...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review.</b></p>
<p>Surgery. 2012 Feb 6;</p>
<p>Authors:  Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moulton CA, Ruo L, Wei AC, McLeod RS,  </p>
<p>Abstract<br/><br />
        BACKGROUND: To determine the role of liver resection in patients with liver and extrahepatic colorectal cancer metastases and the role of chemotherapy in patients in conjunction with liver resection. METHODS: MEDLINE and EMBASE databases were searched for articles published between 1995 and 2010, along with hand searching. RESULTS: A total of 4875 articles were identified, and 83 were retained for inclusion. Meta-analysis was not performed because of heterogeneity and poor quality of the evidence. Outcomes in patients who had liver and lung metastases, liver and portal node metastases, and liver and other extrahepatic disease were reported in 14, 10, and 14 studies, respectively. The role of perioperative chemotherapy was assessed in 30 studies, including 1 randomized controlled trial and 1 pooled analysis. Ten studies assessed the role of chemotherapy in patients with initially unresectable disease, and 5 studies assessed the need for operation after a radiologic complete response. CONCLUSION: The review suggests that: (1) select patients with pulmonary and hepatic CRC metastases may benefit from resection; (2) perioperative chemotherapy may improve outcome in patients undergoing a liver resection; (3) patients whose CRC liver metastases are initially unresectable may benefit from chemotherapy to identify a subgroup who may benefit later from resection; (4) after radiographic complete response (RCR), lesions should be resected if possible.<br/>
        </p>
<p>PMID: 22316439 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-role-of-liver-resection-for-colorectal-cancer-metastases-in-an-era-of-multimodality-treatment-a-systematic-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Be cautious in caudate lobectomy for patients with solitary caudate lobe hepatocellular carcinoma and severe cirrhosis.</title>
		<link>http://jsurg.com/blog/be-cautious-in-caudate-lobectomy-for-patients-with-solitary-caudate-lobe-hepatocellular-carcinoma-and-severe-cirrhosis/</link>
		<comments>http://jsurg.com/blog/be-cautious-in-caudate-lobectomy-for-patients-with-solitary-caudate-lobe-hepatocellular-carcinoma-and-severe-cirrhosis/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 00:19:40 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Be cautious in caudate lobectomy for patients with solitary caudate lobe hepatocellular carcinoma and severe cirrhosis.
        Surgery. 2012 Feb 10;
        Authors:  Li H
        PMID: 22325825 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Be cautious in caudate lobectomy for patients with solitary caudate lobe hepatocellular carcinoma and severe cirrhosis.</b></p>
<p>Surgery. 2012 Feb 10;</p>
<p>Authors:  Li H</p>
<p>PMID: 22325825 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/be-cautious-in-caudate-lobectomy-for-patients-with-solitary-caudate-lobe-hepatocellular-carcinoma-and-severe-cirrhosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.</title>
		<link>http://jsurg.com/blog/laparoscopic-resection-of-exocrine-carcinoma-in-central-and-distal-pancreas-results-in-a-high-rate-of-radical-resections-and-long-postoperative-survival/</link>
		<comments>http://jsurg.com/blog/laparoscopic-resection-of-exocrine-carcinoma-in-central-and-distal-pancreas-results-in-a-high-rate-of-radical-resections-and-long-postoperative-survival/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:22:13 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
        Surgery. 2012 Jan 26;
        Authors:  Marangos IP, Buanes T, Røsok BI, Kazar...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.</b></p>
<p>Surgery. 2012 Jan 26;</p>
<p>Authors:  Marangos IP, Buanes T, Røsok BI, Kazaryan AM, Rosseland AR, Grzyb K, Villanger O, Mathisen O, Gladhaug IP, Edwin B</p>
<p>Abstract<br/><br />
        BACKGROUND: The role of laparoscopic resection in patients with pancreatic cancer remains to be clarified, because previous reports have not clearly defined oncologic outcomes. The objective of the present study was to investigate this question with the rate of R0 resection and long-term survival as endpoints. METHODS: This retrospective observational study included prospectively collected data from 40 patients operated laparoscopically with curative intent for exocrine pancreatic malignancies identified among 250 consecutive patients undergoing laparoscopic pancreatic operations since 1997. All 40 patients had histologically verified exocrine pancreatic carcinoma. RESULTS: Ten patients (25%) with typical ductal adenocarcinoma of the pancreas were deemed nonresectable by laparoscopic staging. Laparoscopic distal pancreatectomy was performed in 29 patients; 8 resections were combined with resections of adjacent organs and 1 removal of a malignant intraductal papillary mucinous neoplasm what appeared to be ectopic pancreatic tissue. In 1 patient, the resection was completed by hand-assisted technique, and 1 procedure was converted to open resection. Postoperative morbidity was 23% (n = 7). The median hospital stay was 5 days (range, 1-30). The rate of R0 resections was 93%. Postoperative 3-year survivals rates were 36% for the entire cohort (n = 30) and 30% in typical ductal adenocarcinoma (n = 21). CONCLUSION: Laparoscopic distal pancreatectomy for exocrine pancreatic carcinoma is comparable with outcomes after open surgery and supports the concept that laparoscopic distal pancreatectomy is a safe, oncologic procedure.<br/>
        </p>
<p>PMID: 22284762 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/laparoscopic-resection-of-exocrine-carcinoma-in-central-and-distal-pancreas-results-in-a-high-rate-of-radical-resections-and-long-postoperative-survival/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Early surgical outcomes comparison between robotic and conventional open thyroid surgery for papillary thyroid microcarcinoma.</title>
		<link>http://jsurg.com/blog/early-surgical-outcomes-comparison-between-robotic-and-conventional-open-thyroid-surgery-for-papillary-thyroid-microcarcinoma/</link>
		<comments>http://jsurg.com/blog/early-surgical-outcomes-comparison-between-robotic-and-conventional-open-thyroid-surgery-for-papillary-thyroid-microcarcinoma/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:22:11 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Early surgical outcomes comparison between robotic and conventional open thyroid surgery for papillary thyroid microcarcinoma.
        Surgery. 2012 Jan 26;
        Authors:  Lee S, Ryu HR, Park JH, Kim KH, Kang SW, Jeong JJ, Nam KH, Chung W...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Early surgical outcomes comparison between robotic and conventional open thyroid surgery for papillary thyroid microcarcinoma.</b></p>
<p>Surgery. 2012 Jan 26;</p>
<p>Authors:  Lee S, Ryu HR, Park JH, Kim KH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS</p>
<p>Abstract<br/><br />
        BACKGROUND: Robotic operations have enabled a safer and more meticulous approach to thyroidectomy with the notable benefit of improved cosmesis and decreases in postoperative pain and swallowing discomfort. The aim of this study was to document the early surgical outcomes of robotic thyroidectomy in patients with papillary thyroid carcinoma (PTC) by comparing it with conventional open thyroidectomy. METHODS: From October 2007 to September 2008, 458 patients with PTC underwent thyroidectomy at the Yonsei University Health System. Of these patients, 266 patients were in the conventional open group and 192 patients were in the robotic group. These 2 groups were compared retrospectively with respect to clinicopathologic characteristics and surgical outcomes. RESULTS: The mean follow-up period was 29.1 months. Mean tumor size, incidence of capsular invasion, multiplicity, and central nodal metastasis showed no significant difference between the 2 groups. Total thyroidectomy was performed more frequently in the open group. In terms of operation times, the robotic group had a significantly greater length of time for total thyroidectomy and subtotal thyroidectomy. The total number of retrieved central lymph nodes was greater in the open group (5.7 versus 4.6, P = .004). The 2 groups showed no differences in intraoperative and postoperative complications. The postoperative serum thyroglobulin levels were similar in both groups (0.25 versus 0.22 ng/mL, P = .648) and 2-year follow-up sonography of 433 patients revealed no recurrences. No abnormal I(131) uptake was observed in whole-body scans in either group. CONCLUSION: Robotic thyroidectomy was similar to conventional open thyroidectomy in terms of early surgical outcomes but offers advantages. We conclude that robotic thyroidectomy offers a safe, feasible alternative to conventional open thyroidectomy in patients with PTC.<br/>
        </p>
<p>PMID: 22284763 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/early-surgical-outcomes-comparison-between-robotic-and-conventional-open-thyroid-surgery-for-papillary-thyroid-microcarcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities.</title>
		<link>http://jsurg.com/blog/survival-in-patients-with-recurrent-hepatocellular-carcinoma-after-primary-hepatectomy-comparative-effectiveness-of-treatment-modalities/</link>
		<comments>http://jsurg.com/blog/survival-in-patients-with-recurrent-hepatocellular-carcinoma-after-primary-hepatectomy-comparative-effectiveness-of-treatment-modalities/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:22:10 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities.
        Surgery. 2012 Jan 26;
        Authors:  Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH
        Ab...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities.</b></p>
<p>Surgery. 2012 Jan 26;</p>
<p>Authors:  Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH</p>
<p>Abstract<br/><br />
        BACKGROUND: Insufficient data are available on the survival of recurrent hepatocellular carcinoma after primary hepatectomy in patients receiving different treatments. We evaluated retrospectively the effects of treatment modalities on long-term survival. METHODS: Between 2001 and 2007, 435 posthepatectomy hepatocellular carcinoma patients who developed recurrence were grouped by treatment modality into re-resection, radiofrequency ablation, transarterial chemoembolization, and supportive treatment groups. Treatment strategies for both primary hepatocellular carcinoma and its recurrence were selected using the same criteria. Postrecurrence survival was estimated using the Kaplan-Meier method and compared using the Cox proportional hazard model with adjusted independent prognostic factors. Survival rates after primary resection without recurrence were also compared. RESULTS: In re-resection, radiofrequency ablation, transarterial chemoembolization, and supportive treatment groups, the 2-year postrecurrence survival rates were 90%, 96%, 75%, and 20%, respectively, and the 5-year survival rates were 72%, 83%, 56%, and 0%, respectively. The adjusted hazard of death was less for the re-resection and radiofrequency ablation groups than for the transarterial chemoembolization group, and the adjusted hazard ratios for the re-resection and radiofrequency ablation groups were 0.45 (95% confidence interval, 0.20-0.98) and 0.25 (0.08-0.81), respectively. The adjusted hazard ratio (95% confidence interval) of death for the radiofrequency ablation group compared to the re-resection group was 0.64 (0.19-2.19). Survival in the single resection group did not differ from that in the re-resection and radiofrequency ablation groups. CONCLUSION: Postrecurrence survival in the re-resection and radiofrequency ablation groups was significantly better than that in the transarterial chemoembolization group and similar to that of patients in the primary resection without recurrence group.<br/>
        </p>
<p>PMID: 22284764 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/survival-in-patients-with-recurrent-hepatocellular-carcinoma-after-primary-hepatectomy-comparative-effectiveness-of-treatment-modalities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.</title>
		<link>http://jsurg.com/blog/liposome-encapsulated-curcumin-suppresses-neuroblastoma-growth-through-nuclear-factor-kappa-b%c2%a0inhibition/</link>
		<comments>http://jsurg.com/blog/liposome-encapsulated-curcumin-suppresses-neuroblastoma-growth-through-nuclear-factor-kappa-b%c2%a0inhibition/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:22:08 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.
        Surgery. 2012 Jan 26;
        Authors:  Orr WS, Denbo JW, Saab KR, Myers AL, Ng CY, Zhou J, Morton CL, Pfeffer LM, Davidoff AM...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.</b></p>
<p>Surgery. 2012 Jan 26;</p>
<p>Authors:  Orr WS, Denbo JW, Saab KR, Myers AL, Ng CY, Zhou J, Morton CL, Pfeffer LM, Davidoff AM</p>
<p>Abstract<br/><br />
        BACKGROUND: Nuclear factor-κB (NF-κB) has been implicated in tumor cell proliferation and survival and in tumor angiogenesis. We sought to evaluate the effects of curcumin, an inhibitor of NF-κB, on a xenograft model of disseminated neuroblastoma. METHODS: For in vitro studies, neuroblastoma cell lines NB1691, CHLA-20, and SK-N-AS were treated with various doses of liposomal curcumin. Disseminated neuroblastoma was established in vivo by tail vein injection of NB1691-luc cells into SCID mice, which were then treated with 50 mg/kg/day of liposomal curcumin 5 days/week intraperitoneally. RESULTS: Curcumin suppressed NF-κB activation and proliferation of all neuroblastoma cell lines in vitro. In vivo, curcumin treatment resulted in a significant decrease in disseminated tumor burden. Curcumin-treated tumors had decreased NF-κB activity and an associated significant decrease in tumor cell proliferation and an increase in tumor cell apoptosis, as well as a decrease in tumor vascular endothelial growth factor levels and microvessel density. CONCLUSION: Liposomal curcumin suppressed neuroblastoma growth, with treated tumors showing a decrease in NF-κB activity. Our results suggest that liposomal curcumin may be a viable option for the treatment of neuroblastoma that works via inhibiting the NF-κB pathway.<br/>
        </p>
<p>PMID: 22284765 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/liposome-encapsulated-curcumin-suppresses-neuroblastoma-growth-through-nuclear-factor-kappa-b%c2%a0inhibition/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome.</title>
		<link>http://jsurg.com/blog/resection-of-liver-metastases-from-breast-cancer-estrogen-receptor-status-and-response-to-chemotherapy-before-metastasectomy-define-outcome/</link>
		<comments>http://jsurg.com/blog/resection-of-liver-metastases-from-breast-cancer-estrogen-receptor-status-and-response-to-chemotherapy-before-metastasectomy-define-outcome/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:22:03 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
        Surgery. 2012 Jan 27;
        Authors:  Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Me...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome.</b></p>
<p>Surgery. 2012 Jan 27;</p>
<p>Authors:  Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN</p>
<p>Abstract<br/><br />
        BACKGROUND: The oncologic benefit of resecting liver metastases in patients with breast cancer is unclear. This study was performed to identify predictors of survival after hepatectomy. METHODS: Between 1997 and 2010, 86 patients underwent resection of breast cancer liver metastases. Clinicopathologic characteristics of the primary breast neoplasm, timing of metastasis development, and treatment were recorded. Response to prehepatectomy chemotherapy was evaluated according to Response Criteria in Solid Tumors criteria, and the best response to chemotherapy during treatment and the response immediately before hepatectomy were noted. Univariate and multivariate analyses were performed to identify predictors of disease-free survival and overall survival. RESULTS: Fifty-nine patients (69%) had estrogen receptor- or progesterone receptor- positive primary breast neoplasms. Fifty-three patients (62%) had a solitary breast cancer liver metastasis, and 73 (85%) had breast cancer liver metastases ≤5 cm. Sixty-five patients (76%) received prehepatectomy hormonal and/or chemotherapy. Four patients (6%) had progressive disease as the best response, and 19 patients (30%) had progressive disease before hepatectomy (P &lt; .001). Seventy percent of patients who received preoperative chemotherapy or hormonal therapy had either response or stable disease immediately before hepatectomy. No postoperative deaths were observed. At a 62-month median follow-up, the disease-free survival and overall survival were 14 and 57 months, respectively. On univariate analysis, estrogen receptor/progesterone receptor status of the primary breast neoplasm, best radiographic response, and preoperative radiographic response were associated with overall survival. On multivariate analysis, estrogen receptor-negative primary breast disease (P = .009; hazard ratio, 3.3; 95% confidence interval, 1.4-8.2) and preoperative progressive disease (P = .003; hazard ratio, 3.8; 95% confidence interval, 1.6-9.2) were associated with decreased overall survival. CONCLUSION: Resection of breast cancer liver metastases in patients with estrogen receptor-positive disease that is responding to chemotherapy is associated with improved survival. The timing of operative intervention may be critical; resection before progression is associated with a better outcome.<br/>
        </p>
<p>PMID: 22285778 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/resection-of-liver-metastases-from-breast-cancer-estrogen-receptor-status-and-response-to-chemotherapy-before-metastasectomy-define-outcome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study.</title>
		<link>http://jsurg.com/blog/surgical-management-for-advanced-duodenal-adenomatosis-and-duodenal-cancer-in-dutch-patients-with-familial-adenomatous-polyposis-a-nationwide-retrospective-cohort-study/</link>
		<comments>http://jsurg.com/blog/surgical-management-for-advanced-duodenal-adenomatosis-and-duodenal-cancer-in-dutch-patients-with-familial-adenomatous-polyposis-a-nationwide-retrospective-cohort-study/#comments</comments>
		<pubDate>Sat, 28 Jan 2012 23:00:43 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study.
        Surgery. 2012 Jan 20;
        Authors:  van Heumen BW, Nieuwen...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study.</b></p>
<p>Surgery. 2012 Jan 20;</p>
<p>Authors:  van Heumen BW, Nieuwenhuis MH, van Goor H, Mathus-Vliegen LE, Dekker E, Gouma DJ, Dees J, van Eijck CH, Vasen HF, Nagengast FM</p>
<p>Abstract<br/><br />
        BACKGROUND: Duodenal cancer is a major cause of mortality in patients with familial adenomatous polyposis (FAP). The clinical challenge is to perform duodenectomy before cancer develops; however, procedures are associated with complications. Our aim was to gain insight into the pros and cons of prophylactic duodenectomy. METHODS: Patients with FAP from the nationwide Dutch polyposis registry who underwent prophylactic duodenectomy or were diagnosed with duodenal cancer were identified and classified as having benign disease or cancer at preoperative endoscopy. Surveillance, clinical presentation, surgical management, outcome, survival, and recurrence were compared. RESULTS: Of 1,066 patients with FAP in the registry, 52 (5%; 25 males) were included: 36 with benign adenomatosis (median: 48 years old; including two (6%) cancer cases diagnosed after operation), and 16 with cancer (median: 53 years old). Cancer cases had been diagnosed with colorectal cancer more often (6% vs 44%; P &lt; .01). Forty-three patients underwent duodenectomy (35 benign/eight cancer): 30-day mortality was 4.7% (n = 2), and in-hospital morbidity occurred in 21 patients (49%), without differences between patients with benign adenomatosis and cancer. Adenomas recurred in reconstructed proximal small bowel in 14 of 28 patients (50%, median time to recurrence: 75 months), and one patient developed cancer. Median survival of all 18 cancer cases in the registry (1.7%; 12 ampullary/six duodenal) was 11 months. CONCLUSION: Prognosis of duodenal cancer in patients with FAP is poor, which justifies an aggressive approach to advanced benign adenomatosis. Strict adherence to recommended surveillance intervals is essential for a well-timed intervention. Given the substantial morbidity and mortality of duodenectomy, patients&#8217; individual characteristics are to be critically evaluated preoperatively. As adenomas recur, postoperative endoscopic surveillance is mandatory.<br/>
        </p>
<p>PMID: 22265391 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/surgical-management-for-advanced-duodenal-adenomatosis-and-duodenal-cancer-in-dutch-patients-with-familial-adenomatous-polyposis-a-nationwide-retrospective-cohort-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Selection algorithm for posterior versus lateral approach in laparoscopic adrenalectomy.</title>
		<link>http://jsurg.com/blog/selection-algorithm-for-posterior-versus-lateral-approach-in-laparoscopic-adrenalectomy/</link>
		<comments>http://jsurg.com/blog/selection-algorithm-for-posterior-versus-lateral-approach-in-laparoscopic-adrenalectomy/#comments</comments>
		<pubDate>Sat, 21 Jan 2012 22:27:31 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Selection algorithm for posterior versus lateral approach in laparoscopic adrenalectomy.
        Surgery. 2012 Jan 17;
        Authors:  Agcaoglu O, Sahin DA, Siperstein A, Berber E
        Abstract
        BACKGROUND: There are no objective...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Selection algorithm for posterior versus lateral approach in laparoscopic adrenalectomy.</b></p>
<p>Surgery. 2012 Jan 17;</p>
<p>Authors:  Agcaoglu O, Sahin DA, Siperstein A, Berber E</p>
<p>Abstract<br/><br />
        BACKGROUND: There are no objective selection criteria described in the literature for the laparoscopic posterior retroperitoneal (PR) vs lateral transabdominal (LT) approach in a given patient. The aim of this study is to quantify the algorithm we have been using in our practice. METHODS: Within 11 years, 219 patients underwent laparoscopic adrenalectomy at one institution. The laparoscopic LT technique was used in patients with unilateral tumors &gt;6 cm. In those patients with unilateral tumors &lt;6 cm, anthropometric parameters were used to select between laparoscopic PR and LT approaches. These parameters were quantified for 82 patients from computed tomography scans and their effects on operative time were calculated. Statistical analyses were performed by use of the t test and logistic regression analysis. RESULTS: Fifty-two patients underwent laparoscopic LT and 30 patients underwent PR adrenalectomy. Patients were selected for the PR approach if the distance from Gerota&#8217;s fascia to the skin was less than 5 cm and the 12th rib was at or rostral to the level of renal hilum. On multivariate analysis, total operative time correlated with body mass index in the LT approach and thickness of the perinephric fat and the distance between the adrenal tumor and the upper pole of kidney in the PR approach. CONCLUSION: In this study, we have described an objective algorithm that can be used to select patients with unilateral adrenal tumors &lt;6 cm for a laparoscopic PR or LT approach with favorable perioperative outcomes.<br/>
        </p>
<p>PMID: 22261293 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/selection-algorithm-for-posterior-versus-lateral-approach-in-laparoscopic-adrenalectomy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impact of subcentimeter margin on outcome after hepatic resection for colorectal metastases: A meta-regression approach.</title>
		<link>http://jsurg.com/blog/impact-of-subcentimeter-margin-on-outcome-after-hepatic-resection-for-colorectal-metastases-a-meta-regression-approach/</link>
		<comments>http://jsurg.com/blog/impact-of-subcentimeter-margin-on-outcome-after-hepatic-resection-for-colorectal-metastases-a-meta-regression-approach/#comments</comments>
		<pubDate>Sat, 21 Jan 2012 22:27:27 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Impact of subcentimeter margin on outcome after hepatic resection for colorectal metastases: A meta-regression approach.
        Surgery. 2012 Jan 17;
        Authors:  Cucchetti A, Ercolani G, Cescon M, Bigonzi E, Peri E, Ravaioli M, Pinna ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Impact of subcentimeter margin on outcome after hepatic resection for colorectal metastases: A meta-regression approach.</b></p>
<p>Surgery. 2012 Jan 17;</p>
<p>Authors:  Cucchetti A, Ercolani G, Cescon M, Bigonzi E, Peri E, Ravaioli M, Pinna AD</p>
<p>Abstract<br/><br />
        BACKGROUND: The optimal margin width and its influence on outcomes after hepatic resection for colorectal liver metastases is still controversial: a meta-analysis was conducted to analyze the impact of subcentimeter margin width on patient and disease-free survival after resection. METHODS: A systematic search was performed, covering the last decade, following the Meta-analysis Of Observational Studies in Epidemiology guidelines. Relative risks (RRs) for patient and disease-free survival (DFS) were calculated after resection in relationship to a margin width &gt;1 cm (R0 &gt; 1 cm) and between 1 mm and 1 cm (R0 &lt; 1 cm) using the DerSimonian and Laird random-effects model. Meta-regression was applied for covariate adjustment. RESULTS: Eleven observational studies were identified involving 2823 patients. Overall, 59.1% of patients were R0 &lt; 1 cm and 40.9% were R0 &gt; 1 cm. Meta-analysis showed that compared with patients with margins R0 &gt; 1 cm, a R0 &lt; 1 cm margin lead to decreased 1-, 3-, and 5-year DFS with a RR of 1.17 (95% confidence interval [CI] 1.07-1.27), 1.38 (95% CI 1.16-1.65), and 1.55 (95% CI 1.25-1.91), respectively, but patient survival was obviously affected (P &gt; .05 in all cases). Patients with margins of R0 &lt; 1 cm differ from those with R0 &gt; 1 cm for greater proportions of multiple metastases (RR 1.43; 95% CI 0.25-1.61) and synchronous bowel disease (RR 1.42; 95% CI 0.8-1.92). Meta-regression showed that these two covariates had a significant impact on DFS but not on patient survival. CONCLUSION: A resection margin width &gt;1 cm is desirable even if patient survival is at best only slightly affected by subcentimeter margin as a consequence of a decreased DFS. The presence of multiple metastases and synchronous bowel neoplasm represent potential study selection biases that significantly decrease DFS; well-conducted, matched analyses consequently are essential to clarify the issue.<br/>
        </p>
<p>PMID: 22261294 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/impact-of-subcentimeter-margin-on-outcome-after-hepatic-resection-for-colorectal-metastases-a-meta-regression-approach/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity.</title>
		<link>http://jsurg.com/blog/a-controlled-clinical-trial-of-the-effect-of-gastric-bypass-surgery-and-intensive-lifestyle-intervention-on-nocturnal-hypertension-and-the-circadian-blood-pressure-rhythm-in-patients-with-morbid-obesi/</link>
		<comments>http://jsurg.com/blog/a-controlled-clinical-trial-of-the-effect-of-gastric-bypass-surgery-and-intensive-lifestyle-intervention-on-nocturnal-hypertension-and-the-circadian-blood-pressure-rhythm-in-patients-with-morbid-obesi/#comments</comments>
		<pubDate>Sat, 21 Jan 2012 22:27:24 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity.
        Surgery. 2012 Jan 17;
       ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity.</b></p>
<p>Surgery. 2012 Jan 17;</p>
<p>Authors:  Nordstrand N, Hertel JK, Hofsø D, Sandbu R, Saltvedt E, Røislien J, Os I, Hjelmesæth J</p>
<p>Abstract<br/><br />
        BACKGROUND: Nocturnal hypertension, increased night-to-day systolic blood pressure (BP) ratio and nondipper status (night-to-day systolic BP ratio &gt; 0.9) are associated with an increased risk of cardiovascular disease. Our aim was to compare the 1-year effect of Roux-en-Y gastric bypass (RYGB) vs a program of intensive lifestyle intervention (ILI) only on nocturnal hypertension and circadian BP rhythm. METHODS: The study participants were part of a 1-year, controlled clinical trial comparing the effect of RYGB or ILI on obesity-related comorbidities. Ninety participants (49 in the RYGB group) successfully completed 24-hour ambulatory BP monitoring at baseline and follow-up and were eligible subsequently for analysis. RESULTS: A total of 71 subjects (79%) had nocturnal hypertension at baseline. The number of subjects with nocturnal hypertension decreased from 42 to 14 in the RYGB group (P ≤ .001) and from 29 to 27 (P = .791) in the ILI group. Subjects in the RYGB group had a lesser adjusted odds ratio (OR) of nocturnal hypertension at follow-up (OR 0.15; 95% confidence interval, 0.05-0.42; P ≤ .001); however, after further adjustment for weight loss, there was no additional beneficial effect of RYGB (P = .674). No differences between groups regarding improvement in the night-to-day systolic BP ratio were found after adjustment for 24-hour systolic pressure (P = .107). Both interventions showed a decrease in the proportion of subjects classified as nondippers, namely, 44% (P ≤ .001) and 28% (P = .002) in the RYGB and ILI groups, respectively. CONCLUSION: Only RYGB was associated with a decrease in the prevalence of nocturnal hypertension. Both interventions showed an improvement in dipper status, although RYGB was more effective.<br/>
        </p>
<p>PMID: 22261295 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/a-controlled-clinical-trial-of-the-effect-of-gastric-bypass-surgery-and-intensive-lifestyle-intervention-on-nocturnal-hypertension-and-the-circadian-blood-pressure-rhythm-in-patients-with-morbid-obesi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Variations in surgical outcomes associated with hospital compliance with safety practices.</title>
		<link>http://jsurg.com/blog/variations-in-surgical-outcomes-associated-with-hospital-compliance-with-safety-practices/</link>
		<comments>http://jsurg.com/blog/variations-in-surgical-outcomes-associated-with-hospital-compliance-with-safety-practices/#comments</comments>
		<pubDate>Sat, 21 Jan 2012 22:27:16 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Variations in surgical outcomes associated with hospital compliance with safety practices.
        Surgery. 2012 Jan 17;
        Authors:  Brooke BS, Dominici F, Pronovost PJ, Makary MA, Schneider E, Pawlik TM
        Abstract
        BACKGR...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Variations in surgical outcomes associated with hospital compliance with safety practices.</b></p>
<p>Surgery. 2012 Jan 17;</p>
<p>Authors:  Brooke BS, Dominici F, Pronovost PJ, Makary MA, Schneider E, Pawlik TM</p>
<p>Abstract<br/><br />
        BACKGROUND: The Leapfrog Group aims to improve patient safety by promoting hospital compliance with National Quality Forum (NQF) safe practices. It is unknown, however, whether implementation of these safety practices improve outcomes after high-risk operations. METHODS: We conducted a cross-sectional analysis of 658 nationwide hospitals that responded to the 2005 Leapfrog Group Hospital Quality &amp; Safety survey. A total of 79,462 patients were identified from Medicare claims data who underwent a pancreatectomy, hepatectomy, esophagectomy, open aortic aneurysm repair, colectomy, or gastrectomy procedure from 2004 through 2006. Random effects logistic regression models were used to estimate the association between hospital compliance with NQF safe practices and risk-adjusted odds of complications, rate of failure to rescue, and mortality after adjusting for patient- and hospital-level confounders. RESULTS: Of the 658 hospitals that responded to surveys, 41% had fully implemented NQF safe practices and 59% reported partial compliance with these standards. Compared with hospitals with partial NQF compliance, we found evidence that hospitals with full compliance had an increased likelihood of diagnosing a complication after any of the 6 high-risk operations (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.03-1.25), but had a decreased likelihood of failure to rescue (OR, 0.82; 95% CI, 0.71-0.96), and a decreased odds of mortality (OR, 0.80; 95% CI, 0.71-0.91). CONCLUSION: Despite having a greater rate of postoperative complications, hospitals fully complying with safe practices were associated with less failure to rescue and decreased mortality after high-risk operations. These results highlight the importance of having hospital systems in place to promote safety and manage postoperative complications.<br/>
        </p>
<p>PMID: 22261296 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/variations-in-surgical-outcomes-associated-with-hospital-compliance-with-safety-practices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bile leakage after hepatobiliary and pancreatic surgery: Is the ISGLS definition too simple?</title>
		<link>http://jsurg.com/blog/bile-leakage-after-hepatobiliary-and-pancreatic-surgery-is-the-isgls-definition-too-simple/</link>
		<comments>http://jsurg.com/blog/bile-leakage-after-hepatobiliary-and-pancreatic-surgery-is-the-isgls-definition-too-simple/#comments</comments>
		<pubDate>Fri, 20 Jan 2012 22:24:06 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Bile leakage after hepatobiliary and pancreatic surgery: Is the ISGLS definition too simple?
        Surgery. 2012 Jan 16;
        Authors:  Sonbare D
        PMID: 22257831 [PubMed - as supplied by publisher]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Bile leakage after hepatobiliary and pancreatic surgery: Is the ISGLS definition too simple?</b></p>
<p>Surgery. 2012 Jan 16;</p>
<p>Authors:  Sonbare D</p>
<p>PMID: 22257831 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/bile-leakage-after-hepatobiliary-and-pancreatic-surgery-is-the-isgls-definition-too-simple/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The effect of adding fish oil to parenteral nutrition on hepatic mononuclear cell function and survival after intraportal bacterial challenge in mice.</title>
		<link>http://jsurg.com/blog/the-effect-of-adding-fish-oil-to-parenteral-nutrition-on-hepatic-mononuclear-cell-function-and-survival-after-intraportal-bacterial-challenge-in-mice/</link>
		<comments>http://jsurg.com/blog/the-effect-of-adding-fish-oil-to-parenteral-nutrition-on-hepatic-mononuclear-cell-function-and-survival-after-intraportal-bacterial-challenge-in-mice/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:29 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The effect of adding fish oil to parenteral nutrition on hepatic mononuclear cell function and survival after intraportal bacterial challenge in mice.
        Surgery. 2012 Jan 11;
        Authors:  Moriya T, Fukatsu K, Maeshima Y, Ikezawa F...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The effect of adding fish oil to parenteral nutrition on hepatic mononuclear cell function and survival after intraportal bacterial challenge in mice.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Moriya T, Fukatsu K, Maeshima Y, Ikezawa F, Hashiguchi Y, Saitoh D, Miyazaki M, Hase K, Yamamoto J</p>
<p>Abstract<br/><br />
        BACKGROUND: Parenteral nutrition (PN) is indispensable for meeting caloric and substrate needs of patients who cannot receive adequate amounts of enteral nutrition; however, PN impairs hepatic immunity. We examined the effects of ω-3 and -6 polyunsaturated fatty acids, added individually to fat-free PN, on hepatic immunity in a murine model. We focused on serum liver enzymes, cytokine production, histopathology, and the outcomes after intraportal bacterial challenge. METHODS: Male Institute of Cancer Research mice were randomized into 4 groups; ad libitum chow (CHOW), fat-free PN (FF-PN), PN + fish oil (FO-PN), or PN + safflower oil (SO-PN). After the mice had been fed for 5 days, hepatic mononuclear cells (MNCs) were isolated. The number of MNCs was counted and cytokine production (tumor necrosis factor [TNF]-α and interleukin [IL]-10) by hepatic MNCs in response to lipopolysaccharide (LPS) was measured. Blood samples were analyzed for hepatobiliary biochemical parameters. Moreover, 1.0 × 10(7) pseudomonas aeruginosa were delivered by intraportal injection. Survival and histology were examined. RESULTS: Hepatic MNC numbers were significantly less in the FO-PN and FF-PN than in the CHOW group, whereas the SO-PN group showed moderate recovery of hepatic MNC numbers. The CHOW, FO-PN, and SO-PN groups showed LPS dose-dependent increases in TNF-α levels. These increases were blunted in the FF-PN group. IL-10 levels were increased LPS dose-dependently in the CHOW and FO-PN groups, but no marked changes were observed with LPS stimulation in the SO-PN and FF-PN groups. Plasma levels of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were significantly greater in the FF-PN than in the FO- and SO-PN and CHOW groups. The FO-PN group showed significantly improved survival compared with the SO-PN and FF-PN groups, showing essentially no morphologic hepatic abnormalities. CONCLUSION: Addition of fish oil to PN was advantageous in terms of reversing PN-induced deterioration of hepatic immunity, as reflected by altered cytokine production. Fish oil administration was also useful for preventing PN-induced hepatobiliary dysfunction. These changes seem to result in better survival and to protect against severe tissue damage after intraportal bacterial challenge. This therapy may have the potential to ameliorate PN-induced impairment of host immunity and thereby decrease morbidity and mortality.<br/>
        </p>
<p>PMID: 22244177 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-effect-of-adding-fish-oil-to-parenteral-nutrition-on-hepatic-mononuclear-cell-function-and-survival-after-intraportal-bacterial-challenge-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel use of electronic whiteboard in the operating room increases surgical team compliance with pre-incision safety practices.</title>
		<link>http://jsurg.com/blog/novel-use-of-electronic-whiteboard-in-the-operating-room-increases-surgical-team-compliance-with-pre-incision-safety-practices/</link>
		<comments>http://jsurg.com/blog/novel-use-of-electronic-whiteboard-in-the-operating-room-increases-surgical-team-compliance-with-pre-incision-safety-practices/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:27 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Novel use of electronic whiteboard in the operating room increases surgical team compliance with pre-incision safety practices.
        Surgery. 2012 Jan 11;
        Authors:  Mainthia R, Lockney T, Zotov A, France DJ, Bennett M, St Jacques ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Novel use of electronic whiteboard in the operating room increases surgical team compliance with pre-incision safety practices.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Mainthia R, Lockney T, Zotov A, France DJ, Bennett M, St Jacques PJ, Furman W, Randa S, Feistritzer N, Eavey R, Leming-Lee S, Anders S</p>
<p>Abstract<br/><br />
        BACKGROUND: Despite evidence that use of a checklist during the pre-incision time out improves patient morbidity and mortality, compliance with performing the required elements of the checklist has been low. In an effort to improve compliance, a standardized time out interactive Electronic Checklist System [iECS] was implemented in all hospital operating room (OR) suites at 1 institution. The purpose of this 12-month prospective observational study was to assess whether an iECS in the OR improves and sustains improved surgical team compliance with the pre-incision time out. METHODS: Direct observational analyses of preprocedural time outs were performed on 80 cases 1 month before, and 1 and 9 months after implementation of the iECS, for a total of 240 observed cases. Three observers, who achieved high interrater reliability (kappa = 0.83), recorded a compliance score (yes, 1; no, 0) on each element of the time out. An element was scored as compliant if it was clearly verbalized by the surgical team. RESULTS: Pre-intervention observations indicated that surgical staff verbally communicated the core elements of the time out procedure 49.7 ± 12.9% of the time. After implementation of the iECS, direct observation of 80 surgical cases at 1 and 9 months indicated that surgical staff verbally communicated the core elements of the time out procedure 81.6 ± 11.4% and 85.8 ± 6.8% of the time, respectively, resulting in a statistically significant (P &lt; .0001) increase in time out procedural compliance. CONCLUSION: Implementation of a standardized, iECS can dramatically increase compliance with preprocedural time outs in the OR, an important and necessary step in improving patient outcomes and reducing preventable complications and deaths.<br/>
        </p>
<p>PMID: 22244178 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/novel-use-of-electronic-whiteboard-in-the-operating-room-increases-surgical-team-compliance-with-pre-incision-safety-practices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The state of performance on the American Board of Surgery Qualifying Examination and Certifying Examination and the effect of residency program size on program pass rates.</title>
		<link>http://jsurg.com/blog/the-state-of-performance-on-the-american-board-of-surgery-qualifying-examination-and-certifying-examination-and-the-effect-of-residency-program-size-on-program-pass-rates/</link>
		<comments>http://jsurg.com/blog/the-state-of-performance-on-the-american-board-of-surgery-qualifying-examination-and-certifying-examination-and-the-effect-of-residency-program-size-on-program-pass-rates/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:26 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The state of performance on the American Board of Surgery Qualifying Examination and Certifying Examination and the effect of residency program size on program pass rates.
        Surgery. 2012 Jan 11;
        Authors:  Falcone JL, Hamad GG
...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The state of performance on the American Board of Surgery Qualifying Examination and Certifying Examination and the effect of residency program size on program pass rates.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Falcone JL, Hamad GG</p>
<p>PMID: 22244179 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-state-of-performance-on-the-american-board-of-surgery-qualifying-examination-and-certifying-examination-and-the-effect-of-residency-program-size-on-program-pass-rates/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications.</title>
		<link>http://jsurg.com/blog/video-assisted-thoracoscopic-surgery-for-esophageal-cancer-attenuates-postoperative-systemic-responses-and-pulmonary-complications/</link>
		<comments>http://jsurg.com/blog/video-assisted-thoracoscopic-surgery-for-esophageal-cancer-attenuates-postoperative-systemic-responses-and-pulmonary-complications/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:22 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications.
        Surgery. 2012 Jan 11;
        Authors:  Tsujimoto H, Takahata R, Nomura S, Yaguchi Y, Kumano I, Matsu...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Tsujimoto H, Takahata R, Nomura S, Yaguchi Y, Kumano I, Matsumoto Y, Yoshida K, Horiguchi H, Hiraki S, Ono S, Yamamoto J, Hase K</p>
<p>Abstract<br/><br />
        BACKGROUND: Less invasive operations such as laparoscopic surgery have been developed for treating gastrointestinal malignancies. However, the advantages of video-assisted thoracoscopic surgery for esophageal cancer (VATS-e) with regard to postoperative morbidity and mortality remains controversial. METHODS: We investigated the postoperative clinical course of patients who underwent esophagectomy for esophageal cancer in terms of systemic inflammatory response syndrome (SIRS) induced by VATS-e (VATS-e group) or conventional open surgery (OS group) combined with laparoscopic gastric tube reconstruction. RESULTS: Compared with the OS group (n = 27), the VATS-e group (n = 22) had a greater thoracic operation time (VATS-e versus OS, 181 ± 56 vs 143 ± 45 minutes, respectively), and lesser duration of stay in the intensive care unit (17 ± 2 vs 32 ± 21 hours, respectively). The VATS-e group also had a lesser SIRS duration (1.5 vs 4.3 days), a lesser incidence of SIRS, a lesser number of positive SIRS criteria, and lesser serum interleukin-6 levels immediately after operation and on postoperative day (POD) 1. The heart rate in the VATS-e group was less than that in the OS group on POD 3. The respiratory rate in the VATS-e group was significantly less than that in the OS group on PODs 3, 5, and 7. Although no difference was observed in the frequencies of postoperative complications between the 2 groups, the VATS-e group had less postoperative pneumonia. CONCLUSION: VATS-e attenuates postoperative SIRS, and is therefore a potentially less invasive operative procedure.<br/>
        </p>
<p>PMID: 22244180 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/video-assisted-thoracoscopic-surgery-for-esophageal-cancer-attenuates-postoperative-systemic-responses-and-pulmonary-complications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies.</title>
		<link>http://jsurg.com/blog/prognostic-impact-of-marginal-resection-for-patients-with-solitary-hepatocellular-carcinoma-evidence-from-570-hepatectomies/</link>
		<comments>http://jsurg.com/blog/prognostic-impact-of-marginal-resection-for-patients-with-solitary-hepatocellular-carcinoma-evidence-from-570-hepatectomies/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:19 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies.
        Surgery. 2012 Jan 11;
        Authors:  Nara S, Shimada K, Sakamoto Y, Esaki M, Kishi Y, Kosuge T, Ojima H
...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Nara S, Shimada K, Sakamoto Y, Esaki M, Kishi Y, Kosuge T, Ojima H</p>
<p>Abstract<br/><br />
        BACKGROUND: During resection of a hepatocellular carcinoma, surgeons encounter occasionally a situation where marginal resection is inevitable because of a close association between the hepatocellular carcinoma and major vasculature and/or underlying impaired liver function. We investigated the impact of marginal resection on recurrence-free survival after a resection of a solitary hepatocellular carcinoma. METHODS: The data of 570 patients who underwent macroscopically curative hepatectomy for a solitary hepatocellular carcinoma in our institution between 1990 and 2007 were analyzed. Marginal resection and non-marginal resection were defined as a cancer-negative surgical margin of ≤1 mm and a surgical margin of &gt;1 mm, respectively. The macroscopic appearance of the hepatocellular carcinoma was classified as the simple nodular type or non-simple nodular type based on the classification of the Liver Cancer Study Group of Japan, and patients were categorized into 4 groups: group A, simple nodular type with cirrhosis; group B, simple nodular type without cirrhosis; group C, non-simple nodular type with cirrhosis; and group D, non-simple nodular type without cirrhosis. RESULTS: The surgical margins were diagnosed as cancer-positive in 31 patients, as marginal resection in 165 patients, and as non-marginal resection in 374 patients. The marginal resection group showed a better recurrence-free survival than the positive surgical margin group (P = .001), and also a worse recurrence-free survival than the non-marginal resection group (P = .003). In groups A, B, and C, the recurrence-free survival rates were similar between marginal resection and non-marginal resection patients (P = .458), while in group D, marginal resection was a significant poor prognostic factor of recurrence-free survival in both univariate and multivariate analyses. CONCLUSION: Marginal resection is acceptable in group A, B, and C patients, because it did not negatively affect postoperative recurrence-free survival.<br/>
        </p>
<p>PMID: 22244181 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/prognostic-impact-of-marginal-resection-for-patients-with-solitary-hepatocellular-carcinoma-evidence-from-570-hepatectomies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Capturing the teachable moment: A grounded theory study of verbal teaching interactions in the operating room.</title>
		<link>http://jsurg.com/blog/capturing-the-teachable-moment-a-grounded-theory-study-of-verbal-teaching-interactions-in-the-operating-room/</link>
		<comments>http://jsurg.com/blog/capturing-the-teachable-moment-a-grounded-theory-study-of-verbal-teaching-interactions-in-the-operating-room/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 22:12:10 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Capturing the teachable moment: A grounded theory study of verbal teaching interactions in the operating room.
        Surgery. 2012 Jan 11;
        Authors:  Roberts NK, Brenner MJ, Williams RG, Kim MJ, Dunnington GL
        Abstract
      ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Capturing the teachable moment: A grounded theory study of verbal teaching interactions in the operating room.</b></p>
<p>Surgery. 2012 Jan 11;</p>
<p>Authors:  Roberts NK, Brenner MJ, Williams RG, Kim MJ, Dunnington GL</p>
<p>Abstract<br/><br />
        BACKGROUND: Teaching in the operating room is one of the major cornerstones of surgical education. As time available for intraoperative resident teaching diminishes, such teaching time becomes increasingly precious. We studied how surgeons communicate with residents during an operation, with the goal of enhancing intraoperative teaching opportunities. METHODS: Grounded theory methodology was used to investigate intraoperative verbal communication during four videotaped surgical procedures. Utterance-by-utterance analysis was performed to generate codes for each surgeon-resident interaction. Interactions were then analyzed to determine the percentage time spent in verbal teaching, number of topics covered, times each topic was visited, and time per topic. RESULTS: Four main types of teaching surgeon-resident verbal interaction were identified from 1306 interactions. Instrumental interactions were intended solely to move the operation forward. Pure teaching interactions served to educate the trainee, shape judgment, or enhance performance. Instrumental and Teaching interactions were directive but also contained teaching. Banter was discussion unrelated to the operation. Analysis of a subset of the operations demonstrated 13-29 topics covered per procedure, with each topic addressed between 1 and 8 times, and 25-330 seconds spent per topic. Most teaching instances were prompted by errors in resident performance. CONCLUSION: Instances of verbal teaching were numerous, arose opportunistically in this study, and focused typically on multiple points. To maximize teaching opportunities, the authors propose a structured approach to intraoperative teaching that involves identification of a limited set of specific learning objectives, followed by intraoperative teaching and postoperative debriefing targeted to those objectives.<br/>
        </p>
<p>PMID: 22244182 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/capturing-the-teachable-moment-a-grounded-theory-study-of-verbal-teaching-interactions-in-the-operating-room/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanoma-assocıated hypopıgmentatıon ın assocıatıon wıth locoregıonal relapse of melanoma.</title>
		<link>http://jsurg.com/blog/melanoma-associated-hypopigmentation-in-association-with-locoregional-relapse-of-melanoma/</link>
		<comments>http://jsurg.com/blog/melanoma-associated-hypopigmentation-in-association-with-locoregional-relapse-of-melanoma/#comments</comments>
		<pubDate>Sat, 17 Dec 2011 19:24:42 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Melanoma-assocıated hypopıgmentatıon ın assocıatıon wıth locoregıonal relapse of melanoma.
        Surgery. 2011 Nov;150(5):1011-2
        Authors:  Tas F
        PMID: 20416916 [PubMed - indexed for MEDLINE]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Melanoma-assocıated hypopıgmentatıon ın assocıatıon wıth locoregıonal relapse of melanoma.</b></p>
<p>Surgery. 2011 Nov;150(5):1011-2</p>
<p>Authors:  Tas F</p>
<p>PMID: 20416916 [PubMed - indexed for MEDLINE]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/melanoma-associated-hypopigmentation-in-association-with-locoregional-relapse-of-melanoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Radiation-induced platelet-endothelial cell interactions are mediated by P-selectin and P-selectin glycoprotein ligand-1 in the colonic microcirculation.</title>
		<link>http://jsurg.com/blog/radiation-induced-platelet-endothelial-cell-interactions-are-mediated-by-p-selectin-and-p-selectin-glycoprotein-ligand-1-in-the-colonic-microcirculation/</link>
		<comments>http://jsurg.com/blog/radiation-induced-platelet-endothelial-cell-interactions-are-mediated-by-p-selectin-and-p-selectin-glycoprotein-ligand-1-in-the-colonic-microcirculation/#comments</comments>
		<pubDate>Sat, 17 Dec 2011 19:24:37 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Radiation-induced platelet-endothelial cell interactions are mediated by P-selectin and P-selectin glycoprotein ligand-1 in the colonic microcirculation.
        Surgery. 2011 Dec 6;
        Authors:  Mihaescu A, Thornberg C, Santén S, Matt...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Radiation-induced platelet-endothelial cell interactions are mediated by P-selectin and P-selectin glycoprotein ligand-1 in the colonic microcirculation.</b></p>
<p>Surgery. 2011 Dec 6;</p>
<p>Authors:  Mihaescu A, Thornberg C, Santén S, Mattsson S, Jeppsson B, Thorlacius H</p>
<p>Abstract<br/><br />
        BACKGROUND: Antiplatelet reagents have been reported to protect against intestinal damage associated with abdominal radiotherapy, but the mechanisms behind radiation-induced platelet-endothelium interactions are not known. We sought to define the adhesive mechanisms that regulate radiotherapy-induced platelet-endothelial cell interactions in the colon. METHODS: All mice except the controls were exposed to abdominal radiation with a single dose of 20 Gray. Mice were pretreated with an isotype-matched control antibody or a monoclonal antibody directed against either P-selectin or P-selectin glycoprotein ligand-1 (PSGL-1). Platelet and leukocyte rolling and adhesion in the colon were determined by use of inverted intravital fluorescence microscopy 16 hours after radiation. Radiation-induced intestinal leakage of fluorescein isothiocyanate-conjugated dextran was examined in separate experiments. RESULTS: Immunoneutralization of P-selectin decreased radiation-provoked platelet rolling by 87% and adhesion by 63%. Moreover, inhibition of PSGL-1 decreased platelet rolling and adhesion by 77% and 83%, respectively, in animals exposed to radiation. Similarly, inhibition of P-selectin and PSGL-1 decreased radiation-induced leukocyte rolling and adhesion by more than 84% and 90%, respectively, in the colon. In contrast, inhibition of P-selectin or PSGL-1 had no impact on radiation-induced intestinal leakage. In addition, systemic depletion of platelets and leukocytes did not affect intestinal barrier dysfunction in radiated animals. CONCLUSION: This study demonstrates that radiation-provoked platelet and leukocyte accumulation are mediated in part by P-selectin and PSGL-1. Radiation-induced gut leakage, however, is independent of accumulation of platelets and leukocytes in the intestinal microvasculature.<br/>
        </p>
<p>PMID: 22153123 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/radiation-induced-platelet-endothelial-cell-interactions-are-mediated-by-p-selectin-and-p-selectin-glycoprotein-ligand-1-in-the-colonic-microcirculation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Heparin-binding epidermal growth factor-like growth factor (HB-EGF) preserves gut barrier function by blocking neutrophil-endothelial cell adhesion after hemorrhagic shock and resuscitation in mice.</title>
		<link>http://jsurg.com/blog/heparin-binding-epidermal-growth-factor-like-growth-factor-hb-egf-preserves-gut-barrier-function-by-blocking-neutrophil-endothelial-cell-adhesion-after-hemorrhagic-shock-and-resuscitation-in-mice/</link>
		<comments>http://jsurg.com/blog/heparin-binding-epidermal-growth-factor-like-growth-factor-hb-egf-preserves-gut-barrier-function-by-blocking-neutrophil-endothelial-cell-adhesion-after-hemorrhagic-shock-and-resuscitation-in-mice/#comments</comments>
		<pubDate>Sat, 17 Dec 2011 19:24:33 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Heparin-binding epidermal growth factor-like growth factor (HB-EGF) preserves gut barrier function by blocking neutrophil-endothelial cell adhesion after hemorrhagic shock and resuscitation in mice.
        Surgery. 2011 Dec 7;
        Autho...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Heparin-binding epidermal growth factor-like growth factor (HB-EGF) preserves gut barrier function by blocking neutrophil-endothelial cell adhesion after hemorrhagic shock and resuscitation in mice.</b></p>
<p>Surgery. 2011 Dec 7;</p>
<p>Authors:  Zhang HY, James I, Chen CL, Besner GE</p>
<p>Abstract<br/><br />
        BACKGROUND: We have shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF) protects the intestines from injury in several different animal models, including hemorrhagic shock and resuscitation (HS/R). The current study was designed to explore the mechanisms underlying the anti-inflammatory role of HB-EGF in preservation of gut barrier function after injury. METHODS: In vivo, HS/R was induced in wild-type and neutropenic mice, with or without administration of HB-EGF, and intestinal permeability determined by use of the everted gut sac method. In vitro, cultured human umbilical vein endothelial cells (HUVECs) and freshly isolated human peripheral blood mononuclear cells (PMNs) were used to determine the effects of HB-EGF on HUVEC-PMN adhesion, reactive oxygen species production in PMN, adhesion molecule expression in HUVEC and PMN, and the signaling pathways involved. RESULTS: We found that administration of HB-EGF to healthy mice led to preservation of gut barrier function after HS/R. Likewise, induction of neutropenia in mice also led to preservation of gut barrier function after HS/R. Administration of HB-EGF to neutropenic mice did not lead to further improvement in gut barrier function. In vitro studies showed that HB-EGF decreased neutrophil-endothelial cell (PMN-EC) adherence by down-regulating adhesion molecule expression in EC via the phosphoinositide 3-kinase-Akt pathway, and by inhibiting adhesion molecule surface mobilization and reactive oxygen species production in PMN. CONCLUSION: These results indicate that HB-EGF preserves gut barrier function by inhibiting PMN and EC activation, thereby blocking PMN-EC adherence after HS/R in mice, and support the future use of HB-EGF in disease states manifested by hypoperfusion injury.<br/>
        </p>
<p>PMID: 22153812 [PubMed - as supplied by publisher]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/heparin-binding-epidermal-growth-factor-like-growth-factor-hb-egf-preserves-gut-barrier-function-by-blocking-neutrophil-endothelial-cell-adhesion-after-hemorrhagic-shock-and-resuscitation-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Papillary carcinoma of the thyroid: Balancing principles of oncology with emerging technology.</title>
		<link>http://jsurg.com/blog/papillary-carcinoma-of-the-thyroid-balancing-principles-of-oncology-with-emerging-technology/</link>
		<comments>http://jsurg.com/blog/papillary-carcinoma-of-the-thyroid-balancing-principles-of-oncology-with-emerging-technology/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:38 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Papillary carcinoma of the thyroid: Balancing principles of oncology with emerging technology.
        Surgery. 2011 Dec;150(6):1015-22
        Authors:  Evans DB
        PMID: 22136816 [PubMed - in process]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Papillary carcinoma of the thyroid: Balancing principles of oncology with emerging technology.</b></p>
<p>Surgery. 2011 Dec;150(6):1015-22</p>
<p>Authors:  Evans DB</p>
<p>PMID: 22136816 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/papillary-carcinoma-of-the-thyroid-balancing-principles-of-oncology-with-emerging-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular pathways associated with mortality in papillary thyroid cancer.</title>
		<link>http://jsurg.com/blog/molecular-pathways-associated-with-mortality-in-papillary-thyroid-cancer/</link>
		<comments>http://jsurg.com/blog/molecular-pathways-associated-with-mortality-in-papillary-thyroid-cancer/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:37 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Molecular pathways associated with mortality in papillary thyroid cancer.
        Surgery. 2011 Dec;150(6):1023-31
        Authors:  Nilubol N, Sukchotrat C, Zhang L, He M, Kebebew E
        Abstract
        BACKGROUND: A better understandin...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Molecular pathways associated with mortality in papillary thyroid cancer.</b></p>
<p>Surgery. 2011 Dec;150(6):1023-31</p>
<p>Authors:  Nilubol N, Sukchotrat C, Zhang L, He M, Kebebew E</p>
<p>Abstract<br/><br />
        BACKGROUND: A better understanding of the molecular mechanisms involved in papillary thyroid cancer (PTC)-associated adverse outcome is needed to manage these patients effectively. Our objectives were to identify molecular pathways associated with unfavorable features and outcomes in patients with PTC.<br/><br />
        METHODS: We performed genome-wide expression (GWE) analysis in 64 human tissue samples affected by PTC. Clinical, pathologic, and microarray data were analyzed to identify differentially expressed genes and pathways associated with unfavorable outcomes. Gene set enrichment analysis (GSEA) was used to determine which molecular pathways are associated with mortality.<br/><br />
        RESULTS: GWE analysis identified 43, 115, and 40 genes that were significantly differentially expressed by gender, tumor differentiation status, and mortality, respectively, with a false-discovery rate of &lt;5%. For mortality, GSEA revealed 7 enriched pathways, including transfer RNA synthesis, mitochondria and oxidative phosphorylation, porphyrin and chlorophyll metabolism, and fatty acid synthesis. Leading-edge analysis showed that 341 genes were significantly involved in the enriched pathways. Cluster analysis using 100 differentially expressed genes showed complete separation of patients by mortality.<br/><br />
        CONCLUSION: To our knowledge, this is the first GWE analysis of PTC and adverse outcomes. We found 11 molecular pathways that were significantly associated with mortality resulting from PTC. A 100-gene signature completely separates patients with and without PTC-associated mortality.<br/>
        </p>
<p>PMID: 22136817 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/molecular-pathways-associated-with-mortality-in-papillary-thyroid-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.</title>
		<link>http://jsurg.com/blog/necroptosis-is-a-novel-mechanism-of-radiation-induced-cell-death-in-anaplastic-thyroid-and-adrenocortical-cancers/</link>
		<comments>http://jsurg.com/blog/necroptosis-is-a-novel-mechanism-of-radiation-induced-cell-death-in-anaplastic-thyroid-and-adrenocortical-cancers/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:36 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.
        Surgery. 2011 Dec;150(6):1032-9
        Authors:  Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.</b></p>
<p>Surgery. 2011 Dec;150(6):1032-9</p>
<p>Authors:  Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD, Ruan DT</p>
<p>Abstract<br/><br />
        BACKGROUND: Necroptosis is a recently described mechanism of programmed cellular death. We hypothesize that necroptosis plays an important role in radiation-induced cell death in endocrine cancers.<br/><br />
        METHODS: Thyroid and adrenocortical carcinoma cell lines were exposed to increasing doses of radiation in the presence of necroptosis inhibitor Nec-1 and/or apoptosis-inhibitor zVAD. H295R cells deficient in receptor interacting protein 1 (RIP1), an essential kinase for necroptosis, were used as controls. Survival curves were generated at increasing doses of radiation.<br/><br />
        RESULTS: Nec-1 and zVAD increased cellular survival with increasing doses of radiotherapy in 8505c, TPC-1, and SW13. Both inhibitors used together had an additive effect. At 6 Gy, 8505c, TPC-1, and SW13 cell survival was significantly increased compared to controls by 40%, 33%, and 31% with Nec-1 treatment, by 53%, 47%, and 44% with zVAD treatment, and by 80%, 70%, and 65% with both compounds, respectively (P &lt; .05). H295R showed no change in survival with Nec-1 treatment. The radiobiologic parameter quasithreshold dose was significantly increased in 8505c, TPC-1, and SW13 cells when both Nec-1 and zVAD were used in combination to inhibit necroptosis and apoptosis together, revealing resistance to standard doses of fractionated therapeutic radiation.<br/><br />
        CONCLUSION: Necroptosis contributes to radiation-induced cell death. Future studies should investigate ways to promote the activation of necroptosis to improve radiosensitivity.<br/>
        </p>
<p>PMID: 22136818 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/necroptosis-is-a-novel-mechanism-of-radiation-induced-cell-death-in-anaplastic-thyroid-and-adrenocortical-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter.</title>
		<link>http://jsurg.com/blog/novel-therapy-for-anaplastic-thyroid-carcinoma-cells-using-an-oncolytic-vaccinia-virus-carrying-the-human-sodium-iodide-symporter/</link>
		<comments>http://jsurg.com/blog/novel-therapy-for-anaplastic-thyroid-carcinoma-cells-using-an-oncolytic-vaccinia-virus-carrying-the-human-sodium-iodide-symporter/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:35 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter.
        Surgery. 2011 Dec;150(6):1040-7
        Authors:  Gholami S, Haddad D, Chen CH, Chen NG, Zhang Q, Zanz...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter.</b></p>
<p>Surgery. 2011 Dec;150(6):1040-7</p>
<p>Authors:  Gholami S, Haddad D, Chen CH, Chen NG, Zhang Q, Zanzonico PB, Szalay AA, Fong Y</p>
<p>Abstract<br/><br />
        BACKGROUND: Anaplastic thyroid carcinoma (ATC) is fatal with resistance to radiotherapy because of the loss of intrinsic human sodium iodine symporter (hNIS). We determined whether vaccinia virus carrying hNIS kills and induces hNIS reexpression in ATC cells, facilitating deep-tissue imaging.<br/><br />
        METHODS: Vaccinia virus (GLV-1h153) carrying hNIS was tested against ATC lines for killing and replication via cytotoxicity and viral plaque assays. Cellular radiouptake was determined using radiouptake assays. GLV-1h153-infected ATC xenografts were imaged via (99m)Tc-pertechnetate.<br/><br />
        RESULTS: GLV-1h153 infected, replicated in, and killed all ATC cell lines. GFP expression confirmed viral infection by 24 hours. At a multiplicity of infection (MOI) of 1.0, GLV-1h153 reached near 100% cytotoxicity in 8305c and FRO by day 5 and 70% in the least sensitive cell line, 8505c. GLV-1h153-infected ATC cells had a 14-fold increase of hNIS-specific radiouptake compared with uninfected control 24 hours after infection at an MOI of 1.0. In vivo, GLV-1h153 facilitated imaging of hNIS expression in 8505c tumors using (99m)Tc-pertechnetate.<br/><br />
        CONCLUSION: GLV-1h153 is an effective oncolytic agent against ATC. The results show hNIS-specific radiouptake in infected ATC cells, facilitating deep-tissue imaging. GLV-1h153 is a promising candidate for treatment and imaging, and potentially enhancing susceptibility to radioiodine therapy by converting non-hNIS-expressing cells into hNIS-expressing ATC cells.<br/>
        </p>
<p>PMID: 22136819 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/novel-therapy-for-anaplastic-thyroid-carcinoma-cells-using-an-oncolytic-vaccinia-virus-carrying-the-human-sodium-iodide-symporter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.</title>
		<link>http://jsurg.com/blog/a-multicenter-cohort-study-of-total-thyroidectomy-and-routine-central-lymph-node-dissection-for-cn0-papillary-thyroid-cancer/</link>
		<comments>http://jsurg.com/blog/a-multicenter-cohort-study-of-total-thyroidectomy-and-routine-central-lymph-node-dissection-for-cn0-papillary-thyroid-cancer/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:34 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.
        Surgery. 2011 Dec;150(6):1048-57
        Authors:  Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.</b></p>
<p>Surgery. 2011 Dec;150(6):1048-57</p>
<p>Authors:  Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel M, Arora A, Tolley NS, Palazzo F, Learoyd DL, Sidhu S, Delbridge L, Sywak M, Yeh MW</p>
<p>Abstract<br/><br />
        BACKGROUND: The role of routine central lymph node dissection (CLND) for papillary thyroid cancer (PTC) remains controversial. The aim of this study was to evaluate the impact of routine CLND after total thyroidectomy (TTx) in the management of patients with PTC who were clinically node negative at presentation with emphasis on stimulated thyroglobulin (Tg) levels and reoperation rates.<br/><br />
        METHODS: This retrospective, multicenter, cohort study used pooled data from 3 international Endocrine Surgery units in Australia, the United States, and England. All study participants had PTC &gt;1 cm without preoperative evidence of lymph node disease (cN0). Group A patients had TTx alone and group B had TTx with the addition of CLND.<br/><br />
        RESULTS: There were 606 patients included in the study. Group A had 347 patients and group B 259 patients. Stimulated Tg values were lower in group B before initial radioiodine ablation (15.0 vs 6.6 ng/mL; P = .025). There was a trend toward a lower Tg at final follow-up in group B (1.9 vs 7.2 ng/mL; P = .11). The rate of reoperation in the central compartment was lower in group B (1.5 vs 6.1%; P = .004). The number of CLND procedures required to prevent 1 central compartment reoperation was calculated at 20.<br/><br />
        CONCLUSION: The addition of routine CLND in cN0 papillary thyroid carcinoma is associated with lower postoperative Tg levels and reduces the need for reoperation in the central compartment.<br/>
        </p>
<p>PMID: 22136820 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/a-multicenter-cohort-study-of-total-thyroidectomy-and-routine-central-lymph-node-dissection-for-cn0-papillary-thyroid-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prophylactic central compartment neck dissection for papillary thyroid cancer: The search for justification continues.</title>
		<link>http://jsurg.com/blog/prophylactic-central-compartment-neck-dissection-for-papillary-thyroid-cancer-the-search-for-justification-continues/</link>
		<comments>http://jsurg.com/blog/prophylactic-central-compartment-neck-dissection-for-papillary-thyroid-cancer-the-search-for-justification-continues/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:33 +0000</pubDate>
		<dc:creator>McHenry CR</dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Prophylactic central compartment neck dissection for papillary thyroid cancer: The search for justification continues.
        Surgery. 2011 Dec;150(6):1058-60
        Authors:  McHenry CR
        PMID: 22136821 [PubMed - in process]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Prophylactic central compartment neck dissection for papillary thyroid cancer: The search for justification continues.</b></p>
<p>Surgery. 2011 Dec;150(6):1058-60</p>
<p>Authors:  McHenry CR</p>
<p>PMID: 22136821 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/prophylactic-central-compartment-neck-dissection-for-papillary-thyroid-cancer-the-search-for-justification-continues/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism.</title>
		<link>http://jsurg.com/blog/the-effect-of-vitamin-d-levels-on-postoperative-calcium-requirements-symptomatic-hypocalcemia-and-parathormone-levels-following-parathyroidectomy-for-primary-hyperparathyroidism/</link>
		<comments>http://jsurg.com/blog/the-effect-of-vitamin-d-levels-on-postoperative-calcium-requirements-symptomatic-hypocalcemia-and-parathormone-levels-following-parathyroidectomy-for-primary-hyperparathyroidism/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:32 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism.
        Surgery. 2011 Dec;150(6):1061-8
        Authors:  Pr...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism.</b></p>
<p>Surgery. 2011 Dec;150(6):1061-8</p>
<p>Authors:  Press D, Politz D, Lopez J, Norman J</p>
<p>Abstract<br/><br />
        BACKGROUND: Low vitamin D-25 is common in primary hyperparathyroidism but the effect of this deficiency on postparathyroidectomy calcium requirements is unclear.<br/><br />
        METHODS: A prospective study was conducted on 4 groups based on preoperative vitamin D-25 levels: very low (&lt;20 ng/mL, n = 500); low (21 to 30 ng/mL, n = 500); normal (&gt;30 ng/mL, n = 500); and supplemented (&lt;25 ng/mL supplemented to &gt;40 ng/mL, n = 285). Patients were placed on identical postoperative oral calcium regimens, and hypocalcemia symptoms were recorded. Total calcium requirements for 2 weeks postoperation were calculated and parathormone (PTH) levels were measured for 2-6 months.<br/><br />
        RESULTS: Mean vitamin D levels (ng/mL) for each group were: very low (14.2); low (24.4); normal (38.3); and supplemented (16.5 supplemented to 54.3). Postoperative oral calcium requirements (in grams) were identical for all groups (18.7, 18.2, and 18.6, and 19.0, respectively, all P = NS); the incidence and timing of hypocalcemia symptoms were nearly identical for all groups: 8.1%, 7.9%, and 7.8% (P = .8). Elevated postsurgical PTH was identical (below 8%) and was not influenced by vitamin D levels.<br/><br />
        CONCLUSION: The incidence of hypocalcemic symptoms and the postoperative calcium requirements are identical for patients with very low, low, normal, or supplemented (high) vitamin D. The incidence of persistently elevated PTH postoperatively is also unrelated to preoperative vitamin D levels. Vitamin D supplementation from very low to high levels has no clinical benefit.<br/>
        </p>
<p>PMID: 22136822 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-effect-of-vitamin-d-levels-on-postoperative-calcium-requirements-symptomatic-hypocalcemia-and-parathormone-levels-following-parathyroidectomy-for-primary-hyperparathyroidism/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transient increases in intraoperative parathyroid levels related to anesthetic technique.</title>
		<link>http://jsurg.com/blog/transient-increases-in-intraoperative-parathyroid-levels-related-to-anesthetic-technique/</link>
		<comments>http://jsurg.com/blog/transient-increases-in-intraoperative-parathyroid-levels-related-to-anesthetic-technique/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:30 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Transient increases in intraoperative parathyroid levels related to anesthetic technique.
        Surgery. 2011 Dec;150(6):1069-75
        Authors:  Hong JC, Morris LF, Park EJ, Ituarte PH, Lee CH, Yeh MW
        Abstract
        BACKGROUND:...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Transient increases in intraoperative parathyroid levels related to anesthetic technique.</b></p>
<p>Surgery. 2011 Dec;150(6):1069-75</p>
<p>Authors:  Hong JC, Morris LF, Park EJ, Ituarte PH, Lee CH, Yeh MW</p>
<p>Abstract<br/><br />
        BACKGROUND: Parathyroid hormone (PTH) secretion is partially regulated by circulating catecholamines. We examined the effect of different anesthetic techniques on intraoperative PTH (IOPTH) levels in patients undergoing parathyroidectomy for primary hyperparathyroidism.<br/><br />
        METHODS: We prospectively studied 132 patients divided into 3 anesthetic cohorts: monitored anesthetic care (MAC; n = 45), general anesthesia with laryngeal mask airway (LMA; n = 43), or general endotracheal anesthesia (GETA; n = 39). IOPTH levels were drawn before induction and at defined intervals postinduction.<br/><br />
        RESULTS: All anesthetic techniques increased IOPTH levels from preinduction to 3 minutes postinduction (MAC, 28%; LMA, 45%; GETA, 65%; P &lt; .001). Temporal trends in postinduction IOPTH levels were similar in patients receiving general anesthesia, characterized by a peak effect at 6 minutes. Using a multivariate logistic regression analysis, GETA was &gt;7 times more likely to increase the preinduction IOPTH by ≥50% at 3 minutes postinduction compared with MAC (P &lt; .0001). Using immediate postinduction IOPTH levels in surgical decision making would have led to failed surgery in 2 of 6 patients with multiple gland disease receiving GETA.<br/><br />
        CONCLUSION: Preincision IOPTH samples should be drawn before induction to avoid incorporation of potentially misleading anesthetic-related IOPTH elevations into surgical decision making.<br/>
        </p>
<p>PMID: 22136823 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/transient-increases-in-intraoperative-parathyroid-levels-related-to-anesthetic-technique/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Normocalcemic parathormone elevation after successful parathyroidectomy: Long-term analysis of parathormone variations over 10 years.</title>
		<link>http://jsurg.com/blog/normocalcemic-parathormone-elevation-after-successful-parathyroidectomy-long-term-analysis-of-parathormone-variations-over-10-years/</link>
		<comments>http://jsurg.com/blog/normocalcemic-parathormone-elevation-after-successful-parathyroidectomy-long-term-analysis-of-parathormone-variations-over-10-years/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:29 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Normocalcemic parathormone elevation after successful parathyroidectomy: Long-term analysis of parathormone variations over 10 years.
        Surgery. 2011 Dec;150(6):1076-84
        Authors:  Goldfarb M, Gondek S, Irvin GL, Lew JI
        A...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Normocalcemic parathormone elevation after successful parathyroidectomy: Long-term analysis of parathormone variations over 10 years.</b></p>
<p>Surgery. 2011 Dec;150(6):1076-84</p>
<p>Authors:  Goldfarb M, Gondek S, Irvin GL, Lew JI</p>
<p>Abstract<br/><br />
        BACKGROUND: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear.<br/><br />
        METHOD: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed.<br/><br />
        RESULTS: Of 96 patients followed ≥10 years, 42 had postoperative NPE. Only male gender (P = .008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred.<br/><br />
        CONCLUSION: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.<br/>
        </p>
<p>PMID: 22136824 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/normocalcemic-parathormone-elevation-after-successful-parathyroidectomy-long-term-analysis-of-parathormone-variations-over-10-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.</title>
		<link>http://jsurg.com/blog/risk-stratification-of-indeterminate-thyroid-fine-needle-aspiration-biopsy-specimens-based-on-mutation-analysis/</link>
		<comments>http://jsurg.com/blog/risk-stratification-of-indeterminate-thyroid-fine-needle-aspiration-biopsy-specimens-based-on-mutation-analysis/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:28 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.
        Surgery. 2011 Dec;150(6):1085-91
        Authors:  Filicori F, Keutgen XM, Buitrago D, Aldailami H, Crowley M, Fahey TJ,...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.</b></p>
<p>Surgery. 2011 Dec;150(6):1085-91</p>
<p>Authors:  Filicori F, Keutgen XM, Buitrago D, Aldailami H, Crowley M, Fahey TJ, Zarnegar R</p>
<p>Abstract<br/><br />
        BACKGROUND: Mutation analysis is potentially a powerful tool to enhance the diagnostic accuracy of thyroid fine-needle aspiration (FNA) biopsy specimens. However, some clinicians may rely on a negative mutation panel to exclude malignancy. We aimed to determine the malignancy rate in indeterminate lesions with negative mutation analysis.<br/><br />
        METHODS: A literature review established a mutation analysis model using the prevalence of BRAF, RET, RAS, and PAX8/peroxisome proliferator-activated receptor-γ mutations in indeterminate lesions. This model was applied retrospectively to a study cohort of 466 consecutive indeterminate lesions that underwent hemi- or total thyroidectomy for definitive diagnosis, to evaluate its accuracy for identifying malignancy.<br/><br />
        RESULTS: Of 466 indeterminate lesions in the study, 30% (139) were malignant. These included 66 cases of papillary thyroid cancer, 45 cases of follicular variant of papillary thyroid cancer, 18 cases of follicular thyroid cancer, and 10 others. The risk of malignancy was 42% when cytologic atypia was present vs 17% without. The mutation analysis model would correctly identify only 48 of 139 (34%) of malignant indeterminate lesions. Therefore, when mutation analysis is negative, the overall risk of malignancy would be 23%. When atypia is present, the risk of malignancy would be 31% vs 13% in lesions without.<br/><br />
        CONCLUSION: Indeterminate lesions with a negative mutation analysis still carry a significant risk of malignancy, especially in the presence of atypia, requiring surgery for definitive diagnosis.<br/>
        </p>
<p>PMID: 22136825 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/risk-stratification-of-indeterminate-thyroid-fine-needle-aspiration-biopsy-specimens-based-on-mutation-analysis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Good question.</title>
		<link>http://jsurg.com/blog/good-question/</link>
		<comments>http://jsurg.com/blog/good-question/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:27 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Good question.
        Surgery. 2011 Dec;150(6):1092-4
        Authors:  Carty SE, Zeiger MA
        PMID: 22136826 [PubMed - in process]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Good question.</b></p>
<p>Surgery. 2011 Dec;150(6):1092-4</p>
<p>Authors:  Carty SE, Zeiger MA</p>
<p>PMID: 22136826 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/good-question/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.</title>
		<link>http://jsurg.com/blog/elevated-parathyroid-hormone-predicts-mortality-in-dialysis-patients-undergoing-valve-surgery/</link>
		<comments>http://jsurg.com/blog/elevated-parathyroid-hormone-predicts-mortality-in-dialysis-patients-undergoing-valve-surgery/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:25 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
        Surgery. 2011 Dec;150(6):1095-101
        Authors:  Yan H, Sharma J, Weber CJ, Guyton RA, Perez S, Thourani VH
        Abstract
        BA...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.</b></p>
<p>Surgery. 2011 Dec;150(6):1095-101</p>
<p>Authors:  Yan H, Sharma J, Weber CJ, Guyton RA, Perez S, Thourani VH</p>
<p>Abstract<br/><br />
        BACKGROUND: Dialysis patients requiring valve surgery have high morbidity and mortality rates. Although elevated serum parathyroid hormone (PTH) levels are associated with increased mortality in dialysis patients, this correlation has not been investigated in patients undergoing cardiac valve operations. This study assesses the impact of PTH levels on mortality in dialysis patients undergoing valve operations.<br/><br />
        METHODS: A retrospective analysis of 109 dialysis patients undergoing valve operation with preoperative PTH levels between 1996 and 2007 at a US academic center was performed. Cox regression analyses were done using PTH as a binary variable. The patients were followed from the date of the operative procedure until death or loss to follow-up.<br/><br />
        RESULTS: Higher mortality risk was seen once preoperative PTH exceeded 200 pg/mL (hazard ratio [HR], 3.43; P = .003). Mean survival was improved in the PTH &lt; 200 pg/mL group when compared with the PTH ≥ 200 pg/mL group (86.7 vs 40.3 months, respectively). Other independent predictors of mortality included serum phosphate (HR, 1.20; P = .017), calcium-phosphate product (HR, 1.02; P = .038), and history of myocardial infarction (HR, 2.12; P = .015).<br/><br />
        CONCLUSION: Preoperative PTH level ≥ 200 pg/mL is predictive of increased mortality after valve surgery among dialysis patients. Hyperparathyroidism should be investigated further as a possible modifiable risk factor for postoperative mortality in this high-risk patient cohort.<br/>
        </p>
<p>PMID: 22136827 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/elevated-parathyroid-hormone-predicts-mortality-in-dialysis-patients-undergoing-valve-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: How low can parathyroid hormone go?</title>
		<link>http://jsurg.com/blog/the-phenotype-of-primary-hyperparathyroidism-with-normal-parathyroid-hormone-levels-how-low-can-parathyroid-hormone-go/</link>
		<comments>http://jsurg.com/blog/the-phenotype-of-primary-hyperparathyroidism-with-normal-parathyroid-hormone-levels-how-low-can-parathyroid-hormone-go/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:24 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: How low can parathyroid hormone go?
        Surgery. 2011 Dec;150(6):1102-12
        Authors:  Wallace LB, Parikh RT, Ross LV, Mazzaglia PJ, Foley C, Shin J...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: How low can parathyroid hormone go?</b></p>
<p>Surgery. 2011 Dec;150(6):1102-12</p>
<p>Authors:  Wallace LB, Parikh RT, Ross LV, Mazzaglia PJ, Foley C, Shin JJ, Mitchell JC, Berber E, Siperstein AE, Milas M</p>
<p>Abstract<br/><br />
        BACKGROUND: While normocalcemic hyperparathyroidism is well recognized in primary hyperparathyroidism (PHP), less is known about patients with high calcium but normal intact parathyroid hormone (iPTH). We aimed to describe this entity and designated it normohormonal primary hyperparathyroidism (NHPHP).<br/><br />
        METHODS: From a prospectively maintained database of patients undergoing bilateral parathyroid exploration for PHP, we identified and compared those with preoperative iPTH levels below (NHPHP) and above (typical PHP) normal reference peak (60 pg/mL).<br/><br />
        RESULTS: NHPHP occurred in 46 of 843 patients (5.5%) undergoing initial parathyroidectomy for PHP. All had hypercalcemia (11.1 mg/dL). Regarding preoperative iPTH, 7 patients (15%) had values &lt;40 pg/mL, 19 (41%) had values &lt;60 pg/mL; and 20 (44%) had intermittent values &gt;60 pg/mL. Unlike patients with elevated iPTH, nearly all NHPHP patients had additional testing delaying the operation. Imaging correctly localized NHPHP parathyroid disease in 80%. At the time of operation, 74% of NHPHP patients had single adenomas. Intraoperatively postmobilization, using the same assay that was used preoperatively, 82% had PTH levels &gt;60 pg/mL (mean, 279 pg/mL). During the follow-up period, iPTH levels remained lower among NHPHP patients (21 pg/mL) compared to 41 pg/mL for patients with preoperative iPTH 60 to 100 pg/mL and 56 pg/mL for patients with preoperative iPTH 100 to 200 pg/mL (P &lt; .0001).<br/><br />
        CONCLUSION: Lower PTH set points may exist in some patients with otherwise typical PHP features. Although high normal iPTH is inappropriate for hypercalcemia and should suggest PHP, this disorder may occur with iPTH levels as low as 5 pg/mL. Awareness of the unusual phenotype of NHPHP may facilitate earlier diagnosis and surgery.<br/>
        </p>
<p>PMID: 22136828 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-phenotype-of-primary-hyperparathyroidism-with-normal-parathyroid-hormone-levels-how-low-can-parathyroid-hormone-go/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Population-level predictors of persistent hyperparathyroidism.</title>
		<link>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism-2/</link>
		<comments>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism-2/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:23 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Population-level predictors of persistent hyperparathyroidism.
        Surgery. 2011 Dec;150(6):1113-9
        Authors:  Yeh MW, Wiseman JE, Chu SD, Ituarte PH, Amy Liu IL, Young KL, Kang SJ, Harari A, Haigh PI
        Abstract
        BACKG...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Population-level predictors of persistent hyperparathyroidism.</b></p>
<p>Surgery. 2011 Dec;150(6):1113-9</p>
<p>Authors:  Yeh MW, Wiseman JE, Chu SD, Ituarte PH, Amy Liu IL, Young KL, Kang SJ, Harari A, Haigh PI</p>
<p>Abstract<br/><br />
        BACKGROUND: Systematic study of outcomes of initial surgery for primary hyperparathyroidism (PHPT) has been limited by selection and self-reporting biases. To avoid these biases, we evaluated parathyroidectomy (PTx) outcomes within an integrated health care system encompassing 3.25 million enrollees.<br/><br />
        METHODS: All patients undergoing PTx for PHPT from 1995 to 2010 were studied. Persistent and recurrent disease were defined by a serum calcium level &gt;10.5 mg/dL before or after 6 months postoperatively, respectively. The effect of demographic, clinical, and hospital volume-related variables was assessed by the use of multivariate logistic regression.<br/><br />
        RESULTS: A total of 1,190 initial operations for PHPT were performed at 14 hospitals. Follow-up calcium levels were available in 97% of subjects. The overall success rate was 92%, and 5% of patients developed recurrent disease. Age ≥70 years was predictive of persistent disease (odds ratio 1.80, P &lt; .05). High-volume hospital (&gt;100 cases) predicted against persistent disease (odds ratio 0.42, P &lt; .05) and carried 96% success rate. Negative or equivocal sestamibi scan was associated with a lower success rate (success rate 89% vs 95% for positive scan, P &lt; .05). Reoperation was performed in 12% of patients with persistent or recurrent PHPT.<br/><br />
        CONCLUSION: The success rate of PTx is influenced by patient age, hospital volume, and sestamibi scan result. Surgical outcomes may be optimized by designating high-volume centers in the community setting.<br/>
        </p>
<p>PMID: 22136829 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Population-level predictors of persistent hyperparathyroidism.</title>
		<link>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism/</link>
		<comments>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:22 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Population-level predictors of persistent hyperparathyroidism.
        Surgery. 2011 Dec;150(6):1120-1
        Authors:  Perrier ND, Evans DB
        PMID: 22136830 [PubMed - in process]
    ]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Population-level predictors of persistent hyperparathyroidism.</b></p>
<p>Surgery. 2011 Dec;150(6):1120-1</p>
<p>Authors:  Perrier ND, Evans DB</p>
<p>PMID: 22136830 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/population-level-predictors-of-persistent-hyperparathyroidism/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparison of 6-(18)F-Fluoro-l-DOPA, (18)F-2-deoxy-d-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.</title>
		<link>http://jsurg.com/blog/comparison-of-6-18f-fluoro-l-dopa-18f-2-deoxy-d-glucose-ct-and-mri-in-patients-with-pancreatic-neuroendocrine-neoplasms-with-von-hippel-lindau-disease/</link>
		<comments>http://jsurg.com/blog/comparison-of-6-18f-fluoro-l-dopa-18f-2-deoxy-d-glucose-ct-and-mri-in-patients-with-pancreatic-neuroendocrine-neoplasms-with-von-hippel-lindau-disease/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:19 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Comparison of 6-(18)F-Fluoro-l-DOPA, (18)F-2-deoxy-d-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
        Surgery. 2011 Dec;150(6):1122-8
        Authors:  Kitano M, Millo C, Rahba...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Comparison of 6-(18)F-Fluoro-l-DOPA, (18)F-2-deoxy-d-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.</b></p>
<p>Surgery. 2011 Dec;150(6):1122-8</p>
<p>Authors:  Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E</p>
<p>Abstract<br/><br />
        INTRODUCTION: There are limited data on the utility of 6-(18)F-fluoro-l-3,4-dihydroxyphenylalanine ((18)F-DOPA) and (18)F-2-deoxy-d-glucose ((18)F-FDG) in the workup of patients with pancreatic neuroendocrine tumors (PNETs). The aim of our study was to determine the accuracy of (18)F-DOPA and (18)F-FDG to detect PNETs in patients with von Hippel-Lindau disease (vHL).<br/><br />
        METHODS: We studied prospectively 69 patients with a diagnosis of vHL and pancreatic lesion(s) using computed tomography (CT), magnetic resonance imaging (MRI), (18)F-FDG, and (18)F-DOPA. Clinical, genetic, and laboratory characteristics were analyzed to determine association with imaging study results.<br/><br />
        RESULTS: In sum, 40 patients underwent evaluation by all 4 modalities; 98 PNETs and 55 PNETs were identified on CT and MRI, respectively. Only 11 of the 98 lesions (11%) were positive on (18)F-DOPA and 45 of the 98 (46%) lesions were positive on (18)F-FDG. There were 13 (18)F-DOPA and 26 (18)F-FDG avid extrapancreatic lesions. One patient underwent resection of an (18)F-DOPA avid extrapancreatic lesion in the lung, with pathology demonstrating a NET. There was no association between (18)F-DOPA and (18)F-FDG avidity and tumor size, age, gender, vHL mutation, or serum chromogranin A level.<br/><br />
        CONCLUSION: (18)F-FDG and MRI may be adjuncts to CT in identifying PNETs and metastatic disease. (18)F-DOPA has limited value in identifying PNETs in patients with vHL, but may be useful for identifying extrapancreatic NET lesions.<br/>
        </p>
<p>PMID: 22136831 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/comparison-of-6-18f-fluoro-l-dopa-18f-2-deoxy-d-glucose-ct-and-mri-in-patients-with-pancreatic-neuroendocrine-neoplasms-with-von-hippel-lindau-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zollinger-Ellison syndrome associated with a history of alcohol abuse: Coincidence or consequence?</title>
		<link>http://jsurg.com/blog/zollinger-ellison-syndrome-associated-with-a-history-of-alcohol-abuse-coincidence-or-consequence/</link>
		<comments>http://jsurg.com/blog/zollinger-ellison-syndrome-associated-with-a-history-of-alcohol-abuse-coincidence-or-consequence/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:18 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Zollinger-Ellison syndrome associated with a history of alcohol abuse: Coincidence or consequence?
        Surgery. 2011 Dec;150(6):1129-35
        Authors:  Wilson SD, Doffek KM, Krzywda EA, Quebbeman EJ, Christians KK, Pappas SG
        Ab...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Zollinger-Ellison syndrome associated with a history of alcohol abuse: Coincidence or consequence?</b></p>
<p>Surgery. 2011 Dec;150(6):1129-35</p>
<p>Authors:  Wilson SD, Doffek KM, Krzywda EA, Quebbeman EJ, Christians KK, Pappas SG</p>
<p>Abstract<br/><br />
        BACKGROUND: This 47-year observational study suggests that sporadic Zollinger-Ellison (Z-E) syndrome, particularly duodenal wall gastrinomas (DWG), is associated with a history of alcohol abuse.<br/><br />
        METHODS: Thirty-nine consecutive Z-E patients were followed from 1962 through 2010. The drinking patterns of these patients were assessed and compared with 3,786 community controls.<br/><br />
        RESULTS: Thirty-five patients had extrapancreatic gastrinomas (34 DWG and/or paraduodenal lymph nodes, 1 antral gastrinoma). Total gastrectomy was done in 24; 9 underwent less extensive operations to remove DWG, and 2 patients had no operations. There were no deaths from tumor progression. Four patients presented with pancreatic gastrinoma (PG) and liver metastasis, all died from tumor progression. Alcohol abuse (&gt;50 g/d) was documented in 81% of patients with DWG and/or paraduodenal lymph nodes. The drinking patterns (drinks per day) of DWG patients were significantly different: DWG vs community control-abstainers, 3% vs 24%; 1-2 drinks, 16% vs 62%; 3-5 drinks, 29% vs 12%; and ≥6 drinks, 52% vs 2.5% (P &lt; .01).<br/><br />
        CONCLUSION: Alcohol abuse is strongly associated with and may be a risk factor for sporadic Z-E with extrapancreatic DWG. Liver metastases and tumor deaths were not observed in this subgroup, supporting the concept that DWG and PG are different tumor entities.<br/>
        </p>
<p>PMID: 22136832 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/zollinger-ellison-syndrome-associated-with-a-history-of-alcohol-abuse-coincidence-or-consequence/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.</title>
		<link>http://jsurg.com/blog/sstr5-p335l-monoclonal-antibody-differentiates-pancreatic-neuroendocrine-neuroplasms-with-different-sstr5-genotypes/</link>
		<comments>http://jsurg.com/blog/sstr5-p335l-monoclonal-antibody-differentiates-pancreatic-neuroendocrine-neuroplasms-with-different-sstr5-genotypes/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:16 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.
        Surgery. 2011 Dec;150(6):1136-42
        Authors:  Zhou G, Gingras MC, Liu SH, Sanchez R, Edwards D, Dawson D, Chris...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.</b></p>
<p>Surgery. 2011 Dec;150(6):1136-42</p>
<p>Authors:  Zhou G, Gingras MC, Liu SH, Sanchez R, Edwards D, Dawson D, Christensen K, Paganelli G, Gibbs R, Fisher W, Brunicardi FC</p>
<p>Abstract<br/><br />
        BACKGROUND: Somatostatin receptor type 5 (SSTR5) P335L is a hypofunctional, single nucleotide polymorphism of SSTR5 with implications in the diagnostics and therapy of pancreatic neuroendocrine neoplasms. The purpose of this study is to determine whether a SSTR5 P335L-specific monoclonal antibody could sufficiently differentiate pancreatic neuroendocrine neoplasms (PNENs) with different SSTR5 genotypes.<br/><br />
        METHODS: Cellular proliferation rate, SSTR5 mRNA level, and SSTR5 protein level were measured by performing MTS assay, a quantitative reverse transcription polymerase chain reaction study, Western blot analysis, and immunohistochemistry, respectively. SSTR5 genotype was determined with the TaqMan SNP Genotyping assay (Applied Biosystems, Foster City, CA).<br/><br />
        RESULTS: We found that the SSTR5 analogue RPL-1980 inhibited cellular proliferation of CAPAN-1 cells more than that of PANC-1 cells. Only PANC-1 (TT) cells, but not CAPAN-1 (CC) cells expressed SSTR5 P335L. In 29 white patients with PNENs, 38% had a TT genotype for SSTR5 P335L, 24% had a CC genotype for WT SSTR5, and 38% hada CT genotype for both SSTR5 P335L and WT SSTR5. Immunohistochemistry using SSTR5 P335L monoclonal antibody detected immunostaining signals only from the neuroendocrine specimens with TT and CT genotypes, but not those with CC genotypes.<br/><br />
        CONCLUSION: A SSTR5 P335L monoclonal antibody that specifically recognizes SSTR5 P335L but not WT SSTR5 could differentiate PNENs with different SSTR5 genotypes, thereby providing a potential tool for the clinical diagnosis of PNEN.<br/>
        </p>
<p>PMID: 22136833 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/sstr5-p335l-monoclonal-antibody-differentiates-pancreatic-neuroendocrine-neuroplasms-with-different-sstr5-genotypes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important.</title>
		<link>http://jsurg.com/blog/achieving-eugastrinemia-in-men1-patients-both-duodenal-inspection-and-formal-lymph-node-dissection-are-important/</link>
		<comments>http://jsurg.com/blog/achieving-eugastrinemia-in-men1-patients-both-duodenal-inspection-and-formal-lymph-node-dissection-are-important/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:14 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important.
        Surgery. 2011 Dec;150(6):1143-52
        Authors:  Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB,...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important.</b></p>
<p>Surgery. 2011 Dec;150(6):1143-52</p>
<p>Authors:  Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG</p>
<p>Abstract<br/><br />
        BACKGROUND: Controversy exists regarding the role and extent of operation for patients with multiple endocrine neoplasia type 1 (MEN1) and hypergastrinemia.<br/><br />
        METHODS: An institutional MEN1 database was reviewed to identify patients with evidence of hypergastrinemia. The relationship of extent of resection to achievement of eugastrinemia was evaluated.<br/><br />
        RESULTS: Operation was performed in 20 patients with MEN1 and hypergastrinemia with a median follow-up of 71 months. Duodenal gastrinomas were identified in 85% of patients who underwent duodenal evaluation. Nodal metastases were identified in 80%. Patients who underwent anatomic regional lymph node dissection (RLND) had a median of 16 nodes removed, vs 1 in patients who did not undergo a formal regional lymphadenectomy. Eugastrinemia was achieved in 12 patients (60%), and 8 (40%) had persistent hypergastrinemia. Compared with patients with persistent hypergastrinemia, patients rendered eugastrinemic more often underwent duodenal evaluation (11/12 vs 2/8; P = .01) and RLND (11/12 vs 3/8; P = .03); there was no relationship between pancreatic resection and achievement of eugastrinemia (P = .32).<br/><br />
        CONCLUSION: For patients with MEN1-associated hypergastrinemia selected for operative treatment, a strategy including duodenal evaluation and anatomic regional lymphadenectomy is associated with long-term eugastrinemia. In contrast, the extent of pancreatic resection should be dictated by the extent and distribution of pancreatic neuroendocrine neoplasms, rather than by the presence of hypergastrinemia.<br/>
        </p>
<p>PMID: 22136834 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/achieving-eugastrinemia-in-men1-patients-both-duodenal-inspection-and-formal-lymph-node-dissection-are-important/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Case series of targeted parathyroidectomy with surgeon-performed ultrasonography as the only preoperative imaging study.</title>
		<link>http://jsurg.com/blog/case-series-of-targeted-parathyroidectomy-with-surgeon-performed-ultrasonography-as-the-only-preoperative-imaging-study/</link>
		<comments>http://jsurg.com/blog/case-series-of-targeted-parathyroidectomy-with-surgeon-performed-ultrasonography-as-the-only-preoperative-imaging-study/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:12 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Case series of targeted parathyroidectomy with surgeon-performed ultrasonography as the only preoperative imaging study.
        Surgery. 2011 Dec;150(6):1153-60
        Authors:  Deutmeyer C, Weingarten M, Doyle M, Carneiro-Pla D
        Ab...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Case series of targeted parathyroidectomy with surgeon-performed ultrasonography as the only preoperative imaging study.</b></p>
<p>Surgery. 2011 Dec;150(6):1153-60</p>
<p>Authors:  Deutmeyer C, Weingarten M, Doyle M, Carneiro-Pla D</p>
<p>Abstract<br/><br />
        BACKGROUND: Targeted parathyroidectomy for treatment of sporadic primary hyperparathyroidism (SPHPT) has become the preferred approach in many centers. Therefore, preoperative localization studies are increasingly important. Although surgeon-performed ultrasonography (SUS) is equivalent to sestamibi scanning (MIBI), many surgeons still obtain either a MIBI or both studies before cervical exploration. The goal of this study was to demonstrate the feasibility of targeted parathyroidectomy guided by intraoperative PTH monitoring (IPM) based on SUS localization alone.<br/><br />
        METHODS: We studied 136 consecutive patients with SPHPT undergoing parathyroidectomy guided by IPM. Ninety-six (71%) patients had only SUS, whereas 40 (29%) also had a negative MIBI (total n = 136). Pre-, intra- and postoperative data were analyzed to evaluate SUS accuracy in localizing abnormal glands.<br/><br />
        RESULTS: SUS correctly identified ≥1 abnormal gland in 90% (123/136) of the patients. Sensitivity and overall accuracy of SUS was 87% and 88%, respectively. Operative success was 99% with multiglandular disease incidence of 10%. Unilateral neck exploration was possible in the majority of patients.<br/><br />
        CONCLUSION: Preoperative SUS is accurate in localizing hypersecreting glands; however, IPM remains paramount in determining the extent of neck dissection. The use of SUS as a single imaging method obviates the need for MIBI in most patients and decreases costs of parathyroidectomy guided by IPM.<br/>
        </p>
<p>PMID: 22136835 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/case-series-of-targeted-parathyroidectomy-with-surgeon-performed-ultrasonography-as-the-only-preoperative-imaging-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0.</title>
		<link>http://jsurg.com/blog/the-incidence-of-central-neck-micrometastatic-disease-in-patients-with-papillary-thyroid-cancer-staged-preoperatively-and-intraoperatively-as-n0/</link>
		<comments>http://jsurg.com/blog/the-incidence-of-central-neck-micrometastatic-disease-in-patients-with-papillary-thyroid-cancer-staged-preoperatively-and-intraoperatively-as-n0/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:10 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0.
        Surgery. 2011 Dec;150(6):1161-7
        Authors:  Teixeira G, Teixeira T, Gubert F, Chi...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0.</b></p>
<p>Surgery. 2011 Dec;150(6):1161-7</p>
<p>Authors:  Teixeira G, Teixeira T, Gubert F, Chikota H, Tufano R</p>
<p>Abstract<br/><br />
        BACKGROUND: In papillary thyroid cancer, the incidence of regional lymph node metastasis in the central compartment has been reported to be between 21% and 60%. This study sought to establish the rate of micrometastatic disease in the central neck in patients staged as N0 by preoperative and intraoperative assessment.<br/><br />
        METHODS: We studied 72 consecutive patients with diagnoses of papillary thyroid cancer without preoperative or intraoperative evidence of central neck metastases. They underwent total thyroidectomies and were given elective central compartment neck dissection (CCND) ispsilateral to the lobe harboring the tumor or bilaterally in cases of primary tumor located in the isthmus.<br/><br />
        RESULTS: Of the patients, 30 underwent right CCND, 30 underwent left CCND, and in 12 cases the dissection was bilateral. The incidence of lymph node micrometastasis was 25%. Male gender and histologic type showed association with lymph node micrometasis. Among these cases, 7% had temporary vocal cord palsy, and 8% had temporary hypoparathyroidism. No cases of definitive vocal cord palsy or definitive hypocalcemia were observed. After the procedure 8 patients were up-staged according to the American Joint Committee on Cancer staging system.<br/><br />
        CONCLUSION: Despite being a safe procedure, this relatively low rate of micrometastatic disease emphasizes the need for a careful weighing of the risks and benefits of elective CCND.<br/>
        </p>
<p>PMID: 22136836 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/the-incidence-of-central-neck-micrometastatic-disease-in-patients-with-papillary-thyroid-cancer-staged-preoperatively-and-intraoperatively-as-n0/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.</title>
		<link>http://jsurg.com/blog/preoperative-basal-calcitonin-and-tumor-stage-correlate-with-postoperative-calcitonin-normalization-in-patients-undergoing-initial-surgical-management-of-medullary-thyroid-carcinoma/</link>
		<comments>http://jsurg.com/blog/preoperative-basal-calcitonin-and-tumor-stage-correlate-with-postoperative-calcitonin-normalization-in-patients-undergoing-initial-surgical-management-of-medullary-thyroid-carcinoma/#comments</comments>
		<pubDate>Sun, 11 Dec 2011 19:09:08 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Surgery]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
	
        Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
        Surgery. 2011 Dec;150(6):1168-77
        Authors: ...]]></description>
			<content:encoded><![CDATA[<p></p><table border="0" width="100%">
<tr>
<td align="left"/></tr>
</table>
<p><b>Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.</b></p>
<p>Surgery. 2011 Dec;150(6):1168-77</p>
<p>Authors:  Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Moore FD, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC</p>
<p>Abstract<br/><br />
        BACKGROUND: The optimal initial operative management of medullary thyroid cancer (MTC) and the use of biomarkers to guide the extent of operation remain controversial. We hypothesized that preoperative serum levels of calcitonin and carcinoembryonic antigen (CEA) correlate with extent of disease and postoperative levels reflect the extent of operation performed.<br/><br />
        METHODS: We assessed retrospectively clinical and pathologic factors among patients with MTC undergoing at least total thyroidectomy; these factors were correlated with biomarkers using regression analyses.<br/><br />
        RESULTS: Data were obtained from 104 patients, 28% with hereditary MTC. Preoperative calcitonin correlated with tumor size (P &lt; .001) and postoperative serum calcitonin levels (P = .01) after multivariable adjustment for lymph node positivity, extent of operation, and hereditary MTC. No patient with a preoperative calcitonin level of &lt;53 pg/mL (n = 20) had lymph node metastases. TNM stage (P = .001) and preoperative calcitonin levels (P = .04), but not extent of operation, independently correlated with the failure to normalize postoperative calcitonin. Postoperative CEA correlated with positive margins (adjusted P = 04). Neither preoperative nor postoperative CEA was correlated with lymph node positivity or extent of surgery.<br/><br />
        CONCLUSION: Preoperative serum calcitonin and TMN stage, but not extent of operation, were independent predictors of postoperative normalization of serum calcitonin levels. Future studies should evaluate preoperative serum calcitonin levels as a determinate of the extent of initial operation.<br/>
        </p>
<p>PMID: 22136837 [PubMed - in process]</p>
]]></content:encoded>
			<wfw:commentRss>http://jsurg.com/blog/preoperative-basal-calcitonin-and-tumor-stage-correlate-with-postoperative-calcitonin-normalization-in-patients-undergoing-initial-surgical-management-of-medullary-thyroid-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

